<SEC-DOCUMENT>0001193125-25-027330.txt : 20250214
<SEC-HEADER>0001193125-25-027330.hdr.sgml : 20250214
<ACCEPTANCE-DATETIME>20250214163644
ACCESSION NUMBER:		0001193125-25-027330
CONFORMED SUBMISSION TYPE:	SUPPL
PUBLIC DOCUMENT COUNT:		3
FILED AS OF DATE:		20250214
DATE AS OF CHANGE:		20250214
EFFECTIVENESS DATE:		20250214

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			AURORA CANNABIS INC
		CENTRAL INDEX KEY:			0001683541
		STANDARD INDUSTRIAL CLASSIFICATION:	MEDICINAL CHEMICALS & BOTANICAL PRODUCTS [2833]
		ORGANIZATION NAME:           	03 Life Sciences
		IRS NUMBER:				000000000
		STATE OF INCORPORATION:			A1
		FISCAL YEAR END:			0331

	FILING VALUES:
		FORM TYPE:		SUPPL
		SEC ACT:		
		SEC FILE NUMBER:	333-284958
		FILM NUMBER:		25629936

	BUSINESS ADDRESS:	
		STREET 1:		2207 90B STREET SW
		CITY:			EDMONTON
		STATE:			A0
		ZIP:			T6X 1V8
		BUSINESS PHONE:		604-362-5207

	MAIL ADDRESS:	
		STREET 1:		409 GRANVILLE STREET
		STREET 2:		SUITE 1700
		CITY:			VANCOUVER
		STATE:			A1
		ZIP:			V6C 1T2
</SEC-HEADER>
<DOCUMENT>
<TYPE>SUPPL
<SEQUENCE>1
<FILENAME>d937513dsuppl.htm
<DESCRIPTION>SUPPL
<TEXT>
<HTML><HEAD>
<TITLE>SUPPL</TITLE>
</HEAD>
 <BODY BGCOLOR="WHITE" STYLE="line-height:Normal">
<h5 align="left" style="font-size:10pt;font-weight:bold"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="right"><B>Filed pursuant to General Instruction II.L of Form F-10; <BR>File No. 333-284958 </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>PROSPECTUS SUPPLEMENT </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>TO THE SHORT FORM BASE SHELF PROSPECTUS DATED FEBRUARY&nbsp;14, 2025 </B></P>
<P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="50%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="49%"></TD></TR>


<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"><U>New Issue</U></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top" ALIGN="right">February&nbsp;14, 2025</TD></TR>
</TABLE> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P> <P STYLE="font-size:0pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P> <P STYLE="margin-top:0pt;margin-bottom:0pt" ALIGN="center">


<IMG SRC="g937513g49a27.jpg" ALT="LOGO" STYLE="width:2.36421in;height:1.13478in;">
 </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:24pt; font-family:Times New Roman" ALIGN="center"><B>AURORA CANNABIS INC. </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:14pt; font-family:Times New Roman" ALIGN="center"><B>7,040,875 Common Shares </B></P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">This Prospectus
Supplement relates to: (i)&nbsp;up to 7,040,875 common shares (the &#147;<B>Warrant Shares</B>&#148;) of Aurora Cannabis Inc. (&#147;<B>we</B>&#148;, &#147;<B>our</B>&#148;, &#147;<B>Aurora</B>&#148; or the &#147;<B>Company</B>&#148;), issuable from
time to time upon the exercise of 70,408,750 common share purchase warrants (the &#147;<B>Warrants</B>&#148;) issued by the Company pursuant to the Unit Offering (defined below); and (ii)&nbsp;such indeterminate number of additional Warrant Shares
that may be issuable by reason of the anti-dilution provisions contained in the Warrant Indenture (as defined herein) (the &#147;<B>Offering</B>&#148;). See &#147;<I>Plan of Distribution</I>&#148;. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The Company filed a prospectus supplement (the &#147;<B>Previous Warrant Share Prospectus Supplement</B>&#148;) dated April&nbsp;27, 2023 to its base shelf
prospectus dated April&nbsp;27, 2023 (the &#147;<B>Previous Base Prospectus</B>&#148;) with the securities commission or similar regulatory authority in each of the provinces of Canada, except Qu&eacute;bec, and in connection therewith, filed a
prospectus supplement dated April&nbsp;27, 2023 to its registration statement on Form <FONT STYLE="white-space:nowrap">F-10</FONT> with the United States Securities and Exchange Commission (the &#147;<B>SEC</B>&#148;) relating to the Warrant Shares.
</P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The Company has filed with the securities commission or similar regulatory authority in each of the provinces of Canada, except Qu&eacute;bec, a notice
of withdrawal withdrawing the Previous Base Prospectus effective as of the date hereof. This Prospectus Supplement replaces the Previous Warrant Share Prospectus Supplement in order to maintain the registration of the offering of the Warrant Shares
under the United States Securities Act of 1933, as amended (the &#147;<B>U.S. Securities Act</B>&#148;), beyond the expiry date of the Previous Base Prospectus. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The Warrants were initially qualified for distribution by a prospectus supplement dated May&nbsp;27, 2022 to a base shelf prospectus dated March&nbsp;29, 2021
filed with the securities commission or similar regulatory authority in each of the provinces of Canada, except Qu&eacute;bec, and, in connection therewith, a prospectus supplement dated May&nbsp;27, 2022 to its registration statement on Form <FONT
STYLE="white-space:nowrap">F-10</FONT> with the SEC relating to the offering (the &#147;<B>Unit Offering</B>&#148;) by the Company to the public in Canada and the United States of units (&#147;<B>Units</B>&#148;), each Unit consisting of one common
share of the Company (a &#147;<B>Common Share</B>&#148;) and one Warrant. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Each Warrant entitles the holder thereof to purchase one tenth (1/10<SUP
STYLE="font-size:75%; vertical-align:top">th</SUP>) of a Warrant Share at an exercise price of U.S.$32.00 per whole Warrant Share (after giving effect to the Company&#146;s share consolidation on a 10 to 1 basis completed on February&nbsp;20, 2024)
at any time until 5:00 p.m. (Toronto time) on June&nbsp;1, 2025 (the &#147;<B>Expiry Date</B>&#148;), being the date that is 36 months from the closing of the Unit Offering, subject to adjustment in accordance with the terms of the Warrant
Indenture. The exercise price of the Warrants was determined by negotiation between the Company and a syndicate of underwriters for the Unit Offering (the &#147;<B>Underwriters</B>&#148;). </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">S-i </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left" style="font-size:10pt;font-weight:bold"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The Common Shares are listed on the Toronto Stock Exchange (the &#147;<B>TSX</B>&#148;) and on the Nasdaq
Capital Market (&#147;<B>Nasdaq</B>&#148;) under the symbol &#147;<B>ACB</B>&#148; and on the Frankfurt Stock Exchange (the &#147;<B>FSE</B>&#148;) under the symbol &#147;<B>21P</B>&#148;. The Warrants are listed on the TSX under the symbol
&#147;<B>ACB.WT.U</B>&#148;. The TSX has also approved the listing of the Warrant Shares issuable on exercise of the Warrants on the TSX. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">This Prospectus
Supplement is filed pursuant to (i)&nbsp;the Base Prospectus filed in all of the provinces of Canada except Qu&eacute;bec, and (ii)&nbsp;a base shelf prospectus filed as part of a registration statement on Form
<FONT STYLE="white-space:nowrap">F-10</FONT> under the U.S. Securities Act, which became effective on February&nbsp;14, 2025 upon filing with the SEC (the &#147;<B>Registration Statement</B>&#148;). </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">This Prospectus Supplement should be read in conjunction with, and may not be delivered or utilized without, the Base Prospectus. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">No Underwriter has been involved in the preparation of, or has performed any review of, this Prospectus Supplement or the accompanying Base Prospectus. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>An investment in the Warrant Shares involves significant risks. You should carefully read the &#147;<A HREF="#supprom937513_14">Risk&nbsp;Factors</A>&#148;
section of this Prospectus Supplement beginning on <FONT STYLE="white-space:nowrap">page&nbsp;S-14,</FONT> the &#147;Risk&nbsp;Factors&#148; section in the Base Prospectus beginning on page&nbsp;32 and in the documents incorporated by reference
herein and therein. </B></P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>You should rely only on the information contained in or incorporated by reference into this Prospectus Supplement. The Company
has not authorized anyone to provide you with different information. The Company is not making an offer of these securities in any jurisdiction where the offer is not permitted by law. You should not assume that the information contained in or
incorporated by reference in this Prospectus Supplement is accurate as of any date other than the date on the front of this Prospectus Supplement or the date of such documents incorporated by reference herein, as applicable. </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>This Offering is made by a Canadian issuer that is permitted, under a multijurisdictional disclosure system (the &#147;MJDS&#148;) adopted by the United
States and Canada, to prepare this Prospectus Supplement in accordance with Canadian disclosure requirements. Prospective investors should be aware that such requirements are different from those of the United States. Financial statements included
or incorporated by reference herein have been prepared in accordance with International Financial Reporting Standards (&#147;IFRS&#148;) as issued by the International Accounting Standards Board (&#147;IASB&#148;) and may not be comparable to
financial statements of United States companies. Our financial statements are audited in accordance with the standards of the Public Company Accounting Oversight Board (United States). </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Prospective investors should be aware that the exercise of the Warrants and acquisition of the Warrant Shares described herein may have tax consequences
both in the United States and in Canada. Such consequences for investors who are resident in, or citizens of, the United States may not be described fully herein. You should read the tax discussion in this Prospectus Supplement and the accompanying
Base Prospectus fully and consult with your own tax advisers. See &#147;Certain Canadian Federal Income Tax Considerations&#148;, &#147;Material U.S. Federal Income Tax Considerations&#148; and &#147;Risk Factors&#148;. </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>The enforcement by investors of civil liabilities under United States federal securities laws may be affected adversely by the fact that we are
incorporated under the laws of British Columbia, Canada, that the majority of our officers and directors are not residents of the United States, that some or all of the experts named in the Registration Statement are not residents of the United
States and that a substantial portion of the assets of these persons are located outside the United States. </B></P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>THESE SECURITIES HAVE NOT BEEN
APPROVED OR DISAPPROVED BY THE SEC OR ANY STATE OR CANADIAN SECURITIES COMMISSION NOR HAS ANY SUCH SECURITIES REGULATORY AUTHORITY PASSED UPON THE ACCURACY OR ADEQUACY OF THIS </B></P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">S-ii </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left" style="font-size:10pt;font-weight:bold"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>
PROSPECTUS SUPPLEMENT. ANY REPRESENTATION TO THE CONTRARY IS A CRIMINAL OFFENSE. </B></P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>All
references in this Prospectus Supplement and the Base Prospectus to &#147;dollars&#148; or &#147;C$&#148; are to Canadian dollars and all references to &#147;U.S.$&#148; are to United States dollars. </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Miguel Martin, the Chief Executive Officer and a director of the Company, and Simona King, the Chief Financial Officer of the Company, reside outside of
Canada. Each of Miguel Martin and Simona King has appointed the Company, at its head office located at 2207 90B St. SW, Edmonton, Alberta, Canada T6X 1V8 as their agent for service of process in Canada. Purchasers are advised that it may not be
possible for investors to enforce judgments obtained in Canada against any such person, even though they have each appointed an agent for service of process. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The corporate head office of the Company is located at 2207 90B St. SW, Edmonton, Alberta, Canada T6X 1V8. The registered office of the Company is located at
Suite 1700, 666 Burrard Street, Vancouver, British Columbia, V6C 2X8. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">S-iii </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left" style="font-size:10pt;font-weight:bold"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B><A NAME="toc"></A>TABLE OF CONTENTS </B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>PROSPECTUS SUPPLEMENT </B></P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="95%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD></TD>
<TD></TD>
<TD></TD></TR>


<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><A HREF="#supprom937513_1">IMPORTANT NOTICE</A></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="white-space:nowrap">S-1</FONT></TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><A HREF="#supprom937513_2">DOCUMENTS INCORPORATED BY REFERENCE</A></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="white-space:nowrap">S-1</FONT></TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><A HREF="#supprom937513_3">CAUTIONARY NOTE REGARDING FORWARD-LOOKING STATEMENTS</A></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="white-space:nowrap">S-3</FONT></TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><A HREF="#supprom937513_4">NOTE TO UNITED STATES READERS REGARDING DIFFERENCES BETWEEN UNITED STATES
 AND CANADIAN FINANCIAL REPORTING PRACTICES</A></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="white-space:nowrap">S-6</FONT></TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><A HREF="#supprom937513_5"><FONT STYLE="white-space:nowrap">NON-IFRS</FONT>
MEASURES</A></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="white-space:nowrap">S-6</FONT></TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><A HREF="#supprom937513_6">CURRENCY PRESENTATION AND EXCHANGE RATE INFORMATION</A></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="white-space:nowrap">S-7</FONT></TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><A HREF="#supprom937513_7">OUR BUSINESS</A></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="white-space:nowrap">S-7</FONT></TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><A HREF="#supprom937513_8">USE OF PROCEEDS</A></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="white-space:nowrap">S-7</FONT></TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><A HREF="#supprom937513_9">CONSOLIDATED CAPITALIZATION</A></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="white-space:nowrap">S-8</FONT></TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><A HREF="#supprom937513_10">PRIOR SALES</A></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="white-space:nowrap">S-9</FONT></TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><A HREF="#supprom937513_11">TRADING PRICE AND VOLUME</A></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="white-space:nowrap">S-10</FONT></TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><A HREF="#supprom937513_12">DESCRIPTION OF SECURITIES BEING DISTRIBUTED</A></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="white-space:nowrap">S-10</FONT></TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><A HREF="#supprom937513_13">PLAN OF DISTRIBUTION</A></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="white-space:nowrap">S-11</FONT></TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><A HREF="#supprom937513_14">RISK FACTORS</A></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="white-space:nowrap">S-14</FONT></TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><A HREF="#supprom937513_15">CERTAIN CANADIAN FEDERAL INCOME TAX CONSIDERATIONS</A></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="white-space:nowrap">S-16</FONT></TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><A HREF="#supprom937513_16">MATERIAL U.S. FEDERAL INCOME TAX CONSIDERATIONS</A></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="white-space:nowrap">S-20</FONT></TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><A HREF="#supprom937513_17">AGENT FOR SERVICE OF PROCESS</A></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="white-space:nowrap">S-26</FONT></TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><A HREF="#supprom937513_18">INTERESTS OF EXPERTS</A></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="white-space:nowrap">S-26</FONT></TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><A HREF="#supprom937513_19">LEGAL MATTERS</A></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="white-space:nowrap">S-26</FONT></TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><A HREF="#supprom937513_20">AUDITORS, TRANSFER AGENT AND REGISTRAR AND WARRANT
AGENT</A></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="white-space:nowrap">S-26</FONT></TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><A HREF="#supprom937513_21">ADDITIONAL INFORMATION</A></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="white-space:nowrap">S-27</FONT></TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><A HREF="#supprom937513_22">ENFORCEABILITY OF CIVIL LIABILITIES BY U.S. INVESTORS</A></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="white-space:nowrap">S-28</FONT></TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><A HREF="#supprom937513_23">DOCUMENTS FILED AS PART OF THE REGISTRATION STATEMENT</A></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="white-space:nowrap">S-28</FONT></TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
</TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">S-iv </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left" style="font-size:10pt;font-weight:bold"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>TABLE OF CONTENTS </B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>BASE SHELF PROSPECTUS </B></P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="97%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD></TD>
<TD></TD>
<TD></TD></TR>


<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><A HREF="#toc850789_1">GENERAL MATTERS</A></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">1</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><A HREF="#toc850789_2">ABOUT THIS PROSPECTUS</A></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">1</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><A HREF="#toc850789_3">DOCUMENTS INCORPORATED BY REFERENCE</A></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">1</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><A HREF="#toc850789_4">CAUTIONARY NOTE REGARDING FORWARD LOOKING STATEMENTS</A></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">3</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><A HREF="#toc850789_5">NOTE TO UNITED STATES READERS REGARDING DIFFERENCES BETWEEN UNITED STATES AND
 CANADIAN FINANCIAL REPORTING PRACTICES</A></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">6</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><A HREF="#toc850789_6"><FONT STYLE="white-space:nowrap">NON-IFRS</FONT> MEASURES</A></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">6</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><A HREF="#toc850789_7">CURRENCY PRESENTATION AND EXCHANGE RATE INFORMATION</A></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">7</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><A HREF="#toc850789_8">OUR BUSINESS</A></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">7</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><A HREF="#toc850789_9">THE SELLING SECURITYHOLDERS</A></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">8</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><A HREF="#toc850789_10">USE OF PROCEEDS</A></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">8</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><A HREF="#toc850789_11">EARNINGS COVERAGE RATIO</A></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">8</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><A HREF="#toc850789_12">CONSOLIDATED CAPITALIZATION</A></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">9</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><A HREF="#toc850789_13">TRADING PRICE AND VOLUME</A></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">9</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><A HREF="#toc850789_14">PRIOR SALES</A></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">10</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><A HREF="#toc850789_15">PLAN OF DISTRIBUTION</A></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">11</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><A HREF="#toc850789_16">DESCRIPTION OF SECURITIES</A></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">12</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><A HREF="#toc850789_17">RISK FACTORS</A></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">26</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><A HREF="#toc850789_18">CERTAIN INCOME TAX CONSIDERATIONS</A></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">29</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><A HREF="#toc850789_19">AGENT FOR SERVICE OF PROCESS</A></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">29</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><A HREF="#toc850789_20">INTERESTS OF EXPERTS</A></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">30</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><A HREF="#toc850789_21">LEGAL MATTERS</A></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">30</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><A HREF="#toc850789_22">AUDITORS, TRANSFER AGENT AND REGISTRAR</A></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">30</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><A HREF="#toc850789_23">ADDITIONAL INFORMATION</A></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">30</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><A HREF="#toc850789_24">DOCUMENTS FILED AS PART OF THE REGISTRATION STATEMENT</A></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">31</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><A HREF="#toc850789_25">ENFORCEABILITY OF CIVIL LIABILITIES BY U.S. INVESTORS</A></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">32</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
</TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">S-v </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left" style="font-size:10pt;font-weight:bold"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B><A NAME="supprom937513_1"></A>IMPORTANT NOTICE </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">This document is in two parts. The first part is this Prospectus Supplement, which describes the specific terms of the securities being offered and also adds
to and updates information contained in the Base Prospectus and the documents that are incorporated by reference into this Prospectus Supplement and the Base Prospectus. The second part is the Base Prospectus which provides more general information.
This Prospectus Supplement is deemed to be incorporated by reference into the Base Prospectus solely for the purposes of the Offering. Other documents are also incorporated or deemed to be incorporated by reference into this Prospectus Supplement
and into the Base Prospectus. See &#147;<I>Documents Incorporated by Reference</I>&#148;. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The Company filed the Base Prospectus with the securities
commissions in all Canadian provinces other than Qu&eacute;bec (the &#147;<B>Canadian Qualifying Jurisdictions</B>&#148;) in order to qualify the offering of the securities described in the Base Prospectus in accordance with National Instrument <FONT
STYLE="white-space:nowrap">44-102</FONT> Shelf Distributions. The Alberta Securities Commission issued a receipt dated February&nbsp;14, 2025 in respect of the final Base Prospectus as the principal regulatory authority under Multilateral Instrument
<FONT STYLE="white-space:nowrap">11-102</FONT> Passport System, and each of the other commissions in the Canadian Qualifying Jurisdictions is deemed to have issued a receipt under National Policy <FONT STYLE="white-space:nowrap">11-202</FONT>
Process for Prospectus Review in Multiple Jurisdictions. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The Base Prospectus also forms part of the Registration Statement that we filed with the SEC
under the U.S. Securities Act utilizing the MJDS. The Registration Statement became effective upon filing under the U.S. Securities Act on February&nbsp;14, 2025. The Registration Statement incorporates the Base Prospectus with certain modifications
and deletions permitted by Form <FONT STYLE="white-space:nowrap">F-10.</FONT> This Prospectus Supplement is being filed by the Company with the SEC in accordance with the instructions to Form <FONT STYLE="white-space:nowrap">F-10.</FONT> </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">You should rely only on the information contained in or incorporated by reference in this Prospectus Supplement and the Base Prospectus. If the description of
the Warrant Shares varies between this Prospectus Supplement and the Base Prospectus, you should rely on the information in this Prospectus Supplement. To the extent that any statement made in this Prospectus Supplement differs from those in the
Base Prospectus, the statements made in the Base Prospectus and the information incorporated by reference therein are deemed modified or superseded by the statements made in this Prospectus Supplement and the information incorporated by reference
herein. The Company has not authorized any other person to provide investors with additional or different information. If anyone provides you with any additional, different or inconsistent information, you should not rely on it. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">You should not assume that the information contained in or incorporated by reference in this Prospectus Supplement or the Base Prospectus is accurate as of
any date other than the date of the document in which such information appears. Our business, financial condition, results of operations and prospects may have changed since those dates. Information in this Prospectus Supplement updates and modifies
the information in the Base Prospectus and information incorporated by reference herein and therein. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The Company is not making any offer of the Warrant
Shares in any jurisdiction where the offer is not permitted by law. </P> <P STYLE="margin-top:24pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B><A NAME="supprom937513_2"></A>DOCUMENTS INCORPORATED BY REFERENCE
</B></P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The following documents (&#147;documents incorporated by reference&#148; or &#147;documents incorporated herein by reference&#148;) filed by the
Company with the securities regulatory authorities in the jurisdictions in Canada in which the Company is a reporting issuer and filed with, or furnished to, the SEC, are specifically incorporated by reference into, and form an integral part of,
this Prospectus Supplement: </P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">the annual information form of the Company for the year ended March&nbsp;31, 2024, dated and filed on SEDAR+ on
June&nbsp;20, 2024 (our &#147;<B>2024 AIF</B>&#148;); </P></TD></TR></TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">S-1 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left" style="font-size:10pt;font-weight:bold"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">

<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">the audited consolidated financial statements of the Company, and the notes thereto for the year ended
March&nbsp;31, 2024 and nine months ended March&nbsp;31, 2023, together with the reports of our independent registered public accounting firm thereon, filed on SEDAR+ on June&nbsp;20, 2024 (the &#147;<B>Annual Financial Statements</B>&#148;);
</P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">the management&#146;s discussion and analysis of financial condition and results of operations for the year ended
March&nbsp;31, 2024 and nine months ended March&nbsp;31, 2023, filed on SEDAR+ on June&nbsp;20, 2024 (our &#147;<B>2024 Annual MD&amp;A</B>&#148;); </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">the unaudited interim condensed consolidated financial statements of the Company, and the notes thereto for the
three and nine months ended December&nbsp;31, 2024 and 2023, filed on SEDAR+ on February&nbsp;5, 2025 (our &#147;<B>Interim Financial Statements</B>&#148;); </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">the management&#146;s discussion and analysis of financial condition and results of operations for the three and
nine months ended December&nbsp;31, 2024 and 2023, filed on SEDAR+ on February&nbsp;5, 2025 (our &#147;<B>Interim MD&amp;A</B>&#148;); </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">the management information circular of the Company dated June&nbsp;26, 2024, distributed in connection with the
Company&#146;s annual general and special meeting of shareholders held on August&nbsp;9, 2024, filed on SEDAR+ on July&nbsp;9, 2024; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">the material change report regarding the Company&#146;s commercial collaboration with Cogent International
Manufacturing Inc., dated and filed on SEDAR+ on August&nbsp;7, 2024; and </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">the material change report regarding the company&#146;s strategic supply agreement with SNDL Inc., dated and
filed on SEDAR+ on February 13, 2025. </P></TD></TR></TABLE> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Any document of the type referred to in section 11.1 of Form
<FONT STYLE="white-space:nowrap">44-101F1</FONT> of National Instrument <FONT STYLE="white-space:nowrap">44-101</FONT> &#150; <I>Short Form Prospectus Distributions</I> filed by us with the securities commissions or similar regulatory authorities in
the jurisdictions in Canada in which the Company is a reporting issuer after the date of this Prospectus Supplement and prior to the termination of the Offering shall be deemed to be incorporated by reference into this Prospectus Supplement. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">When new documents of the type referred to in the paragraph above are filed by the Company with the commissions or similar regulatory authorities in the
jurisdictions in Canada in which the Company is a reporting issuer during the currency of this Prospectus Supplement, such documents will be deemed to be incorporated by reference in this Prospectus Supplement and the previous documents of the type
referred to in the paragraph above will no longer be deemed to be incorporated by reference in this Prospectus Supplement. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">To the extent that any
document or information incorporated by reference into this Prospectus Supplement is included in any report on Form <FONT STYLE="white-space:nowrap">6-K,</FONT> Form <FONT STYLE="white-space:nowrap">40-F,</FONT> Form
<FONT STYLE="white-space:nowrap">20-F,</FONT> Form <FONT STYLE="white-space:nowrap">10-K,</FONT> Form <FONT STYLE="white-space:nowrap">10-Q</FONT> or Form <FONT STYLE="white-space:nowrap">8-K</FONT> (or any respective successor form) that is filed
with or furnished to the SEC after the date of this Prospectus Supplement, such document or information shall be deemed to be incorporated by reference as an exhibit to the Registration Statement of which this Prospectus Supplement forms a part. In
addition, the Company may incorporate by reference into this Prospectus Supplement, or the Registration Statement, other information from documents that the Company files with or furnishes to the SEC pursuant to Section&nbsp;13(a) or 15(d) of the
United States <I>Securities Exchange Act</I> <I>of 1934, </I>as amended (the &#147;<B>U.S. Exchange Act</B>&#148;), if and to the extent expressly provided therein. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Any statement contained in this Prospectus Supplement, the Base Prospectus or in a document incorporated or deemed to be incorporated by reference herein
or therein, will be deemed to be modified or superseded, for the purposes of this Prospectus Supplement, to the extent that a statement contained in this Prospectus Supplement or in any other subsequently filed document that is also incorporated or
is deemed to be incorporated by reference in this Prospectus Supplement modifies or supersedes such statement. The modifying or superseding statement need not state that it has modified or superseded a prior statement or include any other
information set forth in the document that it modifies or supersedes. </B></P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">S-2 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left" style="font-size:10pt;font-weight:bold"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>
The making of a modifying or superseding statement will not be deemed an admission for any purpose that the modified or superseded statement, when made, constituted a misrepresentation, an untrue
statement of a material fact or an omission to state a material fact that is required to be stated or that is necessary to make a statement not misleading in light of the circumstances in which it was made. Any statement so modified or superseded
will not be deemed, except as so modified or superseded, to constitute a part of this Prospectus Supplement. </B></P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Information contained on the
Company&#146;s website, www.auroramj.com, is not part of this Prospectus Supplement or the Base Prospectus and is not incorporated herein by reference and may not be relied upon by you in connection with an investment in the Warrant Shares. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Copies of the documents incorporated herein by reference may be obtained from us upon request without charge from Aurora Cannabis Inc., 2207 90B St. SW,
Edmonton, Alberta, Canada T6X 1V8 (Telephone: <FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">1-855-279-4652)</FONT></FONT></FONT> Attn: Corporate Secretary. These documents are also available
electronically from the website of Canadian Securities Administrators at www.sedarplus.ca (&#147;<B>SEDAR+</B>&#148;) and from the SEC&#146;s EDGAR (as defined below) website at www.sec.gov. The Company&#146;s filings through SEDAR+ and EDGAR are
not incorporated by reference in the Prospectus except as specifically set out herein. </P> <P STYLE="margin-top:24pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B><A NAME="supprom937513_3"></A>CAUTIONARY NOTE
REGARDING FORWARD-LOOKING STATEMENTS </B></P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">This Prospectus Supplement, the accompanying Base Prospectus and the documents incorporated by reference herein
and therein, contain forward-looking statements and forward-looking information (collectively, &#147;forward-looking statements&#148;) which may not be based on historical fact. These forward-looking statements are made as of the date of this
Prospectus Supplement, the accompanying Base Prospectus or the applicable document incorporated by reference herein or therein, and the Company does not intend, and does not assume any obligation, to update these forward-looking statements, except
as required under applicable securities legislation. Forward-looking statements relate to future events or future performance and reflect Company management&#146;s expectations or beliefs regarding future events. In certain cases, forward-looking
statements can be identified by the use of words such as &#147;plans&#148;, &#147;expects&#148; or &#147;does not expect&#148;, &#147;is expected&#148;, &#147;budget&#148;, &#147;scheduled&#148;, &#147;estimates&#148;, &#147;forecasts&#148;,
&#147;intends&#148;, &#147;anticipates&#148; or &#147;does not anticipate&#148;, or &#147;believes&#148;, or variations of such words and phrases or statements that certain actions, events or results &#147;may&#148;, &#147;could&#148;,
&#147;would&#148;, &#147;might&#148; or &#147;will be taken&#148;, &#147;occur&#148; or &#147;be achieved&#148; or the negative of these terms or comparable terminology. In this document, certain forward-looking statements are identified by words
including &#147;may&#148;, &#147;future&#148;, &#147;expected&#148;, &#147;intends&#148; and &#147;estimates&#148;. By their very nature forward-looking statements involve known and unknown risks, uncertainties and other factors which may cause the
actual results, performance or achievements of the Company to be materially different from any future results, performance or achievements expressed or implied by the forward-looking statements. The Company provides no assurance that forward-looking
statements will prove to be accurate, as actual results and future events could differ materially from those anticipated in such statements. Accordingly, readers should not place undue reliance on forward-looking statements. Forward-looking
statements in this Prospectus Supplement and the documents incorporated by reference include, but are not limited to, statements with respect to: </P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">pro forma measures including revenue, cash flow, adjusted gross margin before fair value adjustments, expected
SG&amp;A <FONT STYLE="white-space:nowrap">run-rates</FONT> and grams produced; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">the Company&#146;s ability to fund operating activities and cash commitments for investing and financing
activities for the foreseeable future; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">the Company&#146;s objective to deliver profitability and expectation to achieve positive cash flow from
operating activities in future periods; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">expectations regarding production capacity, costs and yields; </P></TD></TR></TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">S-3 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left" style="font-size:10pt;font-weight:bold"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">

<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">statements made under the heading &#147;<I>Our Strategy</I>&#148; in the documents incorporated by reference,
where applicable; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">statements made with respect to the anticipated disposition of legal claims in the documents incorporated by
reference, where applicable; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">the acquisition of Bevo and associated impact on revenue and the creation of long-term value;
</P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">the acquisition of TerraFarma Inc. (the parent Company of Thrive Cannabis), including the anticipated benefits
and impact on the Company&#146;s path to profitability; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">the acquisition of MedReleaf Australia, including the anticipated benefits and impact on the Company&#146;s path
to profitability; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">future strategic plans and opportunities; </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">growth opportunities including the expansion into additional international markets; </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">expectations related to increased legalization of cannabis in medical and consumer markets, including the United
States; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">the repositioning and improvements in the Company&#146;s consumer business and associated impact on future
profitability and access to new global consumer markets as they open; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">competitive advantages and strengths in Canadian and international medical cannabis, scientific leadership,
multi-jurisdictional regulatory expertise, compliance, testing, cultivar breeding and product quality; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">product portfolio and innovation, and associated revenue growth and impact on future long-term success;
</P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">licensing of genetic innovations to other licensed producers and associated impact on revenue growth;
</P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">expectations regarding biosynthetic production and associated intellectual property; and </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">other risks detailed from time to time in the documents incorporated herein by reference, and those risks which
are discussed under the heading &#147;<I>Risk Factors</I>&#148; in this Prospectus Supplement and the Base Prospectus. </P></TD></TR></TABLE> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The above and
other aspects of the Company&#146;s anticipated future operations are forward-looking in nature and, as a result, are subject to certain risks and uncertainties. Such forward-looking statements are estimates reflecting the Company&#146;s best
judgment based upon current information and involve a number of risks and uncertainties, and there can be no assurance that other factors will not affect the accuracy of such forward-looking statements. These risks include, but are not limited to:
the Company has a limited operating history and there is no assurance the Company will be able to achieve or maintain profitability; the Company operates in a highly regulated business and any failure or significant delay in obtaining applicable
regulatory approvals could adversely affect its ability to conduct its business; the timing, magnitude and duration of new or increased tariffs imposed on goods imported from Canada into the United States; the Company&#146;s Canadian licenses are
reliant on its established sites; the failure to maintain its licenses and remain in compliance with regulations could adversely affect the Company&#146;s ability to conduct business; a change in the laws, regulations, and guidelines that impact the
business may cause adverse effects on the Company&#146;s operations; the Company competes for market share with a number of competitors and expects even more competitors to enter our market, and many of the Company&#146;s current and future
competitors may have longer operating histories, more financial resources, and lower costs than the Company; management&#146;s estimates of consumer demand in Canada and in jurisdictions where the Company exports are accurate; expectations of future
results and expenses; management&#146;s estimation that the Company will be able to maintain current SG&amp;A expenditure levels and the SG&amp;A will grow only in proportion to revenue growth, the yield from cannabis growing operations, product
demand, changes in prices of required commodities; the selling prices and the cost of cannabis production may vary based on a number of </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">S-4 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left" style="font-size:10pt;font-weight:bold"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
factors outside of the Company&#146;s control; the Company may not be able to realize our growth targets or successfully manage our growth; the continuance of our contractual relations with
provincial and territorial governments upon which much of the Company&#146;s business depends cannot be guaranteed; the Company&#146;s continued growth and ongoing operations may require additional financing, which may not be available on acceptable
terms or at all; any default under the Company&#146;s existing debt that is not waived by the applicable lenders could materially adversely impact the Company&#146;s results of operations and financial results and may have a material adverse effect
on the trading price of the Company&#146;s Common Shares; the Company is subject to credit risk; the Company may not be able to successfully develop new products or find a market for their sale; the Company may not have supply continuity given the
Company&#146;s asset rationalization initiative; as the cannabis market continues to mature, the Company&#146;s products may become obsolete, less competitive, or less marketable; restrictions on branding and advertising may negatively impact the
Company&#146;s ability to attract and retain customers; the cannabis business may be subject to unfavorable publicity or consumer perception, which may adversely affect the market for cannabis products generally and the Company&#146;s products
specifically; third parties with whom the Company does business may perceive themselves as being exposed to reputational risk by virtue of their relationship with the Company and may ultimately elect to discontinue their relationships with the
Company; there may be unknown health impacts associated with the use of cannabis and cannabis derivative products; the Company may enter into strategic alliances or expand the scope of currently existing relationships with third parties and there
are risks associated with such activities; the Company&#146;s success will depend on attracting and retaining key personnel; the Company is dependent on its senior management; future expansion efforts may not be successful; the Company has expanded
and intends to further expand our business and operations into jurisdictions outside of Canada, and there are risks associated with doing so; the Company may have challenges in accessing banks and/or financial institutions in jurisdictions where
cannabis is not yet federally regulated, which may adversely affect the Company&#146;s growth plans; the business may be affected by political and economic instability and a period of sustained inflation across the markets in which it operates;
failure to comply with the Corruption of Foreign Public Officials Act (Canada) and the Foreign Corrupt Practices Act (United States), as well as the anti-bribery laws of the other nations in which the Company conducts business, could subject the
Company to penalties and other adverse consequences; the Company&#146;s employees, independent contractors and consultants may engage in fraudulent or other illegal activities; the Company may be subject to uninsured or uninsurable risk; the Company
may be subject to product liability claims; the Company&#146;s cannabis products may be subject to recalls for a variety of reasons; the Company is and may become party to litigation, mediation, and/or arbitration from time to time; the
transportation of the Company&#146;s products is subject to security risks and disruptions; the Company&#146;s business is subject to the risks inherent in agricultural operations; the Company has in the past, and may in the future, record
significant write-downs of its assets; the Company&#146;s operations are subject to various environmental and employee health and safety regulations, compliance with which may affect the Company&#146;s cost of operations; the Company may not be able
to protect our intellectual property; the Company may experience breaches of security at our facilities or in respect of electronic documents and data storage and may face risks related to breaches of applicable privacy laws; the Company may be
subject to risks related to our information technology systems, including cyber-attacks; the Company may not be able to successfully identify and execute future acquisitions or dispositions, or to successfully manage the impacts of such transactions
on its operations; as a holding company, Aurora Cannabis Inc. is dependent on its operating subsidiaries to pay dividends and other obligations; management will have substantial discretion concerning the use of proceeds from future share sales and
financing transactions; there is no assurance the Company will continue to meet the listing standards of Nasdaq and the TSX; the financial reporting obligations of being a public company and maintaining a dual listing on the TSX and on Nasdaq
requires significant company resources and management attention; the Company does not anticipate paying any dividends to the holders of Common Shares in the foreseeable future; and other risks detailed from time to time in our annual information
forms, annual financial statements, MD&amp;A, interim financial statements and material change reports filed with and furnished to securities regulators, and those risks which are discussed under the heading &#147;<I>Risk Factors</I>&#148;. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Readers are cautioned that the foregoing list of risk factors is not exhaustive, and it is recommended that prospective investors consult the more complete
discussion of risks and uncertainties facing the Company </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">S-5 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left" style="font-size:10pt;font-weight:bold"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
included in this Prospectus Supplement and the accompanying Base Prospectus under the heading &#147;<I>Risk Factors</I>&#148;, as well as those set out in our 2024 AIF under the heading
&#147;Risk Factors&#148; and in our 2024 Annual MD&amp;A and Interim MD&amp;A, each of which documents are incorporated by reference into this Prospectus Supplement. Readers are urged to consider the risks, uncertainties and assumptions carefully in
evaluating the forward-looking statements and are cautioned not to place undue reliance on such information. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Should one or more of these risks or
uncertainties materialize, or should underlying factors or assumptions prove incorrect, actual results may vary materially from those described in forward looking statements. Material factors or assumptions involved in developing forward-looking
statements include, without limitation, publicly available information from governmental sources as well as from market research and industry analysis and on assumptions based on data and knowledge of the cannabis industry which the Company believes
to be reasonable. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Although the Company believes that the expectations conveyed by the forward-looking statements are reasonable based on the information
available to the Company on the date hereof, no assurance can be given as to future results, approvals or achievements. Forward-looking statements contained in this Prospectus Supplement, the accompanying Base Prospectus and in the documents
incorporated by reference herein and therein are expressly qualified by this cautionary statement. The Company disclaims any duty to update any of the forward-looking statements after the date of this Prospectus Supplement except as otherwise
required by applicable law. </P> <P STYLE="margin-top:24pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B><A NAME="supprom937513_4"></A>NOTE TO UNITED STATES READERS REGARDING DIFFERENCES </B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>BETWEEN UNITED STATES AND CANADIAN FINANCIAL REPORTING PRACTICES </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">We prepare our financial statements in accordance with IFRS, as issued by the IASB, which differs from U.S. generally accepted accounting principles
(&#147;<B>U.S. GAAP</B>&#148;). Accordingly, our financial statements and other financial information included or incorporated by reference in this Prospectus Supplement and the accompanying Base Prospectus may not be comparable to financial
statements of United States companies prepared in accordance with U.S. GAAP. </P> <P STYLE="margin-top:24pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B><A NAME="supprom937513_5"></A><FONT
STYLE="white-space:nowrap">NON-IFRS</FONT> MEASURES </B></P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The information presented in this Prospectus Supplement and the accompanying Base Prospectus,
including certain documents incorporated by reference herein and therein, may include <FONT STYLE="white-space:nowrap">non-IFRS</FONT> measures that are used by us as indicators of financial performance. These financial measures do not have
standardized meanings prescribed under IFRS and our computation may differ from similarly-named computations as reported by other entities and, accordingly, may not be comparable. These financial measures should not be considered as an alternative
to, or more meaningful than, measures of financial performance as determined in accordance with IFRS as an indicator of performance. The Company believes these measures may be useful supplemental information to assist investors in assessing our
operational performance and our ability to generate cash through operations. The <FONT STYLE="white-space:nowrap">non-IFRS</FONT> measures also provide investors with insight into our decision making as we use these
<FONT STYLE="white-space:nowrap">non-IFRS</FONT> measures to make financial, strategic and operating decisions. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Because
<FONT STYLE="white-space:nowrap">non-IFRS</FONT> measures do not have a standardized meaning and may differ from similarly-named computations as reported by other entities, securities regulations require that
<FONT STYLE="white-space:nowrap">non-IFRS</FONT> measures be clearly defined and qualified, reconciled with their nearest IFRS measure and given no more prominence than the closest IFRS measure. If <FONT STYLE="white-space:nowrap">non-IFRS</FONT>
measures are included in documents incorporated by reference herein, information regarding these <FONT STYLE="white-space:nowrap">non-IFRS</FONT> measures are presented in the sections dealing with these financial measures in such documents. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><FONT STYLE="white-space:nowrap">Non-IFRS</FONT> measures are not audited. These <FONT STYLE="white-space:nowrap">non-IFRS</FONT> measures have important
limitations as analytical tools and investors are cautioned not to consider them in isolation or place undue reliance on ratios or percentages calculated using these <FONT STYLE="white-space:nowrap">non-IFRS</FONT> measures. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">S-6 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left" style="font-size:10pt;font-weight:bold"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B><A NAME="supprom937513_6"></A>CURRENCY PRESENTATION AND EXCHANGE RATE INFORMATION </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Unless stated otherwise or as the context otherwise requires, all references to dollar amounts in this Prospectus Supplement are references to Canadian
dollars. References to &#147;C$&#148; are to Canadian dollars and references to &#147;U.S. dollars&#148; or &#147;U.S.$&#148; are to United States dollars. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Except as otherwise noted in our 2024 AIF and the Company&#146;s financial statements and related management&#146;s discussion and analysis of financial
condition and results of operations of the Company that are incorporated by reference into this Prospectus Supplement, the financial information contained in such documents is expressed in Canadian dollars. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The high, low, average and closing daily exchange rates for the United States dollar in terms of Canadian dollars for each of the financial periods of the
Company ended December&nbsp;31, 2024, March&nbsp;31, 2024 and March&nbsp;31, 2023, as quoted by the Bank of Canada, were as follows: </P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="84%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="43%"></TD>

<TD VALIGN="bottom" WIDTH="12%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="12%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="12%"></TD>
<TD></TD>
<TD></TD>
<TD></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Three&nbsp;months&nbsp;ended</B><br><B>December&nbsp;31, 2024</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Year&nbsp;ended</B><br><B>March&nbsp;31,&nbsp;2024</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Nine&nbsp;months&nbsp;ended</B><br><B>March&nbsp;31, 2023<SUP STYLE="font-size:75%; vertical-align:top">(1)</SUP></B></TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="6" ALIGN="center">(expressed in Canadian dollars)</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD COLSPAN="2" VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>


<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">High</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">1.4416</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">1.3875</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">1.3856</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Low</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">1.3854</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">1.3128</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">1.2753</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Average</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">1.4103</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">1.3487</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">1.3384</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Closing</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">1.4389</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">1.3574</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">1.3533</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
</TABLE> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(1)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">The Company&#146;s fiscal year end was changed from June&nbsp;30 to March&nbsp;31 in fiscal 2023.
</P></TD></TR></TABLE> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">On February&nbsp;13, 2025, the daily exchange rate for the United States dollar in terms of Canadian dollars, as quoted by the Bank of
Canada, was U.S.$1.00 = C$1.4242. </P> <P STYLE="margin-top:24pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B><A NAME="supprom937513_7"></A>OUR BUSINESS </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><I>This summary does not contain all the information about the Company that may be important to you. You should read the more detailed information, public
filings and financial statements and related notes that are incorporated by reference into and are considered to be a part of this Prospectus Supplement and the accompanying Base Prospectus. </I></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Aurora is opening the world to cannabis, serving both the medical and consumer markets across Canada, Europe, Australia and South America. Headquartered in
Edmonton, Alberta, Aurora is a pioneer in global cannabis, dedicated to helping people improve their lives. The Company&#146;s adult- use brand portfolio includes Aurora Drift, San Rafael &#145;71, Daily Special, Tasty&#146;s, Being and Greybeard.
Medical cannabis brands include MedReleaf, CanniMed, Aurora and Whistler Medical Marijuana Co., as well as international brands, Pedanios, IndiMed and CraftPlant. Aurora also has a controlling interest in Bevo Farms Ltd., North America&#146;s
leading supplier of propagated agricultural plants. Driven by science and innovation, and with a focus on high-quality cannabis products, Aurora&#146;s brands continue to break through as industry leaders in the medical, wellness and adult
recreational markets wherever they are launched. </P> <P STYLE="margin-top:24pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B><A NAME="supprom937513_8"></A>USE OF PROCEEDS </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">We will receive all proceeds of the full issue price of U.S.$32.00 per whole Warrant Share (after giving effect to the Company&#146;s share consolidation on a
10 to 1 basis completed on February&nbsp;20, 2024) upon the issuance of the Warrant Shares upon any exercise of the Warrants from time to time. Assuming that all of the Warrants are exercised prior to 5:00 p.m. (Toronto time) on the Expiry Date for
cash and that no adjustment based on anti-dilution provisions contained in the Warrant Indenture has taken place, the proceeds to the Company will be </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">S-7 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left" style="font-size:10pt;font-weight:bold"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
U.S.$225,308,000. There is no assurance as to how many Warrants will be exercised, if any. Accordingly, there is no assurance as to how many Warrant Shares will be issued pursuant to this
Prospectus Supplement, if any, or the proceeds of such offering. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">It is currently anticipated that the Company will use any proceeds from the Offering for
general corporate purposes. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Although we intend to use the proceeds from the Offering as set forth above, the actual allocation of the net proceeds may
vary depending on future developments, at the discretion of our board of directors and management. See &#147;<I>Risk Factors &#150; The Company has discretion with respect to the </I><I>use of proceeds</I><I> from this Offering</I>&#148;. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">During the fiscal year ended March&nbsp;31, 2024 and the third fiscal quarter ended December&nbsp;31, 2024, the Company had negative cash flow from operating
activities. Although the Company anticipates it will be able to generate positive cash flow from operating activities in the future, the Company cannot guarantee it will have positive cash flow from operating activities in any future period. To the
extent that the Company has negative operating cash flow in any future period, current working capital and certain of the proceeds from the Offering may be used to fund such negative cash flow from operating activities. See &#147;<I>Risk Factors
&#150; Negative Cash Flow from Operations</I>&#148;. </P> <P STYLE="margin-top:24pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B><A NAME="supprom937513_9"></A>CONSOLIDATED CAPITALIZATION </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">As of February&nbsp;13, 2025, the Company had 54,884,052 Common Shares issued and outstanding. Except as described below, there have been no material changes
in our share and debt capital, on a consolidated basis, since December&nbsp;31, 2024, being the date of the Interim Financial Statements incorporated by reference in this Prospectus Supplement, other than the issuance of a total of<B> </B>6,147<B>
</B>Common Shares related to Aurora&#146;s RSU and PSU share based compensation programs as described further below under &#147;Prior Sales&#148;. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The
following table shows the effect of the Warrants and Warrant Shares (assuming all Warrants are exercised prior to the Expiry Date) on the issued share capital of the Company. This table should be read in conjunction with the consolidated financial
statements of the Company and the related notes and management&#146;s discussion and analysis of financial condition and results of operations in respect of those statements that are incorporated by reference in the Prospectus. </P>
<P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="76%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="54%"></TD>

<TD VALIGN="bottom" WIDTH="14%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="14%"></TD>
<TD></TD>
<TD></TD>
<TD></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom" NOWRAP>
<P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-bottom:1.00pt solid #000000; display:table-cell; font-size:8pt; font-family:Times New Roman; "><B>Description<SUP STYLE="font-size:75%; vertical-align:top">(1)</SUP></B></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>As&nbsp;at&nbsp;December&nbsp;31,<BR>2024, before giving<BR>effect to the<BR>exercise of the<BR>Warrants</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>As&nbsp;at&nbsp;December&nbsp;31,<BR>2024, after giving<BR>effect to the<BR>exercise of
the<BR>Warrants<SUP STYLE="font-size:75%; vertical-align:top">(2)</SUP></B></TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>


<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Common Shares</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">54,877,905</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">61,918,780</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Share Capital (in thousands of $)</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">C$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">6,977,950</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">C$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">7,302,146</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Warrants</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">70,649,810</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">241,060</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
</TABLE> <P STYLE="line-height:8.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1px solid #000000;width:11%">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(1)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">This table does not give effect to issuances of Common Shares that occurred after December&nbsp;31, 2024.
</P></TD></TR></TABLE>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(2)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">Assuming a currency exchange rate equivalent to the daily exchange rate for the United States dollar in terms
of Canadian dollars on December&nbsp;31, 2024, as quoted by the Bank of Canada, being U.S.$1.00 = C$1.4389. </P></TD></TR></TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">S-8 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left" style="font-size:10pt;font-weight:bold"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B><A NAME="supprom937513_10"></A>PRIOR SALES </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The following table sets out details of all Common Shares issued by the Company since the year ended March&nbsp;31, 2024. For details of all Common Shares
issued during the year ended March&nbsp;31, 2024, see the Company&#146;s 2024 AIF. </P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="84%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="47%"></TD>

<TD VALIGN="bottom" WIDTH="8%"></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="8%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="8%"></TD>
<TD></TD>
<TD></TD>
<TD></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom" NOWRAP> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-bottom:1.00pt solid #000000; display:table-cell; font-size:8pt; font-family:Times New Roman; "><B>Date of Issuance</B></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Reason&nbsp;for&nbsp;Issuance</B></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Number&nbsp;of<BR>Securities<BR>Issued</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Issue/Exercise&nbsp;Price<BR>per Security</B></TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>


<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">April&nbsp;4, 2024</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP>RSU&nbsp;Release</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">2,903</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">C$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">82.20</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">June&nbsp;28, 2024</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP>RSU Release</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">85,904</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">C$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">7.60</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">June&nbsp;28, 2024</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP>RSU Release</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">14,890</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">C$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">85.00</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">June&nbsp;28, 2024</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP>RSU Release</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">27</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">C$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">126.10</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">July&nbsp;31, 2024</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP>RSU Release</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">11,256</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">C$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">7.60</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">August&nbsp;16, 2024</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP>Stock&nbsp;Options</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">20,317</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">C$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">4.11</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">August&nbsp;19, 2024</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP>RSU Release</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">4,010</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">C$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">7.60</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">August&nbsp;19, 2024</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP>RSU Release</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">12,070</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">C$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">18.70</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">August&nbsp;19, 2024</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP>RSU Release</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">578</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">C$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">33.20</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">August&nbsp;19, 2024</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP>RSU Release</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">243</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">C$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">82.20</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">September&nbsp;25, 2024</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP>RSU Release</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">157,814</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">C$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">18.70</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">September&nbsp;30, 2024</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP>Stock Options</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">7,148</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">C$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">4.11</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">October&nbsp;1, 2024</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP>RSU Release</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">11,300</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">C$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">82.20</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">October&nbsp;8, 2024</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP>RSU Release</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">2,903</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">C$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">82.20</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">November&nbsp;18, 2024</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP>RSU Release</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">745</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">C$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">19.20</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">January&nbsp;20, 2025</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP>PSU Release</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">441</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">C$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">18.70</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">January&nbsp;20, 2025</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP>PSU Release</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">1,428</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">C$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">7.60</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">January&nbsp;20, 2025</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP>RSU Release</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">688</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">C$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">18.70</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">January&nbsp;20, 2025</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP>RSU Release</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">3,590</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">C$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">7.60</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
</TABLE> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The following table sets out details of all securities convertible or exercisable into Common Shares that were issued or
granted by the Company following the year ended March&nbsp;31, 2024. For details of all securities convertible or exercisable into Common Shares that were issued or granted during the year ended March&nbsp;31, 2024, see the Company&#146;s 2024 AIF.
</P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="84%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="28%"></TD>

<TD VALIGN="bottom" WIDTH="17%"></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="17%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="17%"></TD>
<TD></TD>
<TD></TD>
<TD></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom" NOWRAP> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-bottom:1.00pt solid #000000; display:table-cell; font-size:8pt; font-family:Times New Roman; "><B>Date of Issuance</B></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Type&nbsp;of&nbsp;Security<BR>Issued</B></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Number of Common<BR>Shares Issuable Upon<BR>Exercise&nbsp;or&nbsp;Conversion</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Exercise&nbsp;or&nbsp;Conversion&nbsp;Price<BR>Per Common Share</B></TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>


<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">September&nbsp;19, 2024</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP>Options</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">16,908</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">7.91</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">September&nbsp;19, 2024</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP>RSU</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">2,581</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">N/A</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">June&nbsp;24, 2024</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP>Options</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">732,253</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">7.59</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">June&nbsp;24, 2024</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP>PSU</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">130,662</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">N/A</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">June&nbsp;24, 2024</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP>RSU</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">375,788</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">N/A</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
</TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">S-9 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left" style="font-size:10pt;font-weight:bold"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B><A NAME="supprom937513_11"></A>TRADING PRICE AND VOLUME </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Our Common Shares are listed on the TSX and Nasdaq under the trading symbol &#147;ACB&#148;. The following tables set forth the reported high and low closing
prices and the aggregate trading volume of our Common Shares (reflecting the Company&#146;s share consolidation on a 10 to 1 basis completed on February&nbsp;20, 2024) on the TSX and Nasdaq for each of the months (or, if applicable, partial months)
indicated during the <FONT STYLE="white-space:nowrap">12-month</FONT> period prior to the date of this Prospectus Supplement. </P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="84%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="63%"></TD>

<TD VALIGN="bottom" WIDTH="5%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="5%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="5%"></TD>
<TD></TD>
<TD></TD>
<TD></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom" ROWSPAN="2" NOWRAP> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-bottom:1.00pt solid #000000; display:table-cell; font-size:8pt; font-family:Times New Roman; "><B>Month</B></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="6" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>TSX Price Range</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ROWSPAN="2">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ROWSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Total&nbsp;Volume</B></TD>
<TD VALIGN="bottom" ROWSPAN="2">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>High&nbsp;(C$)</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Low&nbsp;(C$)</B></TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>


<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">February 2024<SUP STYLE="font-size:75%; vertical-align:top">(1)</SUP></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">4.75</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">0.52</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">19,640,132</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">March 2024</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">6.60</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">3.91</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">30,838,642</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">April 2024</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">12.65</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">5.81</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">80,689,612</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">May 2024</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">10.34</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">8.42</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">36,710,387</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">June 2024</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">8.35</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">6.32</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">12,047,222</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">July 2024</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">8.58</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">6.18</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">20,651,756</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">August 2024</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">9.66</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">8.00</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">18,074,668</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">September 2024</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">8.11</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">7.33</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">8,564,948</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">October 2024</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">8.43</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">7.25</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">10,168,569</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">November 2024</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">8.46</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">5.83</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">11,775,122</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">December 2024</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">6.50</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">5.88</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">7,204,357</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">January 2025</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">6.80</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">5.28</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">7,137,637</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">February <FONT STYLE="white-space:nowrap">1-13,</FONT> 2025</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">9.50</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">5.04</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">25,143,262</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
</TABLE> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(1)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">On February&nbsp;20, 2024, the Company completed a share consolidation on a 10 to 1 basis.
</P></TD></TR></TABLE> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="84%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="58%"></TD>

<TD VALIGN="bottom" WIDTH="7%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="7%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="7%"></TD>
<TD></TD>
<TD></TD>
<TD></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom" ROWSPAN="2" NOWRAP> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-bottom:1.00pt solid #000000; display:table-cell; font-size:8pt; font-family:Times New Roman; "><B>Month</B></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="6" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Nasdaq Price Range</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ROWSPAN="2">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ROWSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Total Volume</B></TD>
<TD VALIGN="bottom" ROWSPAN="2">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>High&nbsp;(U.S.$)</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Low&nbsp;(U.S.$)</B></TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>


<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">February 2024<SUP STYLE="font-size:75%; vertical-align:top">(1)</SUP></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">3.47</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">0.38</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">95,852,185</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">March 2024</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">4.86</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">2.89</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">79,865,847</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">April 2024</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">9.23</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">4.31</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">328,049,413</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">May 2024</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">7.61</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">6.15</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">93,272,269</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">June 2024</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">6.09</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">4.62</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">21,900,014</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">July 2024</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">6.25</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">4.52</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">34,031,597</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">August 2024</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">7.05</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">5.54</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">34,171,407</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">September 2024</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">6.08</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">5.41</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">15,044,501</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">October 2024</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">6.10</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">5.32</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">20,346,531</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">November 2024</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">6.11</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">4.18</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">25,302,315</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">December 2024</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">4.63</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">4.10</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">13,859,176</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">January 2025</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">4.70</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">3.65</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">14,397,529</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">February <FONT STYLE="white-space:nowrap">1-13,</FONT> 2025</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$<BR></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">6.62<BR></TD>
<TD NOWRAP VALIGN="bottom">&nbsp;<BR></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">3.46</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">118,983,384</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
</TABLE> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(1)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">On February&nbsp;20, 2024, the Company completed a share consolidation on a 10 to 1 basis.
</P></TD></TR></TABLE> <P STYLE="margin-top:24pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B><A NAME="supprom937513_12"></A>DESCRIPTION OF SECURITIES BEING DISTRIBUTED </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Common Shares </B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The Company is authorized to issue an
unlimited number of Common Shares without par value. For a description of the terms and provisions of the Common Shares, see &#147;<I>Description of Securities Being Distributed &#150; Common Shares</I>&#148; in the Base Prospectus. As of
February&nbsp;13, 2025, there were 54,884,052 Common Shares outstanding. If all of the Warrants are exercised, there will be 61,924,927 Common Shares outstanding. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">S-10 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left" style="font-size:10pt;font-weight:bold"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B><A NAME="supprom937513_13"></A>PLAN OF DISTRIBUTION </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">This Prospectus Supplement relates to: (i)&nbsp;up to 7,040,875 Warrant Shares issuable from time to time on exercise of 70,408,750 Warrants issued by the
Company pursuant to the Unit Offering; and (ii)&nbsp;such indeterminate number of additional Warrant Shares that may be issuable by reason of the anti-dilution provisions contained in the indenture governing the Warrants (the &#147;<B>Warrant
Indenture</B>&#148;) entered into between the Company and Computershare Trust Company of Canada, as warrant agent (the &#147;<B>Warrant Agent</B>&#148;). </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Each Warrant entitles the holder to purchase one tenth (1/10<SUP STYLE="font-size:75%; vertical-align:top">th</SUP>) of a Warrant Share from the treasury of
the Company at the price of U.S.$32.00 per whole Warrant Share (after giving effect to the Company&#146;s share consolidation on a 10 to 1 basis completed on February&nbsp;20, 2024) at any time until 5:00 p.m. (Toronto time) on the Expiry Date,
subject to adjustment and in accordance with the terms and conditions set out in the Warrant Indenture, after which the Warrants will become null and void. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The following summary of certain provisions of the Warrant Indenture does not purport to be complete and is qualified in its entirety by reference to the
detailed provisions of the Warrant Indenture. Reference is made to the Warrant Indenture for the full text of the attributes of the Warrants, which is filed on SEDAR+ under the issuer profile of the Company at www.sedarplus.ca and on the SEC&#146;s
EDGAR website at www.sec.gov. A register of holders of Warrants is maintained at the principal offices of the Warrant Agent in Vancouver, British Columbia. The holders of Warrants do not, as such, have any voting right or other right attached to the
Warrant Shares until and unless the Warrants are duly exercised as provided for in the Warrant Indenture. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The Warrant Indenture provides that the number
of Warrant Shares which may be acquired by a holder of Warrants upon the exercise thereof will be subject to anti-dilution provisions governed by the Warrant Indenture, including provisions for the appropriate adjustment of the class, number and
price of the securities issuable under the Warrant Indenture upon the occurrence of certain events including: </P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">(a)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">the issuance of Common Shares or securities exchangeable for or convertible into Common Shares to all or
substantially all of the holders of Common Shares by way of a stock dividend or other distribution (other than a distribution of Common Shares upon the exercise of any outstanding warrants, options or other convertible securities);
</P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">(b)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">the subdivision, redivision or change of the Common Shares into a greater number of shares;
</P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">(c)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">the consolidation, reduction or combination of the Common Shares into a lesser number of shares;
</P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">(d)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">the issuance to all or substantially all of the holders of Common Shares of rights, options or warrants under
which such holders are entitled, during a period expiring not more than 45 days after the record date for such issuance, to subscribe for or purchase Common Shares, or securities exchangeable for or convertible into Common Shares, at a price per
Common Share to the holder (or at an exchange or conversion price per share) of less than 95% of the &#147;current market price&#148; (as defined in the Warrant Indenture) of Common Shares on such record date; and </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">(e)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">the issuance or distribution to all or substantially all of the holders of Common Shares of
(i)&nbsp;securities, including rights, options or warrants to acquire shares of any class or securities exchangeable or convertible into any such shares or property or assets or (ii)&nbsp;any property or assets, including evidences of indebtedness.
</P></TD></TR></TABLE> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The Warrant Indenture also includes provisions for the appropriate adjustment of the class, number and price of the securities issuable
under the Warrant Indenture upon the occurrence of the following additional events: </P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">(a)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">the reclassification of the Common Shares or exchange or change of the Common Shares into other shares;
</P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">(b)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">the amalgamation, arrangement or merger with or into any other corporation or other entity (other than an
amalgamation, arrangement or merger which does not result in any reclassification of the Company&#146;s outstanding Common Shares or an exchange or change of the Common Shares into other shares); and </P></TD></TR></TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">S-11 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left" style="font-size:10pt;font-weight:bold"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">

<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">(c)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">the transfer of the Company&#146;s undertakings or assets as an entirety or substantially as an entirety to
another corporation or other entity. </P></TD></TR></TABLE> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The Warrant Indenture provides that: (i)&nbsp;no adjustment to the exercise price for the Warrants
will be required to be made unless such adjustment would result in a change of at least 1% in the exercise price for the Warrants; and (ii)&nbsp;no adjustment to the number of Warrant Shares issuable upon exercise of the Warrants will be required to
be made unless such adjustment would result in a change of at least one one-hundredth of a Warrant Share. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The Company has covenanted in the Warrant
Indenture, during the period in which the Warrants are exercisable, to give notice to holders of Warrants of certain stated events, including events that would result in an adjustment to the exercise price for the Warrants or the number of Warrant
Shares issuable upon exercise of the Warrants, a prescribed number of days prior to the record date or effective date, as the case may be, of such event. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The Warrant Indenture provides that, from time to time, the Warrant Agent and the Company, without the consent of the holders of Warrants, is able to amend or
supplement the Warrant Indenture for certain purposes, including rectifying any ambiguities, defective provisions, clerical omissions or mistakes, or other errors contained in the Warrant Indenture or in any deed or indenture supplemental or
ancillary to the Warrant Indenture, provided that, in the opinion of the Warrant Agent, relying on legal counsel, the rights of the holders of Warrants, as a group, are not prejudiced thereby. Subject to the voting rights set forth in the Warrant
Indenture, the rights of holders of the Warrants may, in certain circumstances, be modified by way of an extraordinary resolution passed by the affirmative vote of the holders of not less than 66<SUP STYLE="vertical-align:top">2</SUP>&#8260;<SUB
STYLE="vertical-align:bottom">3</SUB>% of the aggregate number of all the then outstanding Warrants at a meeting duly called and held in accordance with the terms of the Warrant Indenture at which there are present in person or by proxy at least two
holders representing at least 20% of the aggregate number of all the then outstanding Warrants. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The Warrant Indenture also provides that in the event of
an extraordinary transaction, as described in the Warrant Indenture and generally including any merger, arrangement or amalgamation of the Company with or into another entity, sale of all or substantially all of the Company&#146;s assets, tender
offer or exchange offer, or reclassification of the Common Shares, the holders of the Warrants will generally be entitled to receive upon exercise of the Warrants the kind and amount of securities, cash or other property that the holders would have
received had they exercised the Warrants immediately prior to such extraordinary transaction. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The Warrant Indenture includes certain beneficial ownership
limitations under which Warrants are not exercisable to the extent that, after giving effect to the issuance of the Warrant Shares issuable upon such exercise of the Warrants, the holder, together with its affiliates and other persons acting as a
group with the holder or any of its affiliates, would beneficially own in excess of 4.99% of the number of Common Shares outstanding immediately after giving effect to such issuance. Such beneficial ownership limitation may be increased or decreased
by the holder upon notice to the Company, to a maximum of 9.99%. Except as provided in the Warrant Indenture, beneficial ownership will be calculated in accordance with Section&nbsp;13(d) of the U.S. Exchange Act and the rules and regulations
promulgated thereunder. To the extent the beneficial ownership limitations apply, the determination of whether a Warrant is exercisable and of which portion of a Warrant is exercisable shall be in the sole discretion and at the sole responsibility
of the holder, and the submission of an exercise notice in respect of any Warrants shall be deemed to be the holder&#146;s determination of whether the Warrants are exercisable, and neither the Warrant Agent nor the Company will have any obligation
to verify or confirm the accuracy of such determination. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The Company will use commercially reasonable best efforts to maintain a registration statement
effective until the earlier of the Expiry Date or such time as no Warrants remain outstanding (provided, however, that nothing shall prevent the Company&#146;s amalgamation, arrangement, merger or sale, including any take-over bid, and any
associated delisting or deregistration or ceasing to be a reporting issuer, provided that, so long as the Warrants are still outstanding and represent a right to acquire securities of the acquiring company, the acquiring company shall assume the
Company&#146;s obligations under the Warrant Indenture), which could require the additional filing </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">S-12 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left" style="font-size:10pt;font-weight:bold"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
of a new registration statement and/or base shelf prospectus and prospectus supplement if the current Prospectus is no longer usable. If, at any time prior to the Expiry Date, the Company
determines that no registration statement filed with the SEC is effective, or that its use is suspended, no holder of Warrants will be permitted to exercise Warrants unless an exemption from the registration requirements of the U.S. Securities Act
and applicable state securities laws is available, and the holders of Warrants will receive a notice of this determination, together with written confirmation that the Warrants may, until the earlier of (x)&nbsp;a registration statement becoming
effective or ceasing to be suspended and any prospectus supplement necessary in relation thereto having been filed and (y)&nbsp;the Expiry Date, if the Current Market Price (as defined in the Warrant Indenture) of the Common Shares exceeds the
exercise price for the Warrants, also be exercised by means of a &#147;cashless exercise&#148; in which the holder of Warrants will be entitled to receive a certificate for a number of Warrant Shares determined on the basis of the excess of the
current market price over the exercise price for the Warrants. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The principal transfer office of the Warrant Agent in Vancouver, British Columbia is the
location at which Warrants may be surrendered for exercise or transfer. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The Company filed the Previous Warrant Share Prospectus Supplement to the
Previous Base Prospectus on April&nbsp;27, 2023 with the securities commission or similar regulatory authority in each of the provinces of Canada, except Qu&eacute;bec, and, in connection therewith, filed a prospectus supplement dated April&nbsp;27,
2023 to its registration statement on Form <FONT STYLE="white-space:nowrap">F-10</FONT> with the SEC relating to the Warrant Shares. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The Company has
filed with the securities commission or similar regulatory authority in each of the provinces of Canada, except Qu&eacute;bec, a notice of withdrawal withdrawing the Previous Base Prospectus effective as of the date hereof. This Prospectus
Supplement replaces the Previous Warrant Share Prospectus Supplement in order to maintain the registration of the offering of the Warrant Shares under the U.S. Securities Act, beyond the expiry date of the Previous Base Prospectus. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The Warrants were initially qualified for distribution by a prospectus supplement dated May&nbsp;27, 2022 to a base shelf prospectus dated March&nbsp;29, 2021
filed with the securities commission or similar regulatory authority in each of the provinces of Canada, except Qu&eacute;bec, and, in connection therewith, a prospectus supplement dated May&nbsp;27, 2022 to its registration statement on Form <FONT
STYLE="white-space:nowrap">F-10</FONT> with the SEC relating to the Unit Offering, pursuant to which the Company qualified the distribution by the Company of<B> </B>70,408,750 Units at a price of U.S.$2.45 per Unit pursuant to the terms of the
underwriting agreement entered into between the Company and the Underwriters on May&nbsp;27, 2022 (the &#147;<B>Underwriting Agreement</B>&#148;). The Unit Offering was completed on June&nbsp;1, 2022. The exercise price of the Warrants was
determined by negotiation between the Company and the Underwriters. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">This Prospectus Supplement registers the offering of the securities to which it
relates under the U.S. Securities Act in accordance with the MJDS. <B>This Prospectus Supplement does not qualify in any of the provinces or territories of Canada the distribution of the Warrant Shares to which it relates.</B> </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The Warrant Shares to which this Prospectus Supplement relates will be sold directly by the Company to holders of Warrants upon any exercise of such Warrants.
No underwriters, dealers or agents will be involved in these sales. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The Common Shares are listed on the TSX and on Nasdaq under the symbol
&#147;<B>ACB</B>&#148; and on the FSE under the symbol &#147;<B>21P</B>&#148;. The Warrants are listed on the TSX under the symbol &#147;<B>ACB.WT.U</B>&#148;. The TSX has also approved the listing of the Warrant Shares issuable on exercise of the
Warrants on the TSX. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">There is no assurance as to how many of the Warrants will be exercised, and accordingly, there is no assurance as to how many
Warrant Shares will be issued pursuant to this Prospectus Supplement, if any. No party has any obligation to purchase any Warrant Shares qualified by this Prospectus Supplement. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">No fractional Common Shares will be issuable upon the exercise of any Warrants, and no cash or other consideration will be paid in lieu of fractional Common
Shares. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">S-13 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left" style="font-size:10pt;font-weight:bold"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B><A NAME="supprom937513_14"></A>RISK FACTORS </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><I>An investment in the Warrant Shares is highly speculative and subject to a number of known and unknown risks. Only those persons who can bear the risk of
loss of their investment should purchase the Warrant Shares. Investors should consider carefully the risk factors set out herein and contained in and incorporated by reference in the Base Prospectus. Discussions of certain risks affecting us in
connection with our business are set out under the heading &#147;Risk Factors&#148; in the accompanying Base Prospectus as well as in the documents incorporated by reference therein and herein, including, specifically, under the heading &#147;Risk
Factors&#148; in the 2024 AIF. Any of the matters highlighted in these risk factors could have a material adverse effect on our business, results of operations and financial conditions, causing an investor to lose all, or part of, its, his or her
investment. </I></P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I>The Company has discretion with respect to the use of proceeds from this Offering. </I></B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Management will have broad discretion with respect to the use of the proceeds from this Offering, if any, and investors will be relying on the judgment of
management regarding the application of these proceeds. At the date of this Prospectus Supplement, the Company intends to use the proceeds from this Offering as described under the heading &#147;Use of Proceeds&#148;. However, the Company&#146;s
needs may change as its business and the industry the Company addresses evolve. As a result, the proceeds to be received in this Offering may be used in a manner significantly different from the Company&#146;s current expectations. The failure by
management to apply these funds effectively could have a material adverse effect on the Company&#146;s business. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I>Negative Cash Flow from Operations
</I></B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The Company had negative operating cash flows for the fiscal year ended March&nbsp;31, 2024 and the third fiscal quarter ended December&nbsp;31,
2024. Although the Company anticipates it will be able to generate positive cash flow from operating activities in the future, the Company cannot guarantee it will have positive cash flow from operating activities in any future period. To the extent
that the Company has negative operating cash flow in any future period, certain of the proceeds from the Offering may be used to fund such negative cash flow from operating activities. See &#147;<I>Use of Proceeds</I>&#148;. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I>Future sales or issuances of Common Shares could decrease the value of any existing Common Shares or Warrants, dilute voting power of holders of Common
Shares and reduce the Company&#146;s earnings per share. </I></B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Future issuances of equity securities by the Company could decrease the value of any
existing Common Shares and Warrants, dilute voting power of holders of Common Shares, reduce the Company&#146;s earnings per share and make future sales of the Company&#146;s equity securities more difficult. With any additional sale or issuance of
equity securities, holders of Common Shares will suffer dilution of their voting power and may experience dilution in the Company&#146;s earnings per share. Sales of Common Shares by shareholders might also make it more difficult for the Company to
sell equity securities at a time and price that it deems appropriate. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The Company may issue additional equity securities (including through the sale of
securities convertible into, or exchangeable for, Common Shares) under the Company&#146;s current equity incentive plans. In addition, the Company may issue Common Shares to finance its operations or future acquisitions. The Company cannot predict
the size of future sales and issuances of debt or equity securities or the effect, if any, that future sales and issuances of equity securities will have on the market price of the Common Shares and Warrants. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Sales or issuances of a substantial number of equity securities, or the perception that such sales could occur, may adversely affect prevailing market prices
for the Common Shares and the Warrants. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I>The Common Share price has experienced volatility and may be subject to fluctuation in the future based on
market conditions, which could also affect the market price of the Warrants. </I></B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The market prices for the securities of cannabis companies, including
the Company, have historically been, and may in the future be, subject to large fluctuations. The market has from time to time experienced significant price </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">S-14 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left" style="font-size:10pt;font-weight:bold"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
and volume fluctuations that are unrelated to the operating performance of any particular company. In addition, because of the nature of the Company&#146;s business, certain factors such as
announcements and the public&#146;s reaction, the Company&#146;s operating performance and the performance of competitors and other similar companies, government regulations, changes in earnings estimates or recommendations by research analysts who
track the Company&#146;s securities or securities of other companies in the cannabis industry, general market conditions, announcements relating to litigation, the arrival or departure of key personnel and the factors listed under the heading
&#147;<I>Cautionary Note Regarding Forward-Looking Statements</I>&#148; can have an adverse impact on the market price of the Common Shares and Warrants. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Any negative change in the public&#146;s perception of the Company&#146;s prospects could cause the price of the Company&#146;s securities, including the
price of the Common Shares and Warrants, to decrease dramatically. Furthermore, any negative change in the public&#146;s perception of the prospects of cannabis companies in general could depress the price of the Company&#146;s securities, including
the price of the Common Shares and Warrants, regardless of the Company&#146;s results. Following declines in the market price of a corporation&#146;s securities, securities class-action litigation could be instituted. Litigation of this type, if
instituted, could result in substantial costs and a diversion of management&#146;s attention and resources. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I>Liquidity for Warrants may be limited
</I></B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The Warrants are listed on the TSX under the symbol &#147;<B>ACB.WT.U</B>&#148;. There can be no assurance that an active secondary market for
trading in the Warrants will develop or that any secondary market which does develop will continue and if it does develop, that it will be active. This may affect the pricing of the Warrants in the secondary market and the transparency and
availability of trading prices. Without an active market, the liquidity of the Warrants will be limited and you may be unable to sell the Warrants at the prices desired or at all. Each Warrant entitles the holder to purchase one tenth (1/10<SUP
STYLE="font-size:75%; vertical-align:top">th</SUP>) of a Warrant Share from the treasury of the Company at the price of U.S.$32.00 per whole Warrant Share (after giving effect to the Company&#146;s share consolidation on a 10 to 1 basis completed on
February&nbsp;20, 2024) (subject to adjustment in certain circumstances) and can be exercised at any time prior to the Expiry Date. In the event the market price of the Common Shares does not exceed the exercise price of the Warrants during the
period when the Warrants are exercisable, the Warrants may not have any value. Holders of the Warrants have no rights as shareholders of the Company until they exercise the Warrants in accordance with their terms. Upon exercise of the Warrants,
holders of the Warrant Shares deliverable on the exercise of such Warrants will be entitled to exercise the rights of a shareholder in respect of such Warrant Shares only in respect of matters for which the record date occurs after the exercise
date. See &#147;<I>Description of Securities Being Distributed &#150; Warrants</I>&#148; in the Base Prospectus. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I>Return on Investment Risk
</I></B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">There is no guarantee that an investment in Warrant Shares will earn any positive return in the short or long term. An investment in the Warrant
Shares involves a high degree of risk and should be undertaken only by investors whose financial resources are sufficient to enable them to assume such risks, who have no need for immediate liquidity in their investment and who have the financial
capacity to absorb a loss of some or all of their investment. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I>We may be a passive foreign investment company, or &#147;PFIC&#148;, which could
result in adverse U.S. federal income tax consequences to U.S. investors. </I></B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The Company does not believe that it was a PFIC for the year ended
June&nbsp;30, 2022, the nine month fiscal period ended March&nbsp;31, 2023 or the year ended March&nbsp;31, 2024. If we are a PFIC for any taxable year (or portion thereof) that is included in the holding period of a U.S. Holder (as defined in the
section of this Prospectus Supplement captioned &#147;<I>Material U.S. Federal Income Tax Considerations</I>&#148;) of our Common Shares or Warrants, the U.S. Holder may be subject to certain adverse U.S. federal income tax consequences and may be
subject to additional reporting requirements. See &#147;<I>Material U.S. Federal Income Tax Considerations &#150; Passive Foreign Investment Company Considerations</I>&#148;. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">S-15 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left" style="font-size:10pt;font-weight:bold"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B><A NAME="supprom937513_15"></A>CERTAIN CANADIAN FEDERAL INCOME TAX CONSIDERATIONS </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>General </B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The following is a general summary, as of the
date hereof, of the principal Canadian federal income tax considerations under the Income Tax Act (Canada) and the regulations thereunder (collectively, the &#147;<B>Tax Act</B>&#148;), generally applicable to a holder who acquires, as beneficial
owner, Warrant Shares upon exercise of the Warrants, and who, for purposes of the Tax Act and at all relevant times, (i)&nbsp;holds Warrant Shares and Warrants as capital property, (ii)&nbsp;deals at arm&#146;s length with the Company and the
Underwriters, and (iii)&nbsp;is not affiliated with the Company or the Underwriters. A holder who meets all of the foregoing requirements is referred to as a &#147;<B>Holder</B>&#148; herein, and this summary only addresses such Holders. Generally,
the Warrant Shares and Warrants will be considered to be capital property to a Holder unless they are held or acquired in the course of carrying on a business or as part of an adventure or concern in the nature of trade. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">This summary is not applicable to (i)&nbsp;a Holder that is a &#147;financial institution&#148;, as defined in the Tax Act for purposes of the <FONT
STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">mark-to-market</FONT></FONT> rules in the Tax Act, (ii)&nbsp;a Holder that is a &#147;specified financial institution&#148;, as defined in the Tax Act, (iii)&nbsp;a Holder an interest in
which is a &#147;tax shelter investment&#148; as defined in the Tax Act, (iv)&nbsp;a Holder that makes or has made a functional currency reporting election for purposes of the Tax Act, (v)&nbsp;a Holder that has entered into or will enter into a
&#147;derivative forward agreement&#148; or a &#147;synthetic disposition arrangement&#148;, each as defined in the Tax Act, with respect to the Warrants or Warrant Shares, (vi)&nbsp;a Holder that receives dividends on Warrant Shares under or as
part of a &#147;dividend rental arrangement&#148; as defined in the Tax Act, (vii)&nbsp;a Holder that is a partnership or trust, or (viii)&nbsp;a Holder that is exempt from tax under Part I of the Tax Act. In addition, this summary does not address
the deductibility of interest by a Holder who has borrowed money or otherwise incurred debt in connection with the acquisition of Warrant Shares or Warrants. All such Holders should consult their own tax advisors. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Additional considerations, not discussed herein, may be applicable to a Holder that is a corporation resident in Canada and is, or becomes, or does not deal
at arm&#146;s length with a corporation resident in Canada that is, or becomes, controlled by a <FONT STYLE="white-space:nowrap">non-resident</FONT> person, or a group of <FONT STYLE="white-space:nowrap">non-resident</FONT> persons not dealing with
each other at arm&#146;s length, for purposes of the &#147;foreign affiliate dumping&#148; rules in section 212.3 of the Tax Act. Such Holders should consult their own tax advisors with respect to the consequences of acquiring the Warrant Shares.
</P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">This summary is based on the provisions of the Tax Act in force as of the date hereof, all specific proposals to amend the Tax Act that have been
publicly and officially announced by or on behalf of the Minister of Finance (Canada) prior to the date hereof (the &#147;<B>Proposed Amendments</B>&#148;) and our understanding of the current administrative policies and assessing practices of the
Canada Revenue Agency (the &#147;<B>CRA</B>&#148;) published in writing prior to the date hereof. This summary assumes the Proposed Amendments will be enacted in the form proposed. However, no assurance can be given that the Proposed Amendments will
be enacted in their current form, or at all. This summary is not exhaustive of all possible Canadian federal income tax considerations and, except for the Proposed Amendments, does not take into account or anticipate any changes in the law or any
changes in the CRA&#146;s administrative and assessing policies or practices, whether by legislative, governmental or judicial action or decision, nor does it take into account or anticipate any other federal or any provincial, territorial or
foreign tax considerations, which may differ significantly from those discussed herein. Any particular Holder should consult their own tax advisors with respect to provincial, territorial or foreign tax considerations. <B>This summary is not
intended to be, nor should it be construed to be, legal or tax advice to any particular Holder, and no representations with respect to the income tax consequences to any Holder are made. Consequently, Holders should consult their own tax advisors
with respect to the tax consequences applicable to them, having regard to their own particular circumstances. The discussion below is qualified accordingly.</B> </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Currency Conversion </B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Holders are required to compute
their income and gains for Canadian tax purposes in Canadian dollars. Therefore, for purposes of the Tax Act, all amounts relating to the acquisition, holding or disposition of the </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">S-16 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left" style="font-size:10pt;font-weight:bold"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
Warrant Shares must be converted into Canadian dollars based on the exchange rate quoted by the Bank of Canada for the date such amounts arise or such other rate of exchange as is acceptable to
the CRA. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Exercise of Warrants </B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">No gain or loss will
be realized by a Holder on the exercise of a Warrant to acquire a Warrant Share. When a Warrant is exercised, the Holder&#146;s cost of the Warrant Share acquired thereby will be equal to the aggregate of the Holder&#146;s adjusted cost base of such
Warrant and the exercise price paid for the Warrant Share. The Holder&#146;s adjusted cost base of the Warrant Share so acquired will be determined by averaging the cost of the Warrant Share with the adjusted cost base to the Holder of all Common
Shares of the Company held by the Holder as capital property immediately before the acquisition of the Warrant Share. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Taxation of Resident Holders
</B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The following portion of this summary applies to Holders (as defined above) who, for the purposes of the Tax Act, are or are deemed to be resident in
Canada at all relevant times (herein, &#147;<B>Resident Holders</B>&#148;) and this portion of the summary only addresses such Resident Holders. Certain Resident Holders whose Warrant Shares might not otherwise constitute capital property may make,
in certain circumstances, an irrevocable election permitted by subsection 39(4) of the Tax Act to deem such Warrant Shares, and every other &#147;Canadian security&#148; (as defined in the Tax Act) held by such persons, in the taxation year of the
election and each subsequent taxation year, to be capital property. Resident Holders should consult their own tax advisors with respect to whether the election is available and advisable in their particular circumstances. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I>Expiry of Warrants </I></B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">In the event of the expiry of
an unexercised Warrant, a Resident Holder generally will realize a capital loss equal to the Resident Holder&#146;s adjusted cost base of such Warrant. The tax treatment of capital gains and capital losses is discussed in greater detail below under
the heading &#147;<I>Capital Gains and Capital Losses</I>&#148;. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I>Taxation of Dividends </I></B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">A Resident Holder will be required to include in computing income for a taxation year any dividends received, or deemed to be received, in the year by the
Resident Holder on the Warrant Shares. In the case of a Resident Holder that is an individual (other than certain trusts), such dividends will be subject to the <FONT STYLE="white-space:nowrap">gross-up</FONT> and dividend tax credit rules normally
applicable under the Tax Act to taxable dividends received from &#147;taxable Canadian corporations&#148; (as defined in the Tax Act), including the enhanced <FONT STYLE="white-space:nowrap">gross-up</FONT> and dividend tax credit provisions where
the Company designates the dividend as an &#147;eligible dividend&#148; in accordance with the provisions of the Tax Act. There may be restrictions on the ability of the Company to designate any dividend as an &#147;eligible dividend&#148;, and the
Company has made no commitments in this regard. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">A dividend received or deemed to be received by a Resident Holder that is a corporation must be included
in computing its income for a taxation year but will generally be deductible in computing the corporation&#146;s taxable income, subject to all of the rules and restrictions under the Tax Act in that regard. In certain circumstances subsection 55(2)
of the Tax Act will treat a taxable dividend received or deemed to be received by a Resident Holder that is a corporation as proceeds of disposition or a capital gain. A Resident Holder that is a &#147;private corporation&#148; (as defined in the
Tax Act) or any other corporation controlled (whether because of a beneficial interest in one or more trusts or otherwise) by or for the benefit of an individual (other than a trust) or a related group of individuals (other than trusts), generally
will be liable to pay an additional tax (refundable under certain circumstances) under Part IV of the Tax Act on dividends received or deemed to be received on the Warrant Shares in a year to the extent such dividends are deductible in computing
taxable income for the year. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">S-17 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left" style="font-size:10pt;font-weight:bold"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I>Disposition of Warrant Shares </I></B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">A Resident Holder who disposes or is deemed to dispose of a Warrant Share (other than a disposition to the Company that is not a sale in the open market in the
manner in which shares would normally be purchased by any member of the public in an open market) generally will realize a capital gain (or capital loss) equal to the amount, if any, by which the proceeds of disposition, net of any reasonable costs
of disposition, are greater (or are less) than the adjusted cost base to the Resident Holder of such Warrant Shares immediately before the disposition or deemed disposition. The taxation of capital gains and losses is generally described below under
the heading &#147;<I>Capital Gains and Capital Losses</I>&#148;. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I>Capital Gains and Capital Losses </I></B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Generally, a Resident Holder is required to include in computing income for a taxation year <FONT STYLE="white-space:nowrap">one-half</FONT> of the amount of
any capital gain (a &#147;<B>taxable capital gain</B>&#148;) realized by the Resident Holder in such taxation year. Subject to and in accordance with the rules contained in the Tax Act, a Resident Holder is required to deduct <FONT
STYLE="white-space:nowrap">one-half</FONT> of the amount of any capital loss (an &#147;<B>allowable capital loss</B>&#148;) realized in a particular taxation year against taxable capital gains realized by the Resident Holder in the year. Allowable
capital losses in excess of taxable capital gains for the taxation year of disposition may, in general terms, be carried back and deducted in any of the three preceding taxation years, or in any subsequent year, against net taxable capital gains
realized in such years, to the extent and under the circumstances described in the Tax Act. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Subject to the below discussion in respect of recently
proposed developments deferring the effective date of the Capital Gains Tax Proposals (as defined below), for capital gains and capital losses realized on or after June&nbsp;25, 2024, under Proposed Amendments released on September&nbsp;23, 2024
(the &#147;<B>Capital Gains Tax Proposals</B>&#148;), and subject to certain transitional rules discussed below, generally, a Holder is required to include in computing its income <FONT STYLE="white-space:nowrap">two-thirds</FONT> of the amount of
any capital gain realized in the year, and is required to deduct <FONT STYLE="white-space:nowrap">two-thirds</FONT> of the amount of any capital loss realized in a taxation year from taxable capital gains realized in the year by such Holder. Under
the Capital Gains Tax Proposals, a Holder that is an individual (excluding most types of trusts) is required to include in computing its income only <FONT STYLE="white-space:nowrap">one-half</FONT> of net capital gains realized (including net
capital gains realized indirectly through a trust or partnership) in a taxation year (and on or after June&nbsp;25, 2024) up to a maximum of $250,000, with the <FONT STYLE="white-space:nowrap">two-thirds</FONT> inclusion rate applying to the portion
of net capital gains realized in the year that exceeds $250,000. Certain other conditions impacting the computation of the $250,000 threshold may apply. Under the Capital Gains Tax Proposals, different inclusion rates (or a blended inclusion rate)
may apply for taxation years that begin before and end on or after June&nbsp;25, 2024 (the &#147;<B>Transitional Year</B>&#148;). As a result, for its Transitional Year, a Holder will be required to separately identify capital gains and capital
losses realized before June&nbsp;25, 2024 (&#147;<B>Period 1</B>&#148;) and those realized on or after June&nbsp;25, 2024 (&#147;<B>Period 2</B>&#148;). Capital gains and capital losses from the same period will first be netted against each other. A
net capital gain (or net capital loss) will arise if capital gains (or capital losses) from one period exceed capital losses (or capital gains) from that same period. A Holder would effectively be subject to the higher inclusion rate of <FONT
STYLE="white-space:nowrap">two-thirds</FONT> in respect of its net capital gains (or net capital losses) arising in Period 2, to the extent that these net capital gains (or net capital losses) exceed any net capital losses (or net capital gains)
incurred in Period 1. Conversely, a Holder would effectively be subject to the lower inclusion rate of <FONT STYLE="white-space:nowrap">one-half</FONT> in respect of its net capital gains (or net capital losses) arising in Period 1, to the extent
that these net capital gains (or net capital losses) exceed any net capital losses (or net capital gains) incurred in Period 2. The Capital Gains Tax Proposals also provide for corresponding adjustments to the inclusion rate of carried forward or
carried back capital losses, as well as for transitional rules and other consequential amendments. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>The foregoing summary only generally describes the
considerations applicable under the Capital Gains Tax Proposals and is not an exhaustive summary of the considerations that could arise in respect of the Capital Gains Tax Proposals. Furthermore, on January&nbsp;6, 2025, the Parliament of Canada was
prorogued and the Proposed Amendments that would have enacted the Capital Gains Tax Proposals lapsed. At the present time, it is uncertain if the Capital Gains Tax Proposals will be <FONT STYLE="white-space:nowrap">re-introduced</FONT> and enacted
in their </B></P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">S-18 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left" style="font-size:10pt;font-weight:bold"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>
current form or at all. Furthermore, on January&nbsp;31, 2025, the Minister of Finance announced an intention to defer the effective date of the Capital Gains Tax Proposals from June&nbsp;25,
2024 to January&nbsp;1, 2026. The CRA additionally announced on January&nbsp;31, 2025 that in contemplation of the introduction in Parliament in due course of new legislation deferring the effective date of the Capital Gains Tax Proposals that it
would administer capital gains realized before January&nbsp;1, 2026 at the presently enacted capital gains inclusion rate of <FONT STYLE="white-space:nowrap">one-half.</FONT> Prospective purchasers and Holders should consult their own tax advisors
in this regard. </B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The amount of any capital loss realized by a Resident Holder that is a corporation on the disposition or deemed disposition of a
Warrant Share may be reduced by the amount of any dividends received or deemed to have been received by such Resident Holder on such shares, to the extent and under the circumstances described in the Tax Act. Similar rules apply where a corporation
is a member of a partnership or a beneficiary of a trust that owns Warrant Shares, directly or indirectly. Corporations to whom these rules may be relevant should consult their own tax advisors. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I>Refundable Tax </I></B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">A Resident Holder that is
throughout the relevant taxation year a &#147;Canadian-controlled private corporation&#148; (as defined in the Tax Act) or that is at any time in its taxation year a &#147;substantive CCPC&#148; (as defined in the Tax Act) may be liable to pay an
additional tax (refundable in certain circumstances) on certain &#147;aggregate investment income&#148;, including taxable capital gains and dividends received or deemed to be received on a Common Share or Warrant Share to the extent that such
dividends are not deductible in computing the Resident Holder&#146;s taxable income for the taxation year. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I>Alternative Minimum Tax </I></B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Capital gains realized and dividends received or deemed to be received by a Resident Holder that is an individual or a trust, other than certain specified
trusts, may give rise to alternative minimum tax under the Tax Act. Resident Holders should consult their own tax advisors in this regard. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Taxation of
<FONT STYLE="white-space:nowrap">Non-Resident</FONT> Holders </B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The following portion of this summary is generally applicable to Holders (as defined
above) who, for the purposes of the Tax Act and at all relevant times: (i)&nbsp;are not resident or deemed to be resident in Canada, and (ii)&nbsp;do not use or hold, and are not deemed to use or hold Warrants or Warrant Shares in carrying on a
business in Canada. Holders who meet all of the foregoing requirements are referred to herein as &#147;<B><FONT STYLE="white-space:nowrap">Non-Resident</FONT> Holders</B>&#148;, and this portion of the summary only addresses such <FONT
STYLE="white-space:nowrap">Non-Resident</FONT> Holders. Special rules, which are not discussed in this summary, may apply to a <FONT STYLE="white-space:nowrap">Non-Resident</FONT> Holder that is an insurer carrying on business in Canada and
elsewhere or an &#147;authorized foreign bank&#148; (as defined in the Tax Act). Such <FONT STYLE="white-space:nowrap">Non-Resident</FONT> Holders should consult their own tax advisors. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I>Receipt of Dividends </I></B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Dividends paid or credited
or deemed to be paid or credited to a <FONT STYLE="white-space:nowrap">Non-Resident</FONT> Holder by the Company are generally subject to Canadian withholding tax at the rate of 25% of the gross amount of the dividend unless reduced by the terms of
an applicable tax treaty between Canada and the <FONT STYLE="white-space:nowrap">Non-Resident</FONT> Holder&#146;s jurisdiction of residence. <FONT STYLE="white-space:nowrap">Non-Resident</FONT> Holders should consult their own tax advisors in this
regard. For example, under the Canada-United States Tax Convention (1980) (the &#147;<B>Treaty</B>&#148;) as amended, the rate of withholding tax on dividends paid or credited or deemed to be paid or credited to a
<FONT STYLE="white-space:nowrap">Non-Resident</FONT> Holder who is resident in the United States for purposes of the Treaty, fully entitled to benefits under the Treaty and is the beneficial owner of the dividend (a &#147;<B>U.S. Resident
Holder</B>&#148;) is generally limited to 15% of the gross amount of the dividend (or 5% in the case of a U.S. Resident Holder that is a company beneficially owning at least 10% of the Company&#146;s
</P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">S-19 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left" style="font-size:10pt;font-weight:bold"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
voting shares). The Multilateral Convention to Implement Tax Treaty Related Measures to Prevent Base Erosion and Profit Shifting (the &#147;<B>MLI</B>&#148;) of which Canada is a signatory,
affects many of Canada&#146;s tax treaties (but not the Treaty), including the ability to claim benefits thereunder. <FONT STYLE="white-space:nowrap">Non-Resident</FONT> Holders should consult their own tax advisors regarding the application of any
applicable tax treaty to dividends based on their particular circumstances. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I>Disposition of Warrant Shares </I></B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">A <FONT STYLE="white-space:nowrap">Non-Resident</FONT> Holder generally will not be subject to tax under the Tax Act in respect of a capital gain realized on
the disposition or deemed disposition of a Warrant Share, nor will capital losses arising therefrom be recognized under the Tax Act, unless such Warrant Share constitutes &#147;taxable Canadian property&#148; (as defined in the Tax Act) to the <FONT
STYLE="white-space:nowrap">Non-Resident</FONT> Holder at the time of disposition and the gain is not exempt from tax pursuant to the terms of an applicable tax treaty between Canada and the <FONT STYLE="white-space:nowrap">Non-Resident</FONT>
Holder&#146;s jurisdiction of residence. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Provided the Warrant Shares are listed on a &#147;designated stock exchange&#148;, as defined in the Tax Act
(which currently includes the TSX and Nasdaq) at the time of disposition, the Warrant Shares will generally not constitute taxable Canadian property of a <FONT STYLE="white-space:nowrap">Non-Resident</FONT> Holder at that time, unless at any time
during the <FONT STYLE="white-space:nowrap">60-month</FONT> period immediately preceding the disposition the following two conditions are satisfied concurrently: (i)&nbsp;(a) the <FONT STYLE="white-space:nowrap">Non-Resident</FONT> Holder;
(b)&nbsp;persons with whom the <FONT STYLE="white-space:nowrap">Non-Resident</FONT> Holder did not deal at arm&#146;s length; (c)&nbsp;partnerships in which the <FONT STYLE="white-space:nowrap">Non-Resident</FONT> Holder or a person described in
(b)&nbsp;holds a membership interest directly or indirectly through one or more partnerships; or (d)&nbsp;any combination of the persons and partnerships described in (a)&nbsp;through (c), owned 25% or more of the issued shares of any class or
series of shares of the Company; AND (ii)&nbsp;more than 50% of the fair market value of the Warrant Shares was derived directly or indirectly from one or any combination of: real or immovable property situated in Canada, &#147;Canadian resource
properties&#148;, &#147;timber resource properties&#148; (each as defined in the Tax Act), or options in respect of, or interests in or for civil law rights in, such properties. Notwithstanding the foregoing, Warrant Shares may also be deemed to be
taxable Canadian property to a <FONT STYLE="white-space:nowrap">Non-Resident</FONT> Holder under certain other provisions of the Tax Act. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><FONT
STYLE="white-space:nowrap">Non-Resident</FONT> Holders who may hold Warrant Shares as taxable Canadian property should consult their own tax advisors. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">If
the Warrant Shares are, or are deemed to be, taxable Canadian properties to a <FONT STYLE="white-space:nowrap">Non-Resident</FONT> Holder (and the <FONT STYLE="white-space:nowrap">Non-Resident</FONT> Holder is not entitled to an exemption under an
applicable tax treaty or convention between Canada and the country in which the <FONT STYLE="white-space:nowrap">Non-Resident</FONT> Holder is resident), any capital gain (or loss) realized on the disposition or deemed disposition of such Warrant
Shares will generally be computed and taxed in the manner described above under the headings &#147;Taxation of Resident Holders<B> </B>&#150; <I>Disposition of Warrant Shares</I>&#148; and &#147;Taxation of Resident Holders &#150; <I>Capital Gains
and Losses</I>&#148;. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>THE ABOVE SUMMARY IS NOT INTENDED TO CONSTITUTE A COMPLETE ANALYSIS OF ALL CANADIAN TAX CONSIDERATIONS APPLICABLE TO HOLDERS
WITH RESPECT TO THE OWNERSHIP, EXERCISE OR DISPOSITION OF THE WARRANT SHARES. ALL HOLDERS (INCLUDING <FONT STYLE="white-space:nowrap">NON-RESIDENT</FONT> HOLDERS) SHOULD CONSULT THEIR OWN TAX ADVISORS AS TO THE TAX CONSIDERATIONS APPLICABLE TO THEM
IN THEIR PARTICULAR CIRCUMSTANCES. </B></P> <P STYLE="margin-top:24pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B><A NAME="supprom937513_16"></A>MATERIAL U.S. FEDERAL INCOME TAX CONSIDERATIONS </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The following is a discussion of material U.S. federal income tax consequences of the acquisition, ownership, and disposition of the Warrant Shares that are
applicable to a U.S. Holder, as defined below, that acquires the Warrant Shares upon the exercise of Warrants. This discussion is not a complete analysis or listing of all of the possible tax consequences of such transactions and does not address
all tax considerations that might be relevant </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">S-20 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left" style="font-size:10pt;font-weight:bold"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
to particular holders in light of their personal circumstances or to persons that are subject to special tax rules. In particular, the information set forth below deals only with U.S. Holders
that will hold Warrant Shares as capital assets for U.S. federal income tax purposes (generally, property held for investment) and that do not own 10&nbsp;percent or more of the total combined voting power of all classes of Company stock entitled to
vote or 10&nbsp;percent or more of the total value of shares of all classes of Company stock. In addition, this discussion of the U.S. federal income tax consequences does not address the tax treatment of special classes of U.S. Holders, such as:
financial institutions; regulated investment companies; real estate investment trusts; <FONT STYLE="white-space:nowrap">tax-exempt</FONT> entities; insurance companies; persons holding Warrants and the Warrant Shares as part of a hedging, integrated
or conversion transaction, constructive sale or &#147;straddle&#148;; persons who acquired Warrants or Warrant Shares through the exercise or cancellation of employee stock options or otherwise as compensation for their services; U.S. expatriates;
persons subject to an alternative minimum tax; persons that generally mark their securities to market for U.S. federal income tax purposes; dealers or traders in securities or currencies; or holders whose functional currency is not the U.S. dollar.
</P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">This discussion does not address estate and gift tax, any U.S. federal tax other than income tax, or tax consequences under any state, local or foreign
laws. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">For purposes of this section, a &#147;U.S. Holder&#148; is a beneficial owner of the Warrants and Warrant Shares that is: (1)&nbsp;an individual
citizen of the United States or a resident alien of the United States as determined for U.S. federal income tax purposes; (2)&nbsp;a corporation (or other entity treated as a corporation for U.S. federal income tax purposes) created or organized
under the laws of the United States, any state thereof or the District of Columbia; (3)&nbsp;an estate the income of which is subject to U.S. federal income taxation regardless of its source; or (4)&nbsp;a trust (A)&nbsp;if a court within the United
States is able to exercise primary supervision over its administration and one or more U.S. persons have authority to control all substantial decisions of the trust or (B)&nbsp;that has a valid election in effect under applicable U.S. Treasury
regulations to be treated as a U.S. person. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">If a partnership or other pass-through entity is a beneficial owner of the Warrant and Warrant Shares, the
tax treatment of a partner or other owner will generally depend upon the status of the partner (or other owner) and the activities of the entity. A U.S. Holder that is a partner (or other owner) of a pass-through entity that acquires Warrants or
Warrant Shares is urged to consult its own tax advisor regarding the tax consequences of acquiring, owning and disposing of Warrants or Warrant Shares. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The following discussion is based upon the U.S. Internal Revenue Code of 1986, as amended (the &#147;<B>Code</B>&#148;), existing and proposed U.S. Treasury
regulations, U.S. judicial decisions and administrative pronouncements, all as in effect as of the date hereof. All of the preceding authorities are subject to change, possibly with retroactive effect, so as to result in U.S. federal income tax
consequences different from those discussed below. The Company has not requested, and will not request, a ruling from the IRS with respect to any of the U.S. federal income tax consequences described below, and as a result there can be no assurance
that the IRS will not disagree with or challenge any of the conclusions described herein. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">As discussed below, the Company does not believe that it was a
PFIC for the year ended June&nbsp;30, 2022, the nine month fiscal period ended March&nbsp;31, 2023 or the year ended March&nbsp;31, 2024<B>.</B> This discussion assumes that the Company is not a PFIC, as discussed below under &#147;<I>Passive
Foreign Investment Company Considerations</I>&#148;. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>The following discussion is for general information only and is not intended to be, nor should it
be construed to be, legal or tax advice to any holder or prospective holder of Warrants or Warrant Shares and no opinion or representation with respect to the U.S. federal income tax consequences to any such holder or prospective holder is made.
Prospective purchasers are urged to consult their own tax advisors as to the particular consequences to them under U.S. federal, state and local, and applicable foreign, tax laws of the acquisition, ownership and disposition of Warrants or Warrant
Shares. </B></P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">S-21 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left" style="font-size:10pt;font-weight:bold"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Acquisition of Warrant Shares </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">A U.S. Holder generally should not recognize gain or loss on the exercise of Warrants and related receipt of Warrant Shares. A U.S. Holder&#146;s initial tax
basis in the Warrant Shares received on the exercise of a Warrant should be equal to the sum of (a)&nbsp;such U.S. Holder&#146;s tax basis in such Warrant plus (b)&nbsp;the exercise price paid by such U.S. Holder on the exercise of such Warrant. It
is unclear whether a U.S. Holder&#146;s holding period for the Warrant Shares received upon exercise of the Warrant will commence on the date of exercise of the Warrant or the immediately following date. In either case, the holding period will not
include the period during which the U.S. Holder held the Warrant. The U.S. federal income tax treatment of a cashless exercise of a Warrant is uncertain. Each U.S. Holder is urged to consult its own tax advisor regarding the proper treatment of any
cashless exercise of Warrants and the tax basis in, and the holding period for, the Warrant Shares received on such exercise. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Ownership and
Disposition of Warrant Shares </B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The following discussion is subject in its entirety to the rules described below under the heading &#147;Passive Foreign
Investment Company Considerations&#148;. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I>Distributions </I></B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Subject to the PFIC rules discussed below, the gross amount of any distribution made by the Company (without reduction for any Canadian income tax withheld
from such distribution) will generally be subject to U.S. federal income tax as dividend income to the extent paid out of the Company&#146;s current or accumulated earnings and profits, as determined under U.S. federal income tax principles. Such
amount will be includable in gross income by a U.S. Holder on the date that the U.S. Holder actually or constructively receives the distribution in accordance with its regular method of accounting for U.S. federal income tax purposes. The amount of
any distribution made by the Company in property other than cash will be the fair market value of such property on the date of the distribution. Dividends paid by the Company will not be eligible for the dividends received deduction allowed to
corporations. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Subject to applicable exceptions with respect to short-term and hedged positions, certain dividends received by <FONT
STYLE="white-space:nowrap">non-corporate</FONT> U.S. Holders from a &#147;qualified foreign corporation&#148; may be eligible for reduced rates of taxation. If the requirements for such reduced rates are not satisfied,
<FONT STYLE="white-space:nowrap">a&nbsp;non-corporate&nbsp;U.S.</FONT> Holder may be subject to tax on the dividend at regular ordinary income tax rates. A qualified foreign corporation includes a foreign corporation that is eligible for the
benefits of a comprehensive income tax treaty with the United States that the U.S. Treasury Department determines to be satisfactory for these purposes and that includes an exchange of information provision. The U.S. Treasury Department has
determined that the income tax treaty between the United States and Canada meets these requirements, and the Company believes that it is eligible for the benefits of this treaty. A foreign corporation is also treated as a qualified foreign
corporation with respect to dividends paid by that corporation on ordinary shares that are readily tradable on an established securities market in the United States. U.S. Treasury Department guidance indicates that the Company&#146;s securities will
be readily tradable on an established securities market in the United States; however, there can be no assurance that the Warrant Shares will be considered readily tradable on an established securities market in the United States in future years.
Dividends received by U.S. investors from a foreign corporation that was a PFIC in either the taxable year of the distribution or the preceding taxable year will not constitute dividends eligible for the reduced rates of taxation described above.
Instead, such dividends would be subject to tax at ordinary income rates and to additional rules described below under &#147;Passive Foreign Investment Company Considerations&#148;. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">To the extent that a distribution exceeds the amount of the Company&#146;s current and accumulated earnings and profits, as determined under U.S. federal
income tax principles, it will be treated first as a <FONT STYLE="white-space:nowrap">tax-free</FONT> return of capital, causing a reduction in the U.S. Holder&#146;s adjusted tax basis in the Warrant Shares held by such U.S. Holder (thereby
increasing the amount of gain, or decreasing the amount of loss, to be recognized by such U.S. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">S-22 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left" style="font-size:10pt;font-weight:bold"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
Holder upon a subsequent disposition of the Warrant Shares), with any amount that exceeds the adjusted tax basis being treated as a capital gain recognized on a sale, exchange or other taxable
disposition (as discussed below). However, the Company does not intend to maintain calculations of its earnings and profits in accordance with U.S. federal income tax principles, and a U.S. Holder should therefore assume that any distribution by the
Company with respect to the Warrant Shares will be treated as dividends for U.S. federal income tax purposes. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">In general, any Canadian withholding tax
imposed on dividend payments in respect of the Warrant Shares will be treated as a foreign income tax eligible for credit against a U.S. Holder&#146;s U.S. federal income tax liability (or, at a U.S. Holder&#146;s election, may, in certain
circumstances, be deducted in computing taxable income). Dividends paid on the Warrant Shares will be treated as foreign-source income, and generally will be treated as &#147;passive category income&#148; for U.S. foreign tax credit purposes. The
Code applies various complex limitations on the amount of foreign taxes that may be claimed as a credit by U.S. taxpayers. Accordingly, U.S. Holders are urged to consult their own tax advisors regarding the availability of the foreign tax credit
under their particular circumstances. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I>Sale, Exchange or Other Taxable Disposition of Warrant Shares </I></B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">A U.S. Holder generally will recognize gain or loss upon the sale, exchange or other taxable disposition of Warrant Shares in an amount equal to the difference
between (i)&nbsp;the amount realized upon the sale, exchange or other taxable disposition and (ii)&nbsp;such U.S. Holder&#146;s adjusted tax basis in the Warrant Shares. Generally, subject to the application of the PFIC rules discussed below, such
gain or loss will be capital gain or loss and will be long-term capital gain or loss if, on the date of the sale, exchange or other taxable disposition, the U.S. Holder has held the Warrant Shares for more than one year. For <FONT
STYLE="white-space:nowrap">non-corporate</FONT> U.S. Holders, long-term capital gains are subject to taxation at favorable rates. The deductibility of capital losses is subject to limitations under the Code. Gain or loss, if any, realized upon a
sale, exchange or other taxable disposition of the Warrant Shares will be treated as having a United States source for U.S. foreign tax credit limitation purposes. Consequently, a U.S. Holder may not be able to use any foreign tax credits arising
from any Canadian tax imposed on the sale, exchange or other taxable disposition of the Warrant Shares unless such credit can be applied (subject to applicable limitations) against tax due on other income treated as derived from foreign sources or
unless an applicable treaty provides otherwise. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Passive Foreign Investment Company Considerations </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Special, generally unfavorable, U.S. federal income tax rules apply to U.S. persons owning stock of a PFIC. A foreign corporation will be considered a PFIC for
any taxable year in which, after taking into account the income and assets of the corporation and certain subsidiaries pursuant to applicable &#147;look through&#148; rules, either (1)&nbsp;at least 75&nbsp;percent of its gross income is
&#147;passive&#148; income (the &#147;income test&#148;) or (2)&nbsp;at least 50&nbsp;percent of the average value of its assets is attributable to assets that produce passive income or are held for the production of passive income (the &#147;asset
test&#148;). For purposes of determining whether a foreign corporation will be considered a PFIC, such foreign corporation will be treated as holding its proportionate share of the assets and receiving directly its proportionate share of the income
of any other corporation in which it owns, directly or indirectly, more than 25&nbsp;percent (by value) of the stock. PFIC status is fundamentally factual in nature. It generally cannot be determined until the close of the taxable year in question
and is determined annually. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The Company does not believe that it was a PFIC for the year ended June&nbsp;30, 2022, the nine month fiscal period ended
March&nbsp;31, 2023 or the year ended March&nbsp;31, 2024<B>.</B> The determination of PFIC status for any year is very fact specific, being based on the types of income the Company earns and the types and value of the Company&#146;s assets from
time to time, all of which are subject to change, as well as, in part, the application of complex U.S. federal income tax rules, which are subject to differing interpretations. As a result, there can be no assurance in this regard, and the IRS may
challenge the Company&#146;s classification. Accordingly, it is possible that the Company may be classified as a PFIC in a past year, in its current taxable year, or in future years. If the Company is classified as a PFIC in any year during which a
U.S. Holder holds the Warrant Shares, the Company </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">S-23 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left" style="font-size:10pt;font-weight:bold"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
generally will continue to be treated as a PFIC as to such U.S. Holder in all succeeding years, regardless of whether the Company continues to meet the income or asset test discussed above. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">If the Company were classified as a PFIC for any taxable year during which a U.S. Holder holds the Warrants or Warrant Shares, such U.S. Holder would be
subject to increased tax liability (generally including an interest charge) upon the sale, exchange or other disposition of the Warrants or Warrant Shares or upon the receipt of certain distributions treated as &#147;excess distributions&#148;,
regardless of whether such income was actually distributed. An excess distribution generally would be the portion of any distributions to a U.S. Holder with respect to the Warrants or Warrant Shares during a single taxable year that are in total
greater than 125% of the average annual distributions received by such U.S. Holder with respect to the Warrants or Warrant Shares during the three preceding taxable years or, if shorter, during such U.S. Holder&#146;s holding period for such
Warrants or Warrant Shares. Generally, a U.S. Holder would be required to allocate any excess distribution or gain from the sale or other disposition of the Warrants or Warrant Shares rateably over its holding period for such Warrants or Warrant
Shares. Such amounts would be taxed as ordinary income at the highest applicable rate in effect for each taxable year of the holding period, and amounts allocated to prior taxable years would be subject to an interest charge at a rate applicable to
underpayments of tax. As described below under &#147;<I>Information Reporting and Backup Withholding</I>&#148;, if the Company were classified as a PFIC, such U.S. Holders would generally be required to file IRS Form 8261. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">If the Company were classified as a PFIC, certain elections could be available to mitigate the consequences described above. If the Warrant Shares are
regularly traded on a registered national securities exchange or certain other exchanges or markets, then such Warrant Shares will constitute &#147;marketable stock&#148; for purposes of the PFIC rules. The Company expects that the Warrant Shares
will constitute &#147;marketable stock&#148; for purposes of the PFIC rules. U.S. Holders that make a <FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">&#147;mark-to-market</FONT></FONT> election&#148; with respect to such marketable
stock would not be subject to the foregoing PFIC rules. After making such an election, a U.S. Holder generally would include as ordinary income each year during which the election is in effect and during which the Company is a PFIC the excess, if
any, of the fair market value of the Warrant Shares at the end of the taxable year over the U.S. Holder&#146;s adjusted tax basis in such Warrant Shares. These amounts of ordinary income would not be eligible for the favourable tax rates applicable
to qualified dividend income or long-term capital gains. A U.S. Holder with a <FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">mark-to-market</FONT></FONT> election in effect also would be allowed to take an ordinary loss in respect
of the excess, if any, of its adjusted tax basis in the Warrant Shares over their fair market value at the end of the taxable year (but only to the extent of the net amount of income that was previously included as a result of the <FONT
STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">mark-to-market</FONT></FONT> election). A U.S. Holder&#146;s tax basis in the Warrant Shares would be adjusted to reflect any income or loss amounts resulting from a <FONT
STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">mark-to-market</FONT></FONT> election. If made, a <FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">mark-to-market</FONT></FONT> election would be effective for the taxable
year for which the election was made and for all subsequent taxable years unless the Warrant Shares ceased to qualify as &#147;marketable stock&#148; for purposes of the PFIC rules or the IRS consented to the revocation of the election. In the event
that the Company is classified as a PFIC, U.S. Holders are urged to consult their own tax advisor regarding the availability of the <FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">mark-to-market</FONT></FONT> election, and whether
the election would be advisable in their particular circumstances. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The PFIC tax rules outlined above also would not apply, and different rules would
apply, to a U.S. Holder that elected to treat the Company as a &#147;qualified electing fund&#148; or &#147;QEF&#148; by making a timely and valid QEF election (if eligible to do so) in the first taxable year in which such U.S. Holder held (or was
deemed to hold) Warrant Shares and the Company is classified as a PFIC. Generally, a QEF election should be made on or before the due date for filing such U.S. Holder&#146;s U.S. federal income tax return for such taxable year. An election with
respect to Warrant Shares to treat the Company as a QEF will not be available, however, if the Company does not provide the information necessary to make such an election. There can be no assurance that the Company will provide to a U.S. Holder the
necessary information in order to enable such U.S. Holder to make and maintain a QEF Election. There is also no assurance that the Company will have timely knowledge of its status as a PFIC in the future or of the required information to be
provided. For purposes of making a QEF election, a U.S. Holder&#146;s holding period in Warrant Shares includes its holding period in the Warrants exercised in exchange for such </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">S-24 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left" style="font-size:10pt;font-weight:bold"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
Warrant Shares. A QEF election may not be made with respect to Warrants. U.S. Holders are urged to consult their own tax advisor regarding the manner and consequences of making a QEF election.
</P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">As discussed above in &#147;Distributions&#148;, notwithstanding any election made with respect to Warrant Shares, if the Company is a PFIC in either the
taxable year of the distribution or the preceding taxable year, dividends received with respect to Warrant Shares will not qualify for reduced rates of taxation. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Receipt of Foreign Currency </B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The gross amount of any
payment in a currency other than U.S. dollars will be included by each U.S. Holder in income in a U.S. dollar amount calculated by reference to the exchange rate in effect on the day such U.S. Holder actually or constructively receives the payment
in accordance with its regular method of accounting for U.S. federal income tax purposes regardless of whether the payment is in fact converted into U.S. dollars at that time. If the foreign currency is converted into U.S. dollars on the date of the
payment, the U.S. Holder should not be required to recognize any foreign currency gain or loss with respect to the receipt of foreign currency. If, instead, the foreign currency is converted at a later date, any currency gains or losses resulting
from the conversion of the foreign currency will be treated as U.S. source ordinary income or loss for U.S. foreign tax credit purposes. U.S. Holders are urged to consult their own U.S. tax advisors regarding the U.S. federal income tax consequences
of receiving, owning, and disposing of foreign currency. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Additional Tax on Passive Income </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">U.S. Holders that are individuals, estates or trusts are required to pay an additional 3.8% tax on the lesser of (1)&nbsp;the U.S. Holder&#146;s &#147;net
investment income&#148; for the relevant taxable year and (2)&nbsp;the excess of the U.S. Holder&#146;s modified adjusted gross income for the taxable year over a certain threshold. A U.S. Holder&#146;s &#147;net investment income&#148; generally
includes, among other things, dividends and net gains from disposition of property (other than property held in the ordinary course of the conduct of a trade or business). Accordingly, dividends on and capital gain from the sale, exchange or other
taxable disposition of Warrant Shares may be subject to this additional tax. U.S. Holders are urged to consult their own tax advisors regarding the additional tax on passive income. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Information Reporting and Backup Withholding </B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">In general,
dividends paid to a U.S. Holder in respect of Warrant Shares and the proceeds received by a U.S. Holder from the sale, exchange or other disposition of Warrant Shares within the United States or through certain U.S.-related financial intermediaries
will be subject to U.S. information reporting rules, unless a U.S. Holder is a corporation or other exempt recipient and properly establishes such exemption. Backup withholding may apply to such payments if a U.S. Holder does not establish an
exemption from backup withholding and fails to provide a correct taxpayer identification number and make any other required certifications. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Backup
withholding is not an additional tax. Any amounts withheld under the backup withholding rules will be allowed as a refund or credit against U.S. federal income tax liability, provided that the required information is timely furnished to the IRS.
</P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">In addition, U.S. Holders should be aware of reporting requirements with respect to the holding of certain foreign financial assets, including stock of
foreign issuers which is not held in an account maintained by certain financial institutions, if the aggregate value of all of such assets exceeds U.S.$50,000. U.S. Holders must attach a complete IRS Form 8938, Statement of Specified Foreign
Financial Assets, with their return for each year in which they hold Warrant Shares. U.S. Holders should also be aware that if the Company were a PFIC, they would generally be required to file IRS Form 8261, Information Return by a Shareholder of a
Passive Foreign Investment Company or Qualified Electing Fund, during any taxable year in which such U.S. Holder recognizes gain or receives an excess distribution or with respect to which the U.S. Holder has made certain elections. U.S. Holders are
urged to consult their own tax advisors regarding the application of the information reporting rules to Warrant Shares and their particular situations. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">S-25 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left" style="font-size:10pt;font-weight:bold"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>EACH PROSPECTIVE INVESTOR IS URGED TO CONSULT ITS OWN TAX ADVISOR ABOUT THE TAX CONSEQUENCES TO IT OF AN
INVESTMENT IN WARRANT SHARES IN LIGHT OF THE INVESTOR&#146;S OWN CIRCUMSTANCES. </B></P> <P STYLE="margin-top:24pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B><A NAME="supprom937513_17"></A>AGENT FOR SERVICE OF
PROCESS </B></P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Miguel Martin, the Chief Executive Officer and a director of the Company, and Simona King, the Chief Financial Officer of the Company, reside
outside of Canada. Each of Miguel Martin and Simona King has appointed the Company, at its head office located at 2207 90B St. SW, Edmonton, Alberta, Canada T6X 1V8 as their agent for service of process in Canada. Purchasers are advised that it may
not be possible for investors to enforce judgments obtained in Canada against any such person, even though they have each appointed an agent for service of process. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Investors are advised that it may not be possible for investors to enforce judgments obtained in Canada against any person who resides outside of Canada or a
company that is incorporated, continued or otherwise organized under the laws of a foreign jurisdiction, even if the party has appointed an agent for service of process. </P>
<P STYLE="margin-top:24pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B><A NAME="supprom937513_18"></A>INTERESTS OF EXPERTS </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The following persons or companies are named as having prepared or certified a report, valuation, statement or opinion in this Prospectus, either directly or
in a document incorporated herein by reference, and whose profession or business gives authority to the report, valuation, statement or opinion made by the expert. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">KPMG LLP, Chartered Professional Accountants, is the former auditor of the Company and the auditor of the Annual Financial Statements. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">KPMG LLP has confirmed that they are independent of the Company within the meaning of the relevant rules and related interpretations prescribed by the
relevant professional bodies in Canada and any applicable legislation or regulations and also that they are independent accountants with respect to the Company under all relevant U.S. professional and regulatory standards. </P>
<P STYLE="margin-top:24pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B><A NAME="supprom937513_19"></A>LEGAL MATTERS </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Certain legal matters relating to the Offering under this Prospectus Supplement will be passed upon on behalf of the Company by Stikeman Elliott LLP, as to
matters of Canadian law, and Paul, Weiss, Rifkind, Wharton&nbsp;&amp; Garrison LLP, as to matters of United States law. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">As of the date of this Prospectus
Supplement, the partners and associates of Stikeman Elliott LLP, as a group, beneficially, directly or indirectly, own less than 1% of any class of securities of the Company. </P>
<P STYLE="margin-top:24pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B><A NAME="supprom937513_20"></A>AUDITORS, TRANSFER AGENT AND REGISTRAR AND WARRANT AGENT </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Ernst&nbsp;&amp; Young LLP, Chartered Professional Accountants was appointed as the new auditor of the Company, effective June&nbsp;25, 2024. Ernst&nbsp;&amp;
Young LLP are the independent accountants of the Company within the meaning of the relevant rules and related interpretations prescribed by the relevant professional bodies in Canada and any applicable legislation or regulations and also are
independent accountants with respect to the Company under all relevant U.S. professional and regulatory standards. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">S-26 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left" style="font-size:10pt;font-weight:bold"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The transfer agent and registrar for the Common Shares of the Company is Computershare Trust Company of
Canada at its principal office in Vancouver, British Columbia and Toronto, Ontario, and the United States <FONT STYLE="white-space:nowrap">co-transfer</FONT> agent for the Common Shares is Computershare Trust Company, N.A., at its office in Canton,
Massachusetts. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The warrant agent for the Warrants is Computershare Trust Company of Canada at its principal office in Vancouver, British Columbia. </P>
<P STYLE="margin-top:24pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B><A NAME="supprom937513_21"></A>ADDITIONAL INFORMATION </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The Company has filed the Registration Statement with the SEC. This Prospectus Supplement and the accompanying Base Prospectus, which constitute part of the
Registration Statement, together do not contain all of the information set forth in the Registration Statement or the accompanying exhibits and schedules, as certain items that are not included in the Prospectus are included in the Registration
Statement in accordance with the rules and regulations of the SEC. For further information with respect to us and the securities offered in the Prospectus, see the Registration Statement and the accompanying exhibits and schedules. Statements
contained in the Prospectus Supplement and Base Prospectus regarding the contents of any contract, agreement or any other document are summaries of the material terms of these contracts, agreements or other documents. With respect to each of these
contracts, agreements or other documents filed as an exhibit to the Registration Statement, reference is made to such exhibit for a more complete description of the matter involved. Such contracts, agreements, or other documents are or will also be
filed by the Company on SEDAR+ at www.sedarplus.ca in accordance with applicable Canadian securities laws. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">We are subject to the informational reporting
requirements of the U.S. Exchange Act as the Common Shares are registered under Section&nbsp;12(b) of the U.S. Exchange Act. Accordingly, we are required to publicly file reports and other information with the SEC. Under the MJDS, the Company is
permitted to prepare such reports and other information in accordance with Canadian disclosure requirements, which are different from United States disclosure requirements. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">As a foreign private issuer, we are exempt from the rules under the U.S. Exchange Act prescribing the furnishing and content of proxy statements in connection
with meetings of its shareholders. In addition, the officers, directors and principal shareholders of the Company are exempt from the reporting and short-swing profit recovery rules contained in Section&nbsp;16 of the U.S. Exchange Act. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The Company files annual reports on Form <FONT STYLE="white-space:nowrap">40-F</FONT> with the SEC under the MJDS, which annual reports include: </P>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">the annual information form; </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">management&#146;s annual discussion and analysis of financial condition and results of operations;
</P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">consolidated audited financial statements, which are prepared in accordance with IFRS, as issued by the IASB; and
</P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">other information specified by the Form <FONT STYLE="white-space:nowrap">40-F.</FONT> </P></TD></TR></TABLE>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">As a foreign private issuer, the Company is required to furnish the following types of information to the SEC under cover of Form <FONT
STYLE="white-space:nowrap">6-K:</FONT> </P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">material information that the Company otherwise makes publicly available in reports that the Company files with
securities regulatory authorities in Canada; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">material information that the Company files with, and which is made public by, the TSX and Nasdaq; and
</P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">material information that the Company distributes to its shareholders in Canada. </P></TD></TR></TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">S-27 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left" style="font-size:10pt;font-weight:bold"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Investors may read and download the documents the Company has filed with the SEC&#146;s Electronic Data
Gathering and Retrieval system (&#147;<B>EDGAR</B>&#148;) website at www.sec.gov. Investors may read and download any public document that the Company has filed with the securities commissions or similar regulatory authorities in Canada at
www.sedarplus.ca. </P> <P STYLE="margin-top:24pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B><A NAME="supprom937513_22"></A>ENFORCEABILITY OF CIVIL LIABILITIES BY U.S. INVESTORS </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The Company is a corporation existing under the <I>Business Corporations Act</I> (British Columbia). Other than Martin Miguel, Margaret Shan Atkins and Lance
Friedmann, all of our directors and officers, and all of the experts named in this Prospectus Supplement or the accompanying Base Prospectus, are residents of Canada or otherwise reside outside the United States, and all or a substantial portion of
their assets, and a majority of the Company&#146;s assets, are located outside the United States. The Company has appointed an agent for service of process in the United States, but it may be difficult for holders of Warrant Shares who reside in the
United States to effect service within the United States upon those directors, officers and experts who are not residents of the United States. It may also be difficult for holders of the Securities who reside in the United States to realize upon
judgments of courts of the United States predicated upon the Company&#146;s civil liability and the civil liability of its directors, officers and experts under the United States federal securities laws. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">We have been advised by our Canadian legal counsel, Stikeman Elliott LLP, that a judgment of a United States court predicated solely upon civil liability
under United States federal securities laws would probably be enforceable in Canada if the United States court in which the judgment was obtained has a basis for jurisdiction in the matter that would be recognized by a Canadian court for the same
purposes. We have also been advised by Stikeman Elliott LLP, however, that there is substantial doubt whether an action could be brought in Canada in the first instance on the basis of liability predicated solely upon United States federal
securities laws. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The Company filed with the SEC, concurrently with our Registration Statement, an appointment of agent for service of process on Form <FONT
STYLE="white-space:nowrap">F-X.</FONT> Under the Form <FONT STYLE="white-space:nowrap">F-X,</FONT> the Company appointed Puglisi&nbsp;&amp; Associates as our agent for service of process in the United States in connection with any investigation or
administrative proceeding conducted by the SEC, and any civil suit or action brought against or involving the Company in a United States court arising out of, related to, or concerning the Warrant Shares under this Prospectus Supplement and the
accompanying Base Prospectus. </P> <P STYLE="margin-top:24pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B><A NAME="supprom937513_23"></A>DOCUMENTS FILED AS PART OF THE REGISTRATION STATEMENT </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">In addition to the documents referred to in the Base Prospectus, the following documents have been or will (through post-effective amendment or incorporation
by reference) be filed with the SEC as part of the Registration Statement: </P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">(i)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">the documents referred to under the heading &#147;Documents Incorporated by Reference&#148; in this Prospectus
Supplement and in the Base Prospectus; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">(ii)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">the Underwriting Agreement among the Company and the Underwriters; </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">(iii)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">the Warrant Indenture between the Company and the Warrant Agent; and </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">(iv)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">the consent of Stikeman Elliott LLP, the Company&#146;s Canadian counsel. </P></TD></TR></TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">S-28 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left" style="font-size:10pt;font-weight:bold"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>SHORT FORM BASE SHELF PROSPECTUS </B></P>
<P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="51%"></TD>

<TD VALIGN="bottom" WIDTH="2%"></TD>
<TD WIDTH="47%"></TD></TR>


<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"><U>New Issue and/or Secondary Offering</U></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top" ALIGN="right">February 14, 2025</TD></TR>
</TABLE> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P> <P STYLE="font-size:0pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P> <P STYLE="margin-top:0pt;margin-bottom:0pt" ALIGN="center">


<IMG SRC="g850789g81j29.jpg" ALT="LOGO" STYLE="width:2.42483in;height:1.18223in;">
 </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:20pt; font-family:Times New Roman" ALIGN="center"><B>AURORA CANNABIS INC. </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:14pt; font-family:Times New Roman" ALIGN="center"><B>U.S.$250,000,000 </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:14pt; font-family:Times New Roman" ALIGN="center"><B>Common Shares </B></P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:14pt; font-family:Times New Roman" ALIGN="center"><B>Warrants
</B></P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:14pt; font-family:Times New Roman" ALIGN="center"><B>Options </B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:14pt; font-family:Times New Roman" ALIGN="center"><B>Subscription Receipts </B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:14pt; font-family:Times New Roman" ALIGN="center"><B>Debt Securities </B></P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:14pt; font-family:Times New Roman" ALIGN="center"><B>Units
</B></P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">This short form base shelf prospectus (the &#147;<B>Prospectus</B>&#148;) relates to the offering for sale of common shares (the &#147;<B>Common
Shares</B>&#148;), warrants (the &#147;<B>Warrants</B>&#148;), options (the &#147;<B>Options</B>&#148;), subscription receipts (the &#147;<B>Subscription Receipts</B>&#148;), debt securities (the &#147;<B>Debt Securities</B>&#148;), or any
combination of such securities (the &#147;<B>Units</B>&#148;) (all of the foregoing, collectively, the &#147;<B>Securities</B>&#148;) by Aurora Cannabis Inc. (the &#147;<B>Company</B>&#148; or &#147;<B>Aurora</B>&#148;) from time to time, during the
<FONT STYLE="white-space:nowrap">25-month</FONT> period that the Prospectus, including any amendments hereto, remains effective, in one or more series or issuances, with a total offering price of the Securities in the aggregate, of up to
U.S.$250,000,000. The Securities may be offered in amounts and at prices to be determined based on market conditions at the time of the sale and set forth in an accompanying prospectus supplement (a &#147;<B>Prospectus Supplement</B>&#148;). In
addition, Securities may be offered and issued in consideration for the acquisition of other businesses, assets or securities by the Company or a subsidiary of the Company. The consideration for any such acquisition may consist of any of the
Securities separately, a combination of Securities or any combination of, among other things, Securities, cash and assumption of liabilities. One or more securityholders of the Company may also offer and sell Securities under this Prospectus. See
&#147;<I>The Selling Securityholders</I>&#148;. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>This offering is made by a Canadian issuer that is permitted, under a multijurisdictional disclosure
system adopted by the United States and Canada (&#147;MJDS&#148;), to prepare this Prospectus in accordance with Canadian disclosure requirements. Prospective investors should be aware that such requirements are different from those of the United
States. Financial statements included or incorporated by reference herein have been prepared in accordance with International Financial Reporting Standards (&#147;IFRS&#148;) as issued by the International Accounting Standards Board
(&#147;IASB&#148;) and may not be comparable to financial statements of United States companies. Our financial statements are audited in accordance with the standards of the Public Company Accounting Oversight Board (United States). </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>The enforcement by investors of civil liabilities under United States federal securities laws may be affected adversely by the fact that the Company is
incorporated under the laws of British Columbia, Canada, that the majority of its officers and directors are residents of Canada, that some or all of the experts named in the registration statement are not residents of the United States, and that a
substantial portion of the assets of the Company and said persons are located outside the United States. </B></P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">i </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left" style="font-size:10pt;font-weight:bold"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>THESE SECURITIES HAVE NOT BEEN APPROVED OR DISAPPROVED BY THE UNITED STATES SECURITIES AND EXCHANGE
COMMISSION (THE &#147;SEC&#148;) OR ANY STATE OR CANADIAN SECURITIES COMMISSION NOR HAS ANY SUCH SECURITIES REGULATORY AUTHORITY PASSED UPON THE ACCURACY OR ADEQUACY OF THIS PROSPECTUS. ANY REPRESENTATION TO THE CONTRARY IS A CRIMINAL OFFENCE.
</B></P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Investing in Securities of the Company involves a high degree of risk. You should carefully review the risks outlined in this Prospectus (together
with any Prospectus Supplement) and in the documents incorporated by reference in this Prospectus and any Prospectus Supplement and consider such risks in connection with an investment in such Securities. See &#147;</B><B><I>Risk
Factors</I></B><B>&#148;. </B></P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Prospective investors should be aware that the acquisition of the Securities described herein may have tax consequences
both in the United States and in Canada. Such consequences for investors who are resident in, or citizens of, the United States may not be described fully herein. Prospective investors should read the tax discussion contained in the applicable
Prospectus Supplement with respect to a particular offering of Securities. </B></P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The specific terms of the Securities with respect to a particular offering
will be set out in one or more Prospectus Supplements and may include, where applicable: (i)&nbsp;in the case of Common Shares, the number of Common Shares offered, the offering price and any other specific terms; (ii)&nbsp;in the case of Warrants
or Options, the number of Warrants or Options offered, the offering price, the designation, number and terms of the Common Shares issuable upon exercise of the Warrants or Options, any procedures that will result in the adjustment of these numbers,
the exercise price, dates and periods of exercise, the currency in which the Warrants or Options are issued and any other specific terms; (iii)&nbsp;in the case of Subscription Receipts, the number of Subscription Receipts offered, the offering
price, the procedures for the exchange of the Subscription Receipts for Common Shares or Warrants, as the case may be, and any other specific terms; (iv)&nbsp;in the case of Debt Securities, the specific designation, aggregate principal amount, the
currency or the currency unit for which the Debt Securities may be purchased, the maturity, interest provisions, authorized denominations, offering price, covenants, events of default, any terms for redemption, any exchange or conversion terms,
whether the debt is senior, senior subordinated or subordinated, whether the debt is secured or unsecured and any other terms specific to the Debt Securities being offered; and (v)&nbsp;in the case of Units, the designation, number and terms of the
Common Shares, Warrants, Options, Subscription Receipts or Debt Securities comprising the Units. Where required by statute, regulation or policy, and where Securities are offered in currencies other than Canadian dollars, appropriate disclosure of
foreign exchange rates applicable to the Securities will be included in the Prospectus Supplement describing the Securities. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">In addition, the Debt
Securities that may be offered may be guaranteed by certain direct and indirect subsidiaries of Aurora with respect to the payment of the principal, premium, if any, and interest on the Debt Securities. The Company expects that any guarantee
provided in respect of senior Debt Securities would constitute a senior and unsecured obligation of the applicable guarantor. For a more detailed description of the Debt Securities that may be offered, see &#147;<I>Description of Securities &#150;
Debt Securities &#150; Guarantees</I>&#148;, below. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">All information permitted under applicable securities legislation to be omitted from the Prospectus
will be contained in one or more Prospectus Supplements that is required to be delivered to purchasers together with the Prospectus, except in cases where an exemption from such delivery requirement is available. Each Prospectus Supplement will be
incorporated by reference into the Prospectus for the purposes of applicable securities legislation as of the date of the Prospectus Supplement and only for the purposes of the distribution of the Securities to which the Prospectus Supplement
pertains. Investors should read the Prospectus and any applicable Prospectus Supplement carefully before investing in the Securities. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">This Prospectus
constitutes a public offering of the Securities only in those jurisdictions where they may be lawfully offered for sale and only by persons permitted to sell the Securities in such jurisdictions. We may offer and sell Securities to, or through,
underwriters, dealers or selling securityholders, directly to one or more other </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">ii </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left" style="font-size:10pt;font-weight:bold"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
purchasers, or through agents pursuant to exemptions from registration or qualification under applicable securities laws. A Prospectus Supplement relating to each issue of Securities will set
forth the names of any underwriters, dealers, agents or selling securityholders involved in the offering and sale of the Securities and will set forth the terms of the offering of the Securities, the method of distribution of the Securities,
including, to the extent applicable, the proceeds to us and any fees, discounts, concessions or other compensation payable to the underwriters, dealers or agents, and any other material terms of the plan of distribution. <B>This Prospectus may
qualify an <FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">at-the-market</FONT></FONT> distribution through a stock market or stock exchange outside of Canada. In connection with any offering of the Securities, other than an <FONT
STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">&#147;at-the-market</FONT></FONT> distribution&#148; (as defined under National Instrument <FONT STYLE="white-space:nowrap">44-102</FONT> &#150; </B><B><I>Shelf Distributions</I></B><B>
(&#147;NI <FONT STYLE="white-space:nowrap">44-102&#148;)</FONT> of the Canadian Securities Administrators) unless otherwise specified in a Prospectus Supplement, the underwriters or agents may over-allot or effect transactions which stabilize or
maintain the market price of the Securities offered at a higher level than that which might exist in the open market. Such transaction, if commenced, may be interrupted or discontinued at any time. See &#147;Plan of Distribution&#148;.</B> </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">No underwriter or dealer involved in an <FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">at-the-market</FONT></FONT> distribution under this
Prospectus, no affiliate of such an underwriter or dealer and no person or company acting jointly or in concert with such an underwriter or dealer will over-allot securities in connection with such distribution or effect any other transactions that
are intended to stabilize or maintain the market price of the Securities sold in the <FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">at-the-market</FONT></FONT> distribution. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>No underwriter has been involved in the preparation of the Prospectus or performed any review of the contents of the Prospectus. </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The Company&#146;s outstanding Common Shares are listed for trading on the Toronto Stock Exchange (the &#147;<B>TSX</B>&#148;) and on the Nasdaq Capital
Market (&#147;<B>Nasdaq</B>&#148;) under the trading symbol &#147;ACB&#148; and on the Frankfurt Stock Exchange (&#147;<B>FSE</B>&#148;) under the symbol &#147;21P&#148;. The closing price of the Company&#146;s Common Shares on the TSX, Nasdaq and
FSE on February 13, 2025 was $9.40<B> </B>per Common Share, U.S.$6.62 per Common Share and &#128;6.20 per Common Share, respectively. <B>Unless otherwise disclosed in any applicable Prospectus Supplement, the Debt Securities, the Warrants, the
Options, the Subscription Receipts and the Units will not be listed on any securities exchange. Unless the Securities are disclosed to be listed, there will be no market through which these Securities may be sold and purchasers may not be able to
resell these Securities purchased under this Prospectus. This may affect the pricing of such Securities in the secondary market, the transparency and availability of trading prices, the liquidity of such Securities, and the extent of issuer
regulation. See &#147;</B><B><I>Risk Factors</I></B><B>&#148;. </B> </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>All references in this Prospectus to &#147;dollars&#148; or &#147;C$&#148; are to
Canadian dollars and all references to &#147;U.S.$&#148; are to United States dollars. </B></P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Miguel Martin, the Chief Executive Officer and a director of
the Company, and Simona King, the Chief Financial Officer of the Company have appointed the Company, at its head office located at 2207 90B St. SW, Edmonton, Alberta, Canada T6X 1V8 as their agent for service of process in Canada. Purchasers are
advised that it may not be possible for investors to enforce judgments obtained in Canada against any such person, even though they have each appointed an agent for service of process. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The corporate head office of the Company is located at 2207 90B St. SW, Edmonton, Alberta, Canada T6X 1V8. The registered office of the Company is located at
Suite 1700, 666 Burrard Street, Vancouver, British Columbia, V6C 2X8. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">iii </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left" style="font-size:10pt;font-weight:bold"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B><A HREF="#toc">TABLE OF CONTENTS</A> </B></P>
<P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="97%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD></TD>
<TD></TD>
<TD></TD></TR>


<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><A HREF="#toc850789_1">General Matters</A></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">1</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><A HREF="#toc850789_2">About This Prospectus</A></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">1</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><A HREF="#toc850789_3">Documents Incorporated by Reference</A></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">1</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><A HREF="#toc850789_4">Cautionary Note Regarding Forward Looking Statements</A></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">3</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><A HREF="#toc850789_5">Note to United States Readers Regarding Differences Between United States and
 Canadian Financial Reporting Practices</A></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">6</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><A HREF="#toc850789_6"><FONT STYLE="white-space:nowrap">Non-IFRS</FONT> Measures</A></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">6</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><A HREF="#toc850789_7">Currency Presentation and Exchange Rate Information</A></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">7</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><A HREF="#toc850789_8">Our Business</A></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">7</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><A HREF="#toc850789_9">The Selling Securityholders</A></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">8</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><A HREF="#toc850789_10">Use of Proceeds</A></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">8</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><A HREF="#toc850789_11">Earnings Coverage Ratio</A></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">8</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><A HREF="#toc850789_12">Consolidated Capitalization</A></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">9</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><A HREF="#toc850789_13">Trading Price and Volume</A></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">9</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><A HREF="#toc850789_14">Prior Sales</A></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">10</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><A HREF="#toc850789_15">Plan of Distribution</A></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">11</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><A HREF="#toc850789_16">Description of Securities</A></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">12</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><A HREF="#toc850789_17">Risk Factors</A></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">26</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><A HREF="#toc850789_18">Certain Income Tax Considerations</A></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">29</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><A HREF="#toc850789_19">Agent for Service of Process</A></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">29</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><A HREF="#toc850789_20">Interests of Experts</A></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">30</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><A HREF="#toc850789_21">Legal Matters</A></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">30</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><A HREF="#toc850789_22">Auditors, Transfer Agent and Registrar</A></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">30</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><A HREF="#toc850789_23">Additional Information</A></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">30</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><A HREF="#toc850789_24">Documents Filed as Part of the Registration Statement</A></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">31</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><A HREF="#toc850789_25">Enforceability of Civil Liabilities by U.S. Investors</A></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">32</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
</TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">iv </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left" style="font-size:10pt;font-weight:bold"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B><A NAME="toc850789_1"></A>GENERAL MATTERS </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">In this Prospectus, &#147;Aurora&#148;, &#147;we&#148;, &#147;us&#148; and &#147;our&#148; refers, collectively, to Aurora Cannabis Inc. and our wholly owned
subsidiaries. </P> <P STYLE="margin-top:24pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B><A NAME="toc850789_2"></A>ABOUT THIS PROSPECTUS </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">We are a British Columbia company that is a &#147;reporting issuer&#148; under Canadian securities laws in each of the provinces of Canada. In addition, our
Common Shares are registered under Section&nbsp;12(b) of the United States <I>Securities Exchange Act of 1934</I>, as amended (the &#147;<B>Exchange Act</B>&#148;). Our Common Shares are traded in Canada on the TSX and in the United States on Nasdaq
under the symbol &#147;ACB&#148;. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">This Prospectus is a base shelf prospectus that: </P>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">we have filed with the securities commissions in each of the provinces of Canada, except Qu&eacute;bec (the
&#147;<B>Canadian Qualifying Jurisdictions</B>&#148;) in order to qualify the offering of the Securities described in this Prospectus in accordance with NI <FONT STYLE="white-space:nowrap">44-102;</FONT> and </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">forms part of a registration statement on Form <FONT STYLE="white-space:nowrap">F-10</FONT> (the
&#147;<B>Registration Statement</B>&#148;) that we have or will file with the Securities and Exchange Commission (&#147;<B>SEC</B>&#148;) under the <I>United States Securities Act of 1933</I>, as amended (the &#147;<B>U.S. Securities Act</B>&#148;),
under the MJDS. </P></TD></TR></TABLE> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Under this Prospectus, we may sell any combination of the Securities described in this Prospectus in one or more
offerings up to a total aggregate initial offering price of U.S.$250,000,000. This Prospectus provides you with a general description of the Securities that we may offer. Each time we sell Securities under this Prospectus we will provide a
Prospectus Supplement that will contain specific information about the terms of that specific offering. The specific terms of the Securities in respect of which this Prospectus is being delivered will be set forth in the Prospectus Supplement. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The Company currently has an effective base shelf prospectus dated April&nbsp;27, 2023 (the &#147;<B>Original Base Prospectus</B>&#148;). The Company does not
currently have any plans to initiate additional drawdowns under the Original Base Prospectus and intends to withdraw the Original Base Prospectus when this Prospectus becomes effective. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>You should rely only on the information contained in or incorporated by reference into this Prospectus and in any applicable Prospectus Supplement. The
Company has not authorized anyone to provide you with different information. The Company is not making any offer of these Securities in any jurisdiction where the offer is not permitted by law. </B></P>
<P STYLE="margin-top:24pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B><A NAME="toc850789_3"></A>DOCUMENTS INCORPORATED BY REFERENCE </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>We incorporate by reference into this Prospectus documents that we have filed with securities commissions or similar authorities in Canada, which have also
been filed with, or furnished to, the SEC.</B> You may obtain copies of the documents incorporated herein by reference without charge from Aurora Cannabis Inc., 2207 90B St. SW Edmonton, Alberta, Canada T6X 1V8 (Telephone: <FONT
STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">1-855-279-4652)</FONT></FONT></FONT> Attn:&nbsp;Corporate Secretary. These documents are also available electronically from the website of Canadian
Securities Administrators at www.sedarplus.ca (&#147;<B>SEDAR+</B>&#148;) and from the SEC&#146;s EDGAR (as defined below) website at www.sec.gov. The Company&#146;s filings through SEDAR+ and EDGAR are not incorporated by reference in the
Prospectus except as specifically set out herein. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The following documents (&#147;<B>documents incorporated by reference</B>&#148; or &#147;<B>documents
incorporated herein by reference</B>&#148;) have been filed by us with various securities commissions or similar authorities in the provinces of </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">1 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left" style="font-size:10pt;font-weight:bold"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
Canada in which we are a reporting issuer, are specifically incorporated herein by reference and form an integral part of this Prospectus: </P>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">the annual information form of the Company for the year ended March&nbsp;31, 2024, dated and filed on SEDAR+ on
June&nbsp;20, 2024 (our &#147;<B>2024 AIF</B>&#148;); </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">the audited consolidated financial statements of the Company, and the notes thereto for the year ended
March&nbsp;31, 2024 and nine months ended March&nbsp;31, 2023, together with the reports of our independent registered public accounting firm thereon, filed on SEDAR+ on June&nbsp;20, 2024 (the &#147;<B>Annual Financial Statements</B>&#148;);
</P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">the management&#146;s discussion and analysis of financial condition and results of operations for the year ended
March&nbsp;31, 2024 and nine months ended March&nbsp;31, 2023, filed on SEDAR+ on June&nbsp;20, 2024 (our &#147;<B>2024 Annual MD&amp;A</B>&#148;);<SUP STYLE="font-size:75%; vertical-align:top"> </SUP> </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">the unaudited interim condensed consolidated financial statements of the Company, and the notes thereto for the
three and nine months ended December&nbsp;31, 2024 and 2023, filed on SEDAR+ on February&nbsp;5, 2025 (our &#147;<B>Interim Financial Statements</B>&#148;); </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">the management&#146;s discussion and analysis of financial condition and results of operations for the three and
nine months ended December&nbsp;31, 2024 and 2023, filed on SEDAR+ on February&nbsp;5, 2025 (our &#147;<B>Interim MD&amp;A</B>&#148;); </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">the management information circular of the Company dated June&nbsp;26, 2024, distributed in connection with the
Company&#146;s annual general and special meeting of shareholders held on August&nbsp;9, 2024, filed on SEDAR+ on July&nbsp;9, 2024; and </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">the material change report regarding the Company&#146;s commercial collaboration with Cogent International
Manufacturing Inc., dated and filed on SEDAR+ on August&nbsp;7, 2024; and </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">the material change report regarding the company&#146;s strategic supply agreement with SNDL Inc., dated and
filed on SEDAR+ on February 13, 2025. </P></TD></TR></TABLE> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Any document of the type referred to in section 11.1 of Form
<FONT STYLE="white-space:nowrap">44-101F1</FONT> of National Instrument <FONT STYLE="white-space:nowrap">44-101</FONT> &#150; <I>Short Form Prospectus Distributions</I> filed by the Company with the securities commissions or similar regulatory
authorities in Canada after the date of this Prospectus and all Prospectus Supplements disclosing additional or updated information filed pursuant to the requirements of applicable securities legislation in Canada and during the period that this
Prospectus is effective shall be deemed to be incorporated by reference into this Prospectus. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">When new documents of the type referred to in the paragraph
above are filed by the Company with the commissions or similar regulatory authorities in the jurisdictions in Canada in which the Company is a reporting issuer during the currency of this Prospectus, such documents will be deemed to be incorporated
by reference in this Prospectus and the previous documents of the type referred to in the paragraph above will no longer be deemed to be incorporated by reference in this Prospectus. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">To the extent that any document or information incorporated by reference into this Prospectus is included in any report on Form
<FONT STYLE="white-space:nowrap">6-K,</FONT> Form <FONT STYLE="white-space:nowrap">40-F,</FONT> Form <FONT STYLE="white-space:nowrap">20-F,</FONT> Form <FONT STYLE="white-space:nowrap">10-K,</FONT> Form <FONT STYLE="white-space:nowrap">10-Q</FONT>
or Form <FONT STYLE="white-space:nowrap">8-K</FONT> (or any respective successor form) that is filed with or furnished to the SEC after the date of this Prospectus, such document or information shall be deemed to be incorporated by reference as an
exhibit to the Registration Statement of which this Prospectus forms a part. In addition, we may incorporate by reference into this Prospectus, or the Registration Statement of which it forms a part, other information from documents that we file
with or furnish to the SEC pursuant to Section&nbsp;13(a) or 15(d) of the Exchange Act, if and to the extent expressly provided therein. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Any statement
contained in this Prospectus, any Prospectus Supplement or in a document incorporated or deemed to be incorporated by reference herein will be deemed to be modified or superseded to the extent that a statement contained herein, in any Prospectus
Supplement or in any other subsequently filed </B></P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">2 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left" style="font-size:10pt;font-weight:bold"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>
document that is also incorporated or is deemed to be incorporated by reference herein modifies or supersedes such statement. The modifying or superseding statement need not state that it has
modified or superseded a prior statement or include any other information set forth in the document that it modifies or supersedes. The making of a modifying or superseding statement will not be deemed an admission for any purpose that the modified
or superseded statement, when made, constituted a misrepresentation, an untrue statement of a material fact or an omission to state a material fact that is required to be stated or that is necessary to make a statement not misleading in light of the
circumstances in which it was made. Any statement so modified or superseded will not be deemed, except as so modified or superseded, to constitute a part of the Prospectus. </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Upon a new annual information form and related annual financial statements being filed by us with, and where required, accepted by, the applicable securities
regulatory authority during the currency of this Prospectus, the previous annual information form, the previous annual financial statements and all interim financial statements, material change reports and information circulars and all Prospectus
Supplements filed prior to the commencement of our financial year in which a new annual information form is filed shall be deemed no longer to be incorporated into this Prospectus for purposes of future offers and sales of Securities hereunder. Upon
condensed consolidated interim financial statements and the accompanying management&#146;s discussion and analysis of financial condition and results of operations being filed by us with the applicable Canadian securities commissions or similar
regulatory authorities during the period that this Prospectus is effective, all condensed consolidated interim financial statements and the accompanying management&#146;s discussion and analysis of financial condition and results of operations filed
prior to such new condensed consolidated interim financial statements and management&#146;s discussion and analysis of financial condition and results of operations shall be deemed to no longer be incorporated into this Prospectus for purposes of
future offers and sales of Securities under this Prospectus. In addition, upon a new management information circular for an annual meeting of shareholders being filed by us with the applicable Canadian securities commissions or similar regulatory
authorities during the period that this Prospectus is effective, the previous management information circular filed in respect of the prior annual meeting of shareholders shall no longer be deemed to be incorporated into this Prospectus for purposes
of future offers and sales of Securities under this Prospectus. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Any template version of any &#147;marketing materials&#148; (as such term is defined in
National Instrument <FONT STYLE="white-space:nowrap">41-101</FONT> &#150; <I>General Prospectus Requirements</I>) filed after the date of a Prospectus Supplement and before the termination of the distribution of the Securities offered pursuant to
such Prospectus Supplement (together with this Prospectus) is deemed to be incorporated by reference in such Prospectus Supplement. </P> <P STYLE="margin-top:24pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B><A NAME="toc850789_4"></A>CAUTIONARY NOTE REGARDING FORWARD LOOKING STATEMENTS </B></P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The Prospectus, including the documents incorporated by reference, contain forward-looking
statements and forward-looking information (collectively, &#147;<B>forward-looking statements</B>&#148;) which may not be based on historical fact. These forward-looking statements are made as of the date of this Prospectus or the applicable
document incorporated by reference herein, and the Company does not intend, and does not assume any obligation, to update these forward-looking statements, except as required under applicable securities legislation. Forward-looking statements relate
to future events or future performance and reflect Company management&#146;s expectations or beliefs regarding future events. In certain cases, forward-looking statements can be identified by the use of words such as &#147;plans&#148;,
&#147;expects&#148; or &#147;does not expect&#148;, &#147;is expected&#148;, &#147;budget&#148;, &#147;scheduled&#148;, &#147;estimates&#148;, &#147;forecasts&#148;, &#147;intends&#148;, &#147;anticipates&#148; or &#147;does not anticipate&#148;, or
&#147;believes&#148;, or variations of such words and phrases or statements that certain actions, events or results &#147;may&#148;, &#147;could&#148;, &#147;would&#148;, &#147;might&#148; or &#147;will be taken&#148;, &#147;occur&#148; or &#147;be
achieved&#148; or the negative of these terms or comparable terminology. In this document, certain forward-looking statements are identified by words including &#147;may&#148;, &#147;future&#148;, &#147;expected&#148;, &#147;intends&#148; and
&#147;estimates&#148;. By their very nature forward-looking statements involve known and unknown risks, uncertainties and other factors which may cause the actual results, performance or achievements of the Company to be materially different from
any future results, performance or achievements expressed or implied by the forward-</P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">3 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left" style="font-size:10pt;font-weight:bold"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
looking statements. The Company provides no assurance that forward-looking statements will prove to be accurate, as actual results and future events could differ materially from those anticipated
in such statements. Accordingly, readers should not place undue reliance on forward-looking statements. Forward-looking statements in this Prospectus and the documents incorporated by reference include, but are not limited to, statements with
respect to: </P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">pro forma measures including revenue, cash flow, adjusted gross margin before fair value adjustments, expected
SG&amp;A <FONT STYLE="white-space:nowrap">run-rates</FONT> and grams produced; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">the Company&#146;s ability to fund operating activities and cash commitments for investing and financing
activities for the foreseeable future; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">the Company&#146;s objective to deliver profitability and expectation to achieve positive cash flow from
operating activities in future periods; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">expectations regarding production capacity, costs and yields; </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">statements made under the heading &#147;<I>Our Strategy</I>&#148; in the documents incorporated by reference,
where applicable; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">statements made with respect to the anticipated disposition of legal claims in the documents incorporated by
reference, where applicable; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">the acquisition of Bevo and associated impact on revenue and the creation of long-term value;
</P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">the acquisition of TerraFarma Inc. (the parent Company of Thrive Cannabis), including the anticipated benefits
and impact on the Company&#146;s path to profitability; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">the acquisition of MedReleaf Australia, including the anticipated benefits and impact on the Company&#146;s path
to profitability; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">future strategic plans and opportunities; </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">growth opportunities including the expansion into additional international markets; </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">expectations related to increased legalization of cannabis in medical and consumer markets, including the United
States; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">the repositioning and improvements in the Company&#146;s consumer business and associated impact on future
profitability and access to new global consumer markets as they open; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">competitive advantages and strengths in Canadian and international medical cannabis, scientific leadership,
multi-jurisdictional regulatory expertise, compliance, testing, cultivar breeding and product quality; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">product portfolio and innovation, and associated revenue growth and impact on future long-term success;
</P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">licensing of genetic innovations to other licensed producers and associated impact on revenue growth;
</P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">expectations regarding biosynthetic production and associated intellectual property; and </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">other risks detailed from time to time in the documents incorporated herein by reference, and those risks which
are discussed under the heading &#147;<I>Risk Factors</I>&#148; in this Prospectus. </P></TD></TR></TABLE> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The above and other aspects of the Company&#146;s
anticipated future operations are forward-looking in nature and, as a result, are subject to certain risks and uncertainties. Such forward-looking statements are estimates reflecting the Company&#146;s best judgment based upon current information
and involve a number of risks and uncertainties, and there can be no assurance that other factors will not affect the accuracy of such forward-looking statements. These risks include, but are not limited to: there is no assurance the Company will be
able to achieve or maintain profitability; the Company operates in a highly regulated business and any failure or significant delay in </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">4 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left" style="font-size:10pt;font-weight:bold"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
obtaining applicable regulatory approvals could adversely affect its ability to conduct its business; the timing, magnitude and duration of new or increased tariffs imposed on goods imported from
Canada into the United States; the Company&#146;s Canadian licenses are reliant on its established sites; the failure to maintain its licenses and remain in compliance with regulations could adversely affect the Company&#146;s ability to conduct
business; a change in the laws, regulations, and guidelines that impact the business may cause adverse effects on the Company&#146;s operations; the Company competes for market share with a number of competitors and expects even more competitors to
enter our market, and many of the Company&#146;s current and future competitors may have longer operating histories, more financial resources, and lower costs than the Company; management&#146;s estimates of consumer demand in Canada and in
jurisdictions where the Company exports are accurate; expectations of future results and expenses; management&#146;s estimation that the Company will be able to maintain current SG&amp;A expenditure levels and the SG&amp;A will grow only in
proportion to revenue growth, the yield from cannabis growing operations, product demand, changes in prices of required commodities; the selling prices and the cost of cannabis production may vary based on a number of factors outside of the
Company&#146;s control; the Company may not be able to realize our growth targets or successfully manage our growth; the continuance of our contractual relations with provincial and territorial governments upon which much of the Company&#146;s
business depends cannot be guaranteed; the Company&#146;s continued growth and ongoing operations may require additional financing, which may not be available on acceptable terms or at all; any default under the Company&#146;s existing debt that is
not waived by the applicable lenders could materially adversely impact the Company&#146;s results of operations and financial results and may have a material adverse effect on the trading price of the Company&#146;s Common Shares; the Company is
subject to credit risk; the Company may not be able to successfully develop new products or find a market for their sale; the Company may not have supply continuity given the Company&#146;s asset rationalization initiative; as the cannabis market
continues to mature, the Company&#146;s products may become obsolete, less competitive, or less marketable; restrictions on branding and advertising may negatively impact the Company&#146;s ability to attract and retain customers; the cannabis
business may be subject to unfavorable publicity or consumer perception, which may adversely affect the market for cannabis products generally and the Company&#146;s products specifically; third parties with whom the Company does business may
perceive themselves as being exposed to reputational risk by virtue of their relationship with the Company and may ultimately elect to discontinue their relationships with the Company; there may be unknown health impacts associated with the use of
cannabis and cannabis derivative products; the Company may enter into strategic alliances or expand the scope of currently existing relationships with third parties and there are risks associated with such activities; the Company&#146;s success will
depend on attracting and retaining key personnel; the Company is dependent on its senior management; future expansion efforts may not be successful; the Company has expanded and intends to further expand our business and operations into
jurisdictions outside of Canada, and there are risks associated with doing so; the Company may have challenges in accessing banks and/or financial institutions in jurisdictions where cannabis is not yet federally regulated, which may adversely
affect the Company&#146;s growth plans; the business may be affected by political and economic instability and a period of sustained inflation across the markets in which it operates; failure to comply with the <I>Corruption of Foreign Public
Officials Act</I> (Canada) and the <I>Foreign Corrupt Practices Act</I> (United States), as well as the anti-bribery laws of the other nations in which the Company conducts business, could subject the Company to penalties and other adverse
consequences; the Company&#146;s employees, independent contractors and consultants may engage in fraudulent or other illegal activities; the Company may be subject to uninsured or uninsurable risk; the Company may be subject to product liability
claims; the Company&#146;s cannabis products may be subject to recalls for a variety of reasons; the Company is and may become party to litigation, mediation, and/or arbitration from time to time; the transportation of the Company&#146;s products is
subject to security risks and disruptions; the Company&#146;s business is subject to the risks inherent in agricultural operations; the Company has in the past, and may in the future, record significant write-downs of its assets; the Company&#146;s
operations are subject to various environmental and employee health and safety regulations, compliance with which may affect the Company&#146;s cost of operations; the Company may not be able to protect our intellectual property; the Company may
experience breaches of security at our facilities or in respect of electronic documents and data storage and may face risks related to breaches of applicable privacy laws; the Company may be subject to risks related to our information technology
systems, including cyber-attacks; the Company may not be able to successfully identify and execute future acquisitions or dispositions, or to successfully manage the impacts of such transactions on its operations; as a holding company,
</P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">5 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left" style="font-size:10pt;font-weight:bold"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
Aurora Cannabis Inc. is dependent on its operating subsidiaries to pay dividends and other obligations; management will have substantial discretion concerning the use of proceeds from future
share sales and financing transactions; there is no assurance the Company will regain and/or continue to meet the listing standards of Nasdaq and the TSX; the financial reporting obligations of being a public company and maintaining a dual listing
on the TSX and on Nasdaq requires significant company resources and management attention; the Company does not anticipate paying any dividends to the holders of Common Shares in the foreseeable future; and other risks detailed from time to time in
our annual information forms, annual financial statements, MD&amp;A, interim financial statements and material change reports filed with and furnished to securities regulators, and those risks which are discussed under the heading &#147;<I>Risk
Factors</I>&#148;. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Readers are cautioned that the foregoing list of risk factors is not exhaustive, and it is recommended that prospective investors
consult the more complete discussion of risks and uncertainties facing the Company included in this Prospectus under the heading &#147;<I>Risk Factors</I>&#148;, as well as those set out in our 2024 AIF under the heading &#147;<I>Risk
Factors</I>&#148; and in our 2024 Annual MD&amp;A and Interim MD&amp;A, each of which documents are incorporated by reference into this Prospectus. Readers are urged to consider the risks, uncertainties and assumptions carefully in evaluating the
forward-looking statements and are cautioned not to place undue reliance on such information. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Should one or more of these risks or uncertainties
materialize, or should underlying factors or assumptions prove incorrect, actual results may vary materially from those described in forward looking statements. Material factors or assumptions involved in developing forward-looking statements
include, without limitation, publicly available information from governmental sources as well as from market research and industry analysis and on assumptions based on data and knowledge of the cannabis industry which the Company believes to be
reasonable. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Although the Company believes that the expectations conveyed by the forward-looking statements are reasonable based on the information
available to the Company on the date hereof, no assurance can be given as to future results, approvals or achievements. Forward-looking statements contained in this Prospectus and in the documents incorporated by reference herein are expressly
qualified by this cautionary statement. The Company disclaims any duty to update any of the forward-looking statements after the date of this Prospectus except as otherwise required by applicable law. </P>
<P STYLE="margin-top:24pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B><A NAME="toc850789_5"></A>NOTE TO UNITED STATES READERS REGARDING DIFFERENCES BETWEEN UNITED STATES AND CANADIAN FINANCIAL REPORTING
PRACTICES </B></P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">We prepare our financial statements in accordance with IFRS as issued by the IASB, which differs from U.S. generally accepted accounting
principles (&#147;<B>U.S. GAAP</B>&#148;). Accordingly, our financial statements and other financial information included or incorporated by reference in this Prospectus may not be comparable to financial statements of United States companies
prepared in accordance with U.S. GAAP. </P> <P STYLE="margin-top:24pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B><A NAME="toc850789_6"></A><FONT STYLE="white-space:nowrap">NON-IFRS</FONT> MEASURES </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The information presented in this Prospectus, including certain documents incorporated by reference herein, may include
<FONT STYLE="white-space:nowrap">non-IFRS</FONT> measures that are used by us as indicators of financial performance. These financial measures do not have standardized meanings prescribed under IFRS and our computation may differ from
similarly-named computations as reported by other entities and, accordingly, may not be comparable. These financial measures should not be considered as an alternative to, or more meaningful than, measures of financial performance as determined in
accordance with IFRS as an indicator of performance. We believe these measures may be useful supplemental information to assist investors in assessing our operational performance and our ability to generate cash through operations. The <FONT
STYLE="white-space:nowrap">non-IFRS</FONT> measures also provide investors with insight into our decision making as we use these <FONT STYLE="white-space:nowrap">non-IFRS</FONT> measures to make financial, strategic and operating decisions. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">6 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left" style="font-size:10pt;font-weight:bold"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Because <FONT STYLE="white-space:nowrap">non-IFRS</FONT> measures do not have a standardized meaning and may
differ from similarly-named computations as reported by other entities, securities regulations require that <FONT STYLE="white-space:nowrap">non-IFRS</FONT> measures be clearly defined and qualified, reconciled with their nearest IFRS measure and
given no more prominence than the closest IFRS measure. If non-IFRS measures are included in documents incorporated by reference herein, information regarding these <FONT STYLE="white-space:nowrap">non-IFRS</FONT> measures are presented in the
sections dealing with these financial measures in such documents. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><FONT STYLE="white-space:nowrap">Non-IFRS</FONT> measures are not audited. These <FONT
STYLE="white-space:nowrap">non-IFRS</FONT> measures have important limitations as analytical tools and investors are cautioned not to consider them in isolation or place undue reliance on ratios or percentages calculated using these <FONT
STYLE="white-space:nowrap">non-IFRS</FONT> measures. </P> <P STYLE="margin-top:24pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B><A NAME="toc850789_7"></A>CURRENCY PRESENTATION AND EXCHANGE RATE INFORMATION
</B></P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Unless stated otherwise or as the context otherwise requires, all references to dollar amounts in this Prospectus and any Prospectus Supplement are
references to Canadian dollars. References to &#147;$&#148; or &#147;C$&#148; are to Canadian dollars and references to &#147;U.S. dollars&#148; or &#147;U.S.$&#148; are to United States dollars. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Except as otherwise noted in our 2024 AIF and the Company&#146;s financial statements and related management&#146;s discussion and analysis of financial
condition and results of operations of the Company that are incorporated by reference into this Prospectus, the financial information contained in such documents is expressed in Canadian dollars. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The high, low, average and closing daily exchange rates for the United States dollar in terms of Canadian dollars for each of the financial periods of the
Company ended December&nbsp;31, 2024, March&nbsp;31, 2024 and March&nbsp;31, 2023, as quoted by the Bank of Canada, were as follows: </P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="84%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="61%"></TD>

<TD VALIGN="bottom" WIDTH="6%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="6%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="6%"></TD>
<TD></TD>
<TD></TD>
<TD></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Three<BR>months<BR>ended<BR>December&nbsp;31,<BR>2024</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Year<BR>ended<BR>March&nbsp;31,<BR>2024</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Nine<BR>months<BR>ended<BR>March&nbsp;31,<BR>2023<SUP STYLE="font-size:75%; vertical-align:top">(1)</SUP></B></TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="10" ALIGN="center">(expressed in Canadian dollars)</TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>


<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">High</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">1.4416</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">1.3875</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">1.3856</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Low</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">1.3854</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">1.3128</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">1.2753</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Average</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">1.4103</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">1.3487</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">1.3384</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Closing</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">1.4389</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">1.3574</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">1.3533</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
</TABLE> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(1)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">The Company&#146;s fiscal year end was changed from June&nbsp;30 to March&nbsp;31 in fiscal 2023.
</P></TD></TR></TABLE> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">On February&nbsp;13, 2025, the daily exchange rate for the United States dollar in terms of Canadian dollars, as quoted by the Bank of
Canada, was U.S.$1.00 = C$1.4242. </P> <P STYLE="margin-top:24pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B><A NAME="toc850789_8"></A>OUR BUSINESS </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><I>This summary does not contain all the information about the Company that may be important to you. You should read the more detailed information, public
filings and financial statements and related notes that are incorporated by reference into and are considered to be a part of this Prospectus. </I></P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Aurora
is opening the world to cannabis, serving both the medical and consumer markets across Canada, Europe, Australia and South America. Headquartered in Edmonton, Alberta, Aurora is a pioneer in global cannabis, dedicated to helping people improve their
lives. The Company&#146;s adult- use brand portfolio includes Aurora Drift, San Rafael &#146;71, Daily Special, Tasty&#146;s, Being and Greybeard. Medical cannabis brands include MedReleaf, CanniMed, Aurora and Whistler Medical Marijuana Co., as
well as international brands, Pedanios, IndiMed and CraftPlant. Aurora also has a controlling interest in Bevo Farms Ltd., North America&#146;s leading supplier of </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">7 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left" style="font-size:10pt;font-weight:bold"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
propagated agricultural plants. Driven by science and innovation, and with a focus on high-quality cannabis products, Aurora&#146;s brands continue to break through as industry leaders in the
medical, wellness and adult recreational markets wherever they are launched. </P> <P STYLE="margin-top:24pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B><A NAME="toc850789_9"></A>THE SELLING SECURITYHOLDERS
</B></P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Securities may be sold under this Prospectus by way of secondary offering by or for the account of certain of our securityholders. The Prospectus
Supplement that we will file in connection with any offering of Securities by selling securityholders will include the following information: </P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">the names of the selling securityholders; </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">the number or amount of Securities owned, controlled or directed of the class being distributed by each selling
securityholder; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">the number or amount of Securities of the class being distributed for the account of each selling securityholder;
</P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">the number or amount of Securities of any class to be owned, controlled or directed by the selling
securityholders after the distribution and the percentage that number, or amount represents of the total number of our outstanding Securities; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">whether the Securities are owned by the selling securityholders both of record and beneficially, of record only,
or beneficially only; and </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">all other information that is required to be included in the applicable Prospectus Supplement.
</P></TD></TR></TABLE> <P STYLE="margin-top:24pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B><A NAME="toc850789_10"></A>USE OF PROCEEDS </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Information regarding the use of the net proceeds from each offering of the Securities will be set forth in the Prospectus Supplement relating to the offering
of the Securities. This information will include the net proceeds to the Company from the sale of the Securities, the use of those proceeds and the specific business objectives that the Company expects to accomplish with such proceeds. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">All expenses relating to an offering of Securities and any compensation paid to underwriters, dealers or agents, as the case may be, will be paid out of our
general funds, unless otherwise stated in the applicable Prospectus Supplement. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">During the fiscal year ended March&nbsp;31, 2024 and the third fiscal
quarter ended December&nbsp;31, 2024, the Company had negative cash flow from operating activities. Although the Company anticipates it will be able to generate positive cash flow from operating activities in the future, the Company cannot guarantee
it will have positive cash flow from operating activities in any future period. To the extent that the Company has negative operating cash flow in any future period, current working capital and certain of the proceeds from the Offering may be used
to fund such negative cash flow from operating activities. See &#147;<I>Risk Factors &#150; Risks Related to Future Offerings &#150; Negative Cash Flow from Operations</I>&#148;. </P>
<P STYLE="margin-top:24pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B><A NAME="toc850789_11"></A>EARNINGS COVERAGE RATIO </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Earnings coverage ratios will be provided as required in the applicable Prospectus Supplement(s) with respect to the issuance of Debt Securities pursuant to
this Prospectus. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">8 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left" style="font-size:10pt;font-weight:bold"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B><A NAME="toc850789_12"></A>CONSOLIDATED CAPITALIZATION </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">As of February&nbsp;13, 2025, the Company had<B> </B>54,884,052<B> </B>Common Shares issued and outstanding. Except as described below, there have been no
material changes in our share and debt capital, on a consolidated basis, since December&nbsp;31, 2024, being the date of the Interim Financial Statements incorporated by reference in this Prospectus, other than the issuance of a total of 6,147
Common Shares related to Aurora&#146;s RSU and PSU share based compensation programs as described further below under &#147;Prior Sales&#148;. </P>
<P STYLE="margin-top:24pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B><A NAME="toc850789_13"></A>TRADING PRICE AND VOLUME </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Our Common Shares are listed on the TSX and Nasdaq under the trading symbol &#147;ACB&#148;. The following tables set forth the reported high and low closing
prices and the aggregate trading volume of our Common Shares (reflecting the Company&#146;s share consolidation on a 10 to 1 basis completed on February&nbsp;20, 2024) on the TSX and Nasdaq for each of the months (or, if applicable, partial months)
indicated during the <FONT STYLE="white-space:nowrap">12-month</FONT> period prior to the date of this Prospectus. </P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="84%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="63%"></TD>

<TD VALIGN="bottom" WIDTH="5%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="5%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="5%"></TD>
<TD></TD>
<TD></TD>
<TD></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom" ROWSPAN="2" NOWRAP> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-bottom:1.00pt solid #000000; display:table-cell; font-size:8pt; font-family:Times New Roman; "><B>Month</B></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="6" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>TSX Price Range</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ROWSPAN="2">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ROWSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Total&nbsp;Volume</B></TD>
<TD VALIGN="bottom" ROWSPAN="2">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>&#8195;High&#8195;</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>&#8195;Low&#8195;</B></TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>


<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">February 2024<SUP STYLE="font-size:75%; vertical-align:top">(1)</SUP></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">4.75</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">0.52</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">19,640,132</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">March 2024</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">6.60</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">3.91</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">30,838,642</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">April 2024</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">12.65</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">5.81</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">80,689,612</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">May 2024</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">10.34</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">8.42</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">36,710,387</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">June 2024</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">8.35</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">6.32</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">12,047,222</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">July 2024</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">8.58</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">6.18</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">20,651,756</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">August 2024</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">9.66</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">8.00</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">18,074,668</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">September 2024</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">8.11</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">7.33</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">8,564,948</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">October 2024</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">8.43</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">7.25</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">10,168,569</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">November 2024</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">8.46</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">5.83</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">11,775,122</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">December 2024</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">6.50</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">5.88</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">7,204,357</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">January 2025</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">6.80</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">5.28</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">7,137,637</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">February <FONT STYLE="white-space:nowrap">1-13,</FONT> 2025</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"> 9.50</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">5.04</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">25,143,262</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
</TABLE> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(1)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">On February&nbsp;20, 2024, the Company completed a share consolidation on a 10 to 1 basis.
</P></TD></TR></TABLE> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="84%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="55%"></TD>

<TD VALIGN="bottom" WIDTH="8%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="8%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="8%"></TD>
<TD></TD>
<TD></TD>
<TD></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom" ROWSPAN="2" NOWRAP> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-bottom:1.00pt solid #000000; display:table-cell; font-size:8pt; font-family:Times New Roman; "><B>Month</B></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="6" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Nasdaq&nbsp;Price&nbsp;Range&nbsp;(in&nbsp;U.S.$)</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ROWSPAN="2">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ROWSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Total Volume</B></TD>
<TD VALIGN="bottom" ROWSPAN="2">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>&#8195;High&#8195;</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>&#8195;Low&#8195;</B></TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>


<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">February 2024<SUP STYLE="font-size:75%; vertical-align:top">(1)</SUP></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">3.47</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">0.38</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">95,852,185</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">March 2024</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">4.86</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">2.89</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">79,865,847</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">April 2024</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">9.23</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">4.31</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">328,049,413</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">May 2024</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">7.61</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">6.15</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">93,272,269</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">June 2024</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">6.09</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">4.62</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">21,900,014</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">July 2024</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">6.25</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">4.52</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">34,031,597</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">August 2024</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">7.05</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">5.54</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">34,171,407</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">September 2024</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">6.08</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">5.41</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">15,044,501</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">October 2024</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">6.10</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">5.32</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">20,346,531</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">November 2024</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">6.11</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">4.18</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">25,302,315</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">December 2024</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">4.63</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">4.10</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">13,859,176</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">January 2025</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">4.70</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">3.65</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">14,397,529</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">February <FONT STYLE="white-space:nowrap">1-13,</FONT> 2025</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">6.62</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">3.46</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">118,983,384</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
</TABLE> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(1)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">On February&nbsp;20, 2024, the Company completed a share consolidation on a 10 to 1 basis.
</P></TD></TR></TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">9 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left" style="font-size:10pt;font-weight:bold"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B><A NAME="toc850789_14"></A>PRIOR SALES </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The following table sets out details of all Common Shares issued by the Company since the year ended March&nbsp;31, 2024. For details of all Common Shares
issued during the year ended March&nbsp;31, 2024, see the 2024 AIF. </P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="84%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="47%"></TD>

<TD VALIGN="bottom" WIDTH="8%"></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="8%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="8%"></TD>
<TD></TD>
<TD></TD>
<TD></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom" NOWRAP> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-bottom:1.00pt solid #000000; display:table-cell; font-size:8pt; font-family:Times New Roman; "><B>Date of Issuance</B></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Reason&nbsp;for&nbsp;Issuance</B></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Number&nbsp;of<BR>Securities<BR>Issued</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Issue/Exercise&nbsp;Price<BR>per Security</B></TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>


<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">April&nbsp;4, 2024</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP>RSU&nbsp;Release</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">2,903</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">C$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">82.20</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">June&nbsp;28, 2024</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP>RSU Release</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">85,904</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">C$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">7.60</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">June&nbsp;28, 2024</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP>RSU Release</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">14,890</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">C$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">85.00</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">June&nbsp;28, 2024</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP>RSU Release</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">27</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">C$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">126.10</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">July&nbsp;31, 2024</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP>RSU Release</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">11,256</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">C$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">7.60</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">August&nbsp;16, 2024</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP>Stock&nbsp;Options</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">20,317</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">C$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">4.11</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">August&nbsp;19, 2024</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP>RSU Release</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">4,010</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">C$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">7.60</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">August&nbsp;19, 2024</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP>RSU Release</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">12,070</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">C$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">18.70</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">August&nbsp;19, 2024</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP>RSU Release</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">578</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">C$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">33.20</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">August&nbsp;19, 2024</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP>RSU Release</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">243</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">C$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">82.20</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">September&nbsp;25, 2024</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP>RSU Release</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">157,814</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">C$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">18.70</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">September&nbsp;30, 2024</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP>Stock Options</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">7,148</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">C$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">4.11</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">October&nbsp;1, 2024</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP>RSU Release</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">11,300</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">C$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">82.20</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">October&nbsp;8, 2024</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP>RSU Release</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">2,903</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">C$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">82.20</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
</TABLE> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="84%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="52%"></TD>

<TD VALIGN="bottom" WIDTH="8%"></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="8%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="8%"></TD>
<TD></TD>
<TD></TD>
<TD></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom" NOWRAP> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-bottom:1.00pt solid #000000; display:table-cell; font-size:8pt; font-family:Times New Roman; "><B>Date of Issuance</B></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Reason&nbsp;for&nbsp;Issuance</B></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Number&nbsp;of<BR>Securities<BR>Issued</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Issue/Exercise<BR>Price per<BR>Security</B></TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>


<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">November&nbsp;18, 2024</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP>RSU&nbsp;Release</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">745</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">C$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">19.20</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">January&nbsp;20, 2025</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP>PSU Release</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">441</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">C$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">18.70</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">January&nbsp;20, 2025</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP>PSU Release</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">1,428</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">C$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">7.60</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">January&nbsp;20, 2025</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP>RSU Release</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">688</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">C$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">18.70</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">January&nbsp;20, 2025</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP>RSU Release</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">3,590</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">C$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">7.60</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
</TABLE> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The following table sets out details of all securities convertible or exercisable into Common Shares that were issued or
granted by the Company following the year ended March&nbsp;31, 2024. For details of all securities convertible or exercisable into Common Shares that were issued or granted during the year ended March&nbsp;31, 2024, see the 2024 AIF. </P>
<P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="84%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="30%"></TD>

<TD VALIGN="bottom" WIDTH="7%"></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="19%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="15%"></TD>
<TD></TD>
<TD></TD>
<TD></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom" NOWRAP> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-bottom:1.00pt solid #000000; display:table-cell; font-size:8pt; font-family:Times New Roman; "><B>Date of Issuance</B></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Type&nbsp;of&nbsp;Security</B><br><B>Issued</B></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Number of&nbsp;Common</B><br><B>Shares&nbsp;Issuable&nbsp;Upon</B><br><B>Exercise&nbsp;or&nbsp;Conversion</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Exercise&nbsp;or&nbsp;Conversion<BR>Price&nbsp;Per&nbsp;Common&nbsp;Share</B></TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>


<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">September&nbsp;19,&nbsp;2024</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP>Options</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">16,908</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">7.91</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">September&nbsp;19,&nbsp;2024</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP>RSU</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">2,581</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">N/A</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">June&nbsp;24, 2024</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP>Options</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">732,253</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">7.59</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">June&nbsp;24, 2024</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP>PSU</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">130,662</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">N/A</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">June&nbsp;24, 2024</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP>RSU</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">375,788</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">N/A</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
</TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">10 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left" style="font-size:10pt;font-weight:bold"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B><A NAME="toc850789_15"></A>PLAN OF DISTRIBUTION </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">We may offer and sell Securities directly to one or more purchasers, through agents, or through underwriters or dealers designated by us from time to time. We
may distribute the Securities from time to time in one or more transactions at fixed prices (which may be changed from time to time), at market prices prevailing at the times of sale, at varying prices determined at the time of sale, at prices
related to prevailing market prices or at negotiated prices, including sales in transactions that are considered <FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">at-the-market</FONT></FONT> distributions made through the facilities
of a stock exchange or stock market outside of Canada, including Nasdaq. A description of such pricing will be disclosed in the applicable Prospectus Supplement. No
<FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">at-the-market</FONT></FONT> offering as defined in NI <FONT STYLE="white-space:nowrap">44-102</FONT> will be made under this Prospectus in Canada or through the facilities of a stock
exchange or stock market in Canada. We may offer different classes of Securities in the same offering, or we may offer different classes of Securities in separate offerings. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">This Prospectus may also, from time to time, relate to the offering of our Securities by certain selling securityholders. The selling securityholders may sell
all or a portion of our Securities beneficially owned by them and offered thereby from time to time directly or through one or more underwriters, broker-dealers or agents. Our Securities may be sold by the selling securityholders in one or more
transactions at fixed prices (which may be changed from time to time), at market prices prevailing at the time of the sale, at varying prices determined at the time of sale, at prices related to prevailing market prices or at negotiated prices. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">A Prospectus Supplement will describe the terms of each specific offering of Securities, including: (i)&nbsp;the terms of the Securities to which the
Prospectus Supplement relates, including the type of Security being offered; (ii)&nbsp;the name or names of any agents, underwriters or dealers involved in such offering of Securities; (iii)&nbsp;the name or names of any selling securityholders;
(iv)&nbsp;the purchase price of the Securities offered thereby and the proceeds to, and the portion of expenses borne by, the Company from the sale of such Securities; (v)&nbsp;any agents&#146; commission, underwriting discounts and other items
constituting compensation payable to agents, underwriters or dealers; and (vi)&nbsp;any discounts or concessions allowed or <FONT STYLE="white-space:nowrap">re-allowed</FONT> or paid to agents, underwriters or dealers. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">If Securities sold pursuant to a Prospectus Supplement are acquired by underwriters for their own account, they may be resold from time to time in one or more
transactions, including negotiated transactions, at a fixed public offering price or at varying prices determined at the time of sale. The obligations of the underwriters to purchase Securities will be subject to the conditions precedent agreed upon
by the parties and the underwriters will be obligated to purchase all Securities under that offering if any are purchased. Any public offering price and any discounts or concessions allowed or <FONT STYLE="white-space:nowrap">re-allowed</FONT> or
paid to agents, underwriters or dealers may be changed from time to time. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Underwriters, dealers and agents who participate in the distribution of the
Securities may be entitled under agreements to be entered into with the Company to indemnification by the Company against certain liabilities, including liabilities under the U.S. Securities Act and Canadian securities legislation, or to
contribution with respect to payments which such underwriters, dealers or agents may be required to make in respect thereof. Such underwriters, dealers and agents may be customers of, engage in transactions with, or perform services for, the Company
in the ordinary course of business. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">In connection with any offering of Securities, other than an <FONT STYLE="white-space:nowrap"><FONT
STYLE="white-space:nowrap">&#147;at-the-market</FONT></FONT> distribution&#148;, the underwriters may over-allot or effect transactions which stabilize or maintain the market price of the Securities offered at a level above that which might
otherwise prevail in the open market. Such transactions, if commenced, may be discontinued at any time. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The Securities may also be sold:
(i)&nbsp;directly by the Company or the selling securityholders at such prices and upon such terms as agreed to; or (ii)&nbsp;through agents designated by the Company or the selling securityholders from time to time. Any agent involved in the
offering and sale of the Securities in respect of which this Prospectus is delivered will be named, and any commissions payable by the Company and/or selling securityholder to such agent will be set forth, in the Prospectus Supplement. Unless
otherwise indicated in the Prospectus Supplement, any agent is acting on a &#147;best efforts&#148; basis for the period of its appointment. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">11 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left" style="font-size:10pt;font-weight:bold"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">We and/or the selling securityholders may agree to pay the underwriters or agents a commission for various
services relating to the issue and sale of any Securities offered under any Prospectus Supplement. In addition, underwriters or agents may sell the securities to or through dealers, and those dealers may receive compensation in the form of
discounts, concessions or commissions from the underwriters or agents and/or commissions from the purchasers for which they may act as agent. Agents, underwriters or dealers who participate in the distribution of the Securities may be entitled under
agreements to be entered into with the Company and/or the selling securityholders to indemnification by the Company and/or the selling securityholders against certain liabilities, including liabilities under securities legislation, or to
contribution with respect to payments which such underwriters, dealers or agents may be required to make in respect thereof. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Each class or series of
Warrants, Options, Subscription Receipts, Debt Securities and Units will be a new issue of Securities with no established trading market. Unless otherwise specified in the applicable Prospectus Supplement, Warrants, Options, Subscription Receipts,
Debt Securities or Units will not be listed on any securities or stock exchange. Unless otherwise specified in the applicable Prospectus Supplement, there is no market through which the Warrants, Options, Subscription Receipts, Debt Securities or
Units may be sold and purchasers may not be able to resell Warrants, Options, Subscription Receipts, Debt Securities or Units purchased under this Prospectus or any Prospectus Supplement. This may affect the pricing of the Warrants, Options,
Subscription Receipts, Debt Securities or Units in the secondary market, the transparency and availability of trading prices, the liquidity of the Securities, and the extent of issuer regulation. Subject to applicable laws, certain dealers may make
a market in the Warrants, Options, Subscription Receipts, Debt Securities or Units, as applicable, but will not be obligated to do so and may discontinue any market making at any time without notice. No assurance can be given that any dealer will
make a market in the Warrants, Options, Subscription Receipts or Units or as to the liquidity of the trading market, if any, for the Warrants, Options, Subscription Receipts, Debt Securities or Units. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">In connection with any offering of Securities, unless otherwise specified in a Prospectus Supplement, underwriters or agents may over-allot or effect
transactions which stabilize, maintain or otherwise affect the market price of Securities offered at levels other than those which might otherwise prevail on the open market. Such transactions may be commenced, interrupted or discontinued at any
time. </P> <P STYLE="margin-top:24pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B><A NAME="toc850789_16"></A>DESCRIPTION OF SECURITIES </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The Securities may be offered under this Prospectus in amounts and at prices to be determined based on market conditions at the time of the sale and such
amounts and prices will be set forth in the accompanying Prospectus Supplement. The Securities may be issued alone or in combination and for such consideration determined by our board of directors. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The Company has filed an undertaking that it will not distribute specified derivatives or asset-backed securities, as the case may be, that, at the time of
distribution, are novel without <FONT STYLE="white-space:nowrap">pre-clearing</FONT> with the regulator the disclosure to be contained in the shelf prospectus supplement pertaining to the distribution of the novel specified derivatives or
asset-backed securities. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Common Shares </B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The holders
of Common Shares are entitled to receive notice of any meeting of the shareholders of the Company and to attend and vote thereat, except those meetings at which only the holders of shares of another class or of a particular series are entitled to
vote. Each Common Share entitles its holder to one vote. The holders of Common Shares are entitled to receive on a <FONT STYLE="white-space:nowrap">pro-rata</FONT> basis such dividends as the board of directors may declare out of funds legally
available therefor. In the event of the dissolution, liquidation, <FONT STYLE="white-space:nowrap">winding-up</FONT> or other distribution of our assets, such holders are entitled to receive on a <FONT STYLE="white-space:nowrap">pro-rata</FONT>
basis all of assets of the Company remaining after payment of all of liabilities. The Common Shares carry no <FONT STYLE="white-space:nowrap">pre-emptive</FONT> or conversion rights. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">12 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left" style="font-size:10pt;font-weight:bold"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Warrants </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">This section describes the general terms that will apply to any Warrants for the purchase of Common Shares. To the extent required under applicable law, we
will not offer Warrants for sale separately to any member of the public in Canada unless the offering of such Warrants is in connection with and forms a part of the consideration for an acquisition or merger transaction, or unless the applicable
Prospectus Supplement containing the specific terms of the Warrants to be offered separately is first approved, in accordance with applicable laws, for filing by the securities commissions or similar regulatory authorities in each of the
jurisdictions where the Warrants will be offered for sale. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Subject to the foregoing, we may issue Warrants independently or together with other
Securities, and Warrants sold with other Securities may be attached to or separate from the other Securities. Warrants may be issued directly by us to the purchasers thereof or under one or more warrant indentures or warrant agency agreements to be
entered into by us and one or more banks or trust companies acting as warrant agent. Warrants, like other Securities that may be sold, may be listed on a securities exchange subject to exchange listing requirements and applicable legal requirements.
</P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The following description, together with the additional information the Company may include in any Prospectus Supplements, summarizes the material terms
and provisions of the Warrants that the Company may offer under the Prospectus, which may consist of Warrants to purchase Common Shares or other Securities and may be issued in one or more series. While the terms summarized below will apply
generally to any Warrants that the Company may offer under the Prospectus, the Company will describe the material terms and conditions of any series of Warrants that it may offer in more detail in the applicable Prospectus Supplement filed in
respect of such Warrants. The terms of any Warrants offered under a Prospectus Supplement may differ from the terms described below. A copy of any warrant indenture governing the terms of Warrants will be filed on SEDAR+, and if applicable, EDGAR,
in connection with any offering of Warrants under this Prospectus. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The material terms and conditions of each issue of Warrants will be described in the
applicable Prospectus Supplement filed in respect of such Warrants. This description will include, where applicable: </P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">the designation and aggregate number of Warrants; </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">the price at which the Warrants will be offered; </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">the currency or currencies in which the Warrants will be offered; </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">the date on which the right to exercise the Warrants will commence and the date on which the right will expire;
</P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">if applicable, the identity of the warrant agent; </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">whether the Warrants will be listed on any securities exchange; </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">any minimum or maximum subscription amount; </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">the number of Common Shares that may be purchased upon exercise of each Warrant and the price at which and
currency or currencies in which the Common Shares may be purchased upon exercise of each Warrant; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">the designation and terms of any securities with which the Warrants will be offered, if any, and the number of
the Warrants that will be offered with each security; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">the date or dates, if any, on or after which the Warrants and the related securities will be transferable
separately; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">whether the Warrants will be subject to redemption and, if so, the terms of such redemption provisions;
</P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">whether the Warrants are to be issued in registered form, &#147;book-entry only&#148; form, <FONT
STYLE="white-space:nowrap">non-certificated</FONT> inventory system form, bearer form or in the form of temporary or permanent global securities and the basis of exchange, transfer and ownership thereof; </P></TD></TR></TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">13 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left" style="font-size:10pt;font-weight:bold"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">

<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">any material risk factors relating to such Warrants and the Common Shares to be issued upon exercise of the
Warrants; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">any other rights, privileges, restrictions and conditions attaching to the Warrants and the Common Shares to be
issued upon exercise of the Warrants; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">material Canadian and United States federal income tax consequences of owning and exercising the Warrants; and
</P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">any other material terms or conditions of the Warrants and the Common Shares to be issued upon exercise of the
Warrants. </P></TD></TR></TABLE> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The terms and provisions of any Warrants offered under a Prospectus Supplement may differ from the terms described above and
may not be subject to or contain any or all of the terms described above. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Prior to the exercise of any Warrants, holders of Warrants will not have any of
the rights of holders of the Common Shares purchasable upon such exercise or the right to vote such underlying securities. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Options </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">We may issue or grant Options in connection with acquisitions, merger transactions, or to directors, officers employees or consultants, as applicable. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The material terms and conditions applicable to each Option issue will be described in the applicable Prospectus Supplement filed in respect of such Options.
This description will include, where applicable: </P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">the designation and aggregate number of Options; </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">the price at which the Options will be offered; </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">the currency or currencies in which the Options will be offered; </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">the date on which the right to exercise the Options will commence and the date on which the right will expire;
</P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">the number of Common Shares that may be issued upon exercise of each Option and the price and currency or
currencies in which the Common Shares may be purchased upon exercise of each Option; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">the date or dates, if any, on or after which the Options and the related securities will be transferable
separately; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">any resale restrictions and vesting criteria related to the Options; </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">any applicable accelerated vesting provisions applicable to the Options; </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">any early termination provisions relating to the Options; </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">any material risk factors relating to such Options and the Common Shares to be issued upon exercise of the
Options; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">any other rights, privileges, restrictions and conditions attaching to the Options and the Common Shares to be
issued upon exercise of the Options; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">material Canadian and United States federal income tax consequences of owning and exercising the Options; and
</P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">any other material terms or conditions of the Options and the Common Shares to be issued upon exercise of the
Options. </P></TD></TR></TABLE> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Prior to the exercise of any Options, holders of Options will not have any of the voting or other rights applicable to holders
of Common Shares. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">14 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left" style="font-size:10pt;font-weight:bold"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Subscription Receipts </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">This section describes the general terms that will apply to any Subscription Receipts that may be offered by us pursuant to the Prospectus. Subscription
Receipts may be offered separately or together with Common Shares or Warrants, as the case may be. The Subscription Receipts will be issued under a subscription receipt agreement. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">In the event we issue Subscription Receipts, we will provide the original purchasers of Subscription Receipts a contractual right of rescission exercisable
following the issuance of Common Shares to such purchasers. </P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The applicable
Prospectus Supplement will include details of the Subscription Receipt agreement covering the Subscription Receipts being offered. A copy of the subscription receipt agreement relating to an offering of Subscription Receipts will be filed by us with
the applicable securities regulatory authorities after it has been entered into by us. The specific terms of the Subscription Receipts, and the extent to which the general terms described in this section apply to those Subscription Receipts, will be
set forth in the applicable Prospectus Supplement. This description will include, where applicable: </P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">the number of Subscription Receipts; </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">the price at which the Subscription Receipts will be offered; </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">the currency at which the Subscription Receipts will be offered and whether the price is payable in installments;
</P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">the procedures for the exchange of the Subscription Receipts into Common Shares, Warrants or Units;
</P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">the number of Common Shares, Warrants or Units that may be issued upon exercise or deemed conversion of each
Subscription Receipt; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">the designation and terms of any other Securities with which the Subscription Receipts will be offered, if any,
and the number of Subscription Receipts that will be offered with each Security; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">conditions to the conversion or exchange of Subscription Receipts into other Securities and the consequences of
such conditions not being satisfied; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">terms applicable to the gross or net proceeds from the sale of the Subscription Receipts plus any interest earned
thereon; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">the dates or periods during which the Subscription Receipts may be converted or exchanged; </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">the circumstances, if any, which will cause the Subscription Receipts to be deemed to be automatically converted
or exchanged; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">provisions applicable to any escrow of the gross or net proceeds from the sale of the Subscription Receipts plus
any interest or income earned thereon, and for the release of such proceeds from such escrow; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">if applicable, the identity of the subscription receipt agent; </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">whether the Subscription Receipts will be listed on any securities exchange; </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">whether the Subscription Receipts will be issued with any other Securities and, if so, the amount and terms of
these Securities; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">any minimum or maximum subscription amount; </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">whether the Subscription Receipts are to be issued in registered form, &#147;book-entry only&#148; form, <FONT
STYLE="white-space:nowrap">non-certificated</FONT> inventory system form, bearer form or in the form of temporary or permanent global securities and the basis of exchange, transfer and ownership thereof; </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">any material risk factors relating to such Subscription Receipts and the Securities to be issued upon conversion
or exchange of the Subscription Receipts; </P></TD></TR></TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">15 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left" style="font-size:10pt;font-weight:bold"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">

<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">any other rights, privileges, restrictions and conditions attaching to the Subscription Receipts and the
Securities to be issued upon exchange of the Subscription Receipts; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">material Canadian and United States income tax consequences of owning or converting or exchanging the
Subscription Receipts; and </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">any other material terms and conditions of the Subscription Receipts and the Securities to be issued upon the
exchange of the Subscription Receipts. </P></TD></TR></TABLE> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The terms and provisions of any Subscription Receipts offered under a Prospectus Supplement may
differ from the terms described above and may not be subject to or contain any or all of the terms described above. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Prior to the exchange of any
Subscription Receipts, holders of such Subscription Receipts will not have any of the rights of holders of the Securities for which the Subscription Receipts may be exchanged, including the right to receive payments of dividends or the right to vote
such underlying securities. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Description of Debt Securities </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">We may issue Debt Securities in one or more series under an indenture (the &#147;<B>Indenture</B>&#148;), entered into between us and Computershare Trust
Company, N.A. (as successor to GLAS Trust Company LLC), as trustee, on May&nbsp;3, 2019, as amended or supplemented. The Indenture is subject to and governed by the United States Trust Indenture Act of 1939, as amended, and will be filed with the
SEC as an exhibit to the Registration Statement. The following description sets forth certain general material terms and provisions of the Debt Securities. If Debt Securities are issued, we will describe in the applicable Prospectus Supplement the
particular material terms and provisions of any series of the Debt Securities and a description of how the general material terms and provisions described below may apply to that series of the Debt Securities. Prospective investors should read both
the Prospectus and the Prospectus Supplement for a complete summary of all material terms relating to a particular series of Debt Securities. Prospective investors should be aware that information in the applicable Prospectus Supplement may update
and supersede the following information. Prospective investors also should refer to the Indenture for a complete description of all terms relating to the Debt Securities. We will file on SEDAR+ and as exhibits to the Registration Statement, of which
this Prospectus is a part, or will incorporate by reference from a report on Form <FONT STYLE="white-space:nowrap">6-K</FONT> that the Company furnishes to the SEC, any Supplemental Indenture (as defined below) describing the terms and conditions of
Debt Securities that we are offering substantially concurrently with the issuance of such Debt Securities. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">We may issue Debt Securities and incur
additional indebtedness other than through the offering of Debt Securities pursuant to this Prospectus. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I>General </I></B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The Indenture will not limit the aggregate principal amount of Debt Securities that we may issue under the Indenture and will not limit the amount of other
indebtedness that we may incur. The Indenture will provide that we may issue Debt Securities from time to time in one or more series and may be denominated and payable in U.S. dollars, Canadian dollars or any foreign currency. Unless otherwise
indicated in the applicable Prospectus Supplement, the Debt Securities will be unsecured obligations of the Company. The Indenture will also permit us to increase the principal amount of any series of the Debt Securities previously issued and to
issue that increased principal amount. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The applicable Prospectus Supplement for any series of Debt Securities that we offer will describe the specific
terms of the Debt Securities and may include, but is not limited to, any of the following: </P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">the title of the Debt Securities; </P></TD></TR></TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">16 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left" style="font-size:10pt;font-weight:bold"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">

<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">any limit on the aggregate principal amount of the Debt Securities and, if no limit is specified, the Company
will have the right to <FONT STYLE="white-space:nowrap">re-open</FONT> such series for the issuance of additional Debt Securities from time to time; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">whether the payment of principal, interest and premium, if any, on the Debt Securities will be our senior, senior
subordinated or subordinated obligations; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">whether payment of principal, interest and premium, if any, on the Debt Securities will be secured by certain
assets of the Company and any applicable guarantors; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">whether payment of the Debt Securities will be guaranteed by any other person; </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">the date or dates, or the method by which such date or dates will be determined or extended, on which the
principal (and premium, if any) of the Debt Securities of the series is payable; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">the rate or rates at which the Securities of the series shall bear interest, if any, or the method by which such
rate or rates shall be determined, whether such interest shall be payable in cash or additional Securities of the same series or shall accrue and increase the aggregate principal amount outstanding of such series, the date or dates from which such
interest shall accrue, or the method by which such date or dates shall be determined; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">the place or places we will pay principal, premium and interest, if any, and the place or places where Debt
Securities can be presented for registration of transfer, exchange or conversion; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">whether and under what circumstances we will be required to pay any additional amounts for withholding or
deduction for taxes with respect to the Debt Securities, and whether and on what terms we will have the option to redeem the Debt Securities rather than pay the additional amounts; </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">whether we will be obligated to redeem, repay or repurchase the Debt Securities pursuant to any sinking or other
provision, or at the option of a holder and the terms and conditions of such redemption, repayment or repurchase; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">whether we may redeem the Debt Securities, in whole or in part, prior to maturity and the terms and conditions of
any such redemption; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">the denominations in which we will issue any registered Debt Securities, if other than denominations of $2,000
and any multiple of $1,000 and, if other than denominations of $5,000, the denominations in which any unregistered Debt Security shall be issuable; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">whether we will make payments on the Debt Securities in a currency other than U.S. dollars;
</P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">whether payments on the Debt Securities will be payable with reference to any index, formula or other method;
</P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">whether we will issue the Debt Securities as global securities and, if so, the identity of the depositary for the
global securities; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">whether we will issue the Debt Securities as unregistered securities, registered securities or both;
</P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">any changes or additions to, or deletions of, events of default or covenants whether or not such events of
default or covenants are consistent with the events of default or covenants in the Indenture; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">the applicability of, and any changes or additions to, the provisions for defeasance described under
&#147;<I>Defeasance</I>&#148; below; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">whether the holders of any series of Debt Securities have special rights if specified events occur;
</P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">the terms, if any, for any conversion or exchange of the Debt Securities for any other securities;
</P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">provisions as to modification, amendment or variation of any rights or terms attaching to the Debt Securities;
and </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">any other terms, conditions, rights and preferences (or limitations on such rights and preferences).
</P></TD></TR></TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">17 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left" style="font-size:10pt;font-weight:bold"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Unless stated otherwise in the applicable Prospectus Supplement, no holder of Debt Securities will have the
right to require us to repurchase the Debt Securities and there will be no increase in the interest rate if we become involved in a highly leveraged transaction or if we have a change of control. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">We may issue Debt Securities bearing no interest or interest at a rate below the prevailing market rate at the time of issuance and may offer and sell the
Debt Securities at a discount below their stated principal amount. We may also sell any of the Debt Securities for a foreign currency or currency unit, and payments on the Debt Securities may be payable in a foreign currency or currency unit. In any
of these cases, we will describe certain Canadian federal and U.S. federal income tax consequences and other special considerations in the applicable Prospectus Supplement. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">We may issue Debt Securities with terms different from those of Debt Securities previously issued and, without the consent of the holders thereof, we may
reopen a previous issue of a series of Debt Securities and issue additional Debt Securities of such series (unless the reopening was restricted when such series was created). </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I>Guarantees </I></B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Our payment obligations under any
series of Debt Securities may be guaranteed by certain of our direct or indirect subsidiaries. In order to comply with certain registration statement form requirements under U.S. law, these guarantees may in turn be guaranteed by the Company. The
terms of such guarantees will be set forth in the applicable Prospectus Supplement. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I>Ranking and Other Indebtedness </I></B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Unless otherwise indicated in an applicable Prospectus Supplement, and except to the extent prescribed by law, each series of Debt Securities shall be senior,
unsubordinated and unsecured obligations of the Company and shall rank <I>pari</I><I> </I><I>passu</I> and ratably without preference among themselves and <I>pari</I><I> </I><I>passu</I> with all other senior, unsubordinated and unsecured
obligations of the Company. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Our Board of Directors may establish the extent and manner, if any, to which payment on or in respect of a series of Debt
Securities will be senior, senior subordinated or will be subordinated to the prior payment of the Company&#146;s other liabilities and obligations, and whether the payment of principal, premium, if any, and interest, if any, will be guaranteed by
any other person and the nature and priority of any security. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I>Debt Securities in Global Form </I></B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><I>The Depositary and Book-Entry </I></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Unless otherwise specified
in the applicable Prospectus Supplement, a series of the Debt Securities may be issued in whole or in part in global form as a &#147;global security&#148; and will be registered in the name of or issued in bearer form and be deposited with a
depositary, or its nominee, each of which will be identified in the applicable Prospectus Supplement relating to that series. Unless and until exchanged, in whole or in part, for the Debt Securities in definitive registered form, a global security
may not be transferred except as a whole by the depositary for such global security to a nominee of the depositary, by a nominee of the depositary to the depositary or another nominee of the depositary or by the depositary or any such nominee to a
successor of the depositary or a nominee of the successor. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The specific terms of the depositary arrangement with respect to any portion of a particular
series of the Debt Securities to be represented by a global security will be described in the applicable Prospectus Supplement relating to such series. The Company anticipates that the provisions described in this section will apply to all
depositary arrangements. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">18 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left" style="font-size:10pt;font-weight:bold"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Upon the issuance of a global security, the depositary therefor or its nominee will credit, on its book
entry and registration system, the respective principal amounts of the Debt Securities represented by the global security to the accounts of such persons, designated as &#147;participants&#148;, having accounts with such depositary or its nominee.
Such accounts shall be designated by the underwriters, dealers or agents participating in the distribution of the Debt Securities or by the Company if such Debt Securities are offered and sold directly by the Company. Ownership of beneficial
interests in a global security will be limited to participants or persons that may hold beneficial interests through participants. Ownership of beneficial interests in a global security will be shown on, and the transfer of that ownership will be
effected only through, records maintained by the depositary therefor or its nominee (with respect to interests of participants) or by participants or persons that hold through participants (with respect to interests of persons other than
participants). The laws of some states in the United States may require that certain purchasers of securities take physical delivery of such securities in definitive form. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">So long as the depositary for a global security or its nominee is the registered owner of the global security or holder of a global security in bearer form,
such depositary or such nominee, as the case may be, will be considered the sole owner or holder of the Debt Securities represented by the global security for all purposes under the Indenture. Except as provided below, owners of beneficial interests
in a global security will not be entitled to have a series of the Debt Securities represented by the global security registered in their names, will not receive or be entitled to receive physical delivery of such series of the Debt Securities in
definitive form and will not be considered the owners or holders thereof under the Indenture. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Any payments of principal, premium, if any, and interest,
if any, on global securities registered in the name of a depositary or securities registrar will be made to the depositary or its nominee, as the case may be, as the registered owner of the global security representing such Debt Securities. None of
the Company, any trustee or any paying agent for the Debt Securities represented by the global securities will have any responsibility or liability for any aspect of the records relating to or payments made on account of beneficial ownership
interests of the global security or for maintaining, supervising or reviewing any records relating to such beneficial ownership interests. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The Company
expects that the depositary for a global security or its nominee, upon receipt of any payment of principal, premium, if any, or interest, if any, will credit participants&#146; accounts with payments in amounts proportionate to their respective
beneficial interests in the principal amount of the global security as shown on the records of such depositary or its nominee. The Company also expects that payments by participants to owners of beneficial interests in a global security held through
such participants will be governed by standing instructions and customary practices, as is now the case with securities held for the accounts of customers registered in &#147;street name&#148;, and will be the responsibility of such participants.
</P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><I>Discontinuance of Depositary&#146;s Services </I></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">If a
depositary for a global security representing a particular series of the Debt Securities is at any time unwilling or unable to continue as depositary or, if at any time the depositary for such series shall no longer be registered or in good standing
under the Exchange Act, and a successor depositary is not appointed by us within 90 days, the Company will issue such series of the Debt Securities in definitive form in exchange for a global security representing such series of the Debt Securities.
If an event of default under the Indenture has occurred and is continuing, Debt Securities in definitive form will be printed and delivered upon written request by the holder to the appropriate trustee. In addition, the Company may at any time and
in the Company&#146;s sole discretion determine not to have a series of the Debt Securities represented by a global security and, in such event, will issue a series of the Debt Securities in definitive form in exchange for all of the global
securities representing that series of Debt Securities. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I>Debt Securities in Definitive Form </I></B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">A series of the Debt Securities may be issued in definitive form, solely as registered securities, solely as unregistered securities or as both registered
securities and unregistered securities. Registered securities will be </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">19 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left" style="font-size:10pt;font-weight:bold"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
issuable in denominations of $2,000 and integral multiples of $1,000 and unregistered securities will be issuable in denominations of $5,000 and integral multiples of $5,000 or, in each case, in
such other denominations as may be set out in the terms of the Debt Securities of any particular series. Unless otherwise indicated in the applicable Prospectus Supplement, unregistered securities will have interest coupons attached. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Unless otherwise indicated in the applicable Prospectus Supplement, payment of principal, premium, if any, and interest, if any, on the Debt Securities in
definitive form will be made at the office or agency designated by the Company, or at the Company&#146;s option the Company can pay principal, interest, if any, and premium, if any, by check mailed to the address of the person entitled at the
address appearing in the security register of the trustee or electronic funds wire transfer to an account of persons who meet certain thresholds set out in the Indenture who are entitled to receive payments by wire transfer. Unless otherwise
indicated in the applicable Prospectus Supplement, payment of interest, if any, will be made to the persons in whose name the Debt Securities are registered at the close of business on the day or days specified by the Company. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">At the option of the holder of Debt Securities, registered securities of any series will be exchangeable for other registered securities of the same series,
of any authorized denomination and of a like aggregate principal amount. If, but only if, provided in an applicable Prospectus Supplement, unregistered securities (with all unmatured coupons, except as provided below, and all matured coupons in
default) of any series may be exchanged for registered securities of the same series, of any authorized denominations and of a like aggregate principal amount and tenor. In such event, unregistered securities surrendered in a permitted exchange for
registered securities between a regular record date or a special record date and the relevant date for payment of interest shall be surrendered without the coupon relating to such date for payment of interest, and interest will not be payable on
such date for payment of interest in respect of the registered security issued in exchange for such unregistered security, but will be payable only to the holder of such coupon when due in accordance with the terms of the Indenture. Unless otherwise
specified in an applicable Prospectus Supplement, unregistered securities will not be issued in exchange for registered securities. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The applicable
Prospectus Supplement may indicate the places to register a transfer of the Debt Securities in definitive form. Service charges may be payable by the holder for any registration of transfer or exchange of the Debt Securities in definitive form, and
the Company may, in certain instances, require a sum sufficient to cover any tax or other governmental charges payable in connection with these transactions. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">We shall not be required to: </P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">issue, register the transfer of or exchange any series of the Debt Securities in definitive form during a period
beginning at the opening of 15&nbsp;days before any selection of securities of that series of the Debt Securities to be redeemed and ending on the relevant date of notice of such redemption, as provided in the Indenture; </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">register the transfer of or exchange any registered security in definitive form, or portion thereof, called for
redemption, except the unredeemed portion of any registered security being redeemed in part; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">exchange any unregistered security called for redemption except to the extent that such unregistered security may
be exchanged for a registered security of that series and like tenor; provided that such registered security will be simultaneously surrendered for redemption; or </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">issue, register the transfer of or exchange any of the Debt Securities in definitive form which have been
surrendered for repayment at the option of the holder, except the portion, if any, of such Debt Securities not to be so repaid. </P></TD></TR></TABLE>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I>Provision of Financial Information </I></B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The Company
will file with the trustee within 15 days after the Company files the same with the SEC, (i)&nbsp;copies of the annual reports containing audited financial statements and copies of quarterly reports containing unaudited
</P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">20 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left" style="font-size:10pt;font-weight:bold"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
financial statements and (ii)&nbsp;copies of the information, documents and other reports (or copies of such portions of any of the foregoing as the Commission may from time to time by
rules&nbsp;and regulations prescribe) which the Company may be required to file with or furnish to the SEC pursuant to Section&nbsp;13 or Section&nbsp;15(d)&nbsp;of the Exchange Act. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">In the event that the Company is not required to remain subject to the reporting requirements of Section&nbsp;13 or 15(d) of the Exchange Act, or otherwise
report on an annual and quarterly basis on forms provided for such annual and quarterly reporting pursuant to rules&nbsp;and regulations promulgated by the SEC, it will continue to file with the SEC and provide the trustee: </P>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">within 140 days after the end of each fiscal year, annual reports on
<FONT STYLE="white-space:nowrap">Form&nbsp;20-F,</FONT> <FONT STYLE="white-space:nowrap">40-F</FONT> or <FONT STYLE="white-space:nowrap">Form&nbsp;10-K,</FONT> as applicable (or any successor form), containing audited financial statements and the
other financial information required to be contained therein (or required in such successor form); and </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">within 60 days after the end of each of the first three fiscal quarters of each fiscal year, reports on <FONT
STYLE="white-space:nowrap">Form&nbsp;6-K</FONT> or <FONT STYLE="white-space:nowrap">Form&nbsp;10-Q</FONT> (or any successor form), containing unaudited financial statements and the other financial information which, regardless of applicable
requirements shall, at a minimum, contain such information required to be provided in quarterly reports under the laws of Canada or any province thereof to security holders of a corporation with securities listed on the Toronto Stock Exchange,
whether or not the Company has any of its securities so listed. </P></TD></TR></TABLE> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I>Events of Default </I></B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Unless otherwise specified in the applicable Prospectus Supplement relating to a particular series of Debt Securities, the following is a summary of events
which will, with respect to any series of the Debt Securities, constitute an event of default under the Indenture with respect to the Debt Securities of that series: </P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">the Company fails to pay principal of, or any premium on any Debt Security of that series when it is due and
payable; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">the Company fails to pay interest payable on any Debt Security of that series when it becomes due and payable,
and such default continues for 30 days; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">the Company fails to make any required sinking fund or analogous payment when due for that series of Debt
Securities; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">the Company fails to observe or perform any of its covenants or agreements in the Indenture that affect or are
applicable to the Debt Securities of that series for 90 days after written notice to the Company by the trustees or to the Company and the trustees by holders of at least 25% in aggregate principal amount of the outstanding Debt Securities of that
series; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">certain events involving the Company&#146;s bankruptcy, insolvency or reorganization; and </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">any other event of default provided for in that series of Debt Securities. </P></TD></TR></TABLE>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">A default under one series of Debt Securities will not necessarily be a default under another series. A trustee may withhold notice to the holders of the Debt
Securities of any default, except in the payment of principal or premium, if any, or interest, if any, if in good faith it considers it in the interests of the holders to do so and so advises the Company in writing. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">If an event of default for any series of Debt Securities occurs and continues, a trustee or the holders of at least 25% in aggregate principal amount of the
Debt Securities of that series may require the Company to repay immediately: </P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">the entire principal and interest of the Debt Securities of the series; or </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">if the Debt Securities are discounted securities, that portion of the principal as is described in the applicable
Prospectus Supplement. </P></TD></TR></TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">21 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left" style="font-size:10pt;font-weight:bold"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">If an event of default relates to events involving the Company&#146;s bankruptcy, insolvency or
reorganization, the principal of all Debt Securities will become immediately due and payable without any action by the trustee or any holder. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Subject to
certain conditions, the holders of a majority of the aggregate principal amount of the Debt Securities of the affected series can rescind and annul an accelerated payment requirement. If Debt Securities are discounted securities, the applicable
Prospectus Supplement will contain provisions relating to the acceleration of maturity of a portion of the principal amount of the discounted securities upon the occurrence or continuance of an event of default. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Other than its duties in case of a default, a trustee is not obligated to exercise any of the rights or powers that it will have under the Indenture at the
request or direction of any holders, unless the holders offer the trustee reasonable security or indemnity. If they provide this reasonable security or indemnity, the holders of a majority in aggregate principal amount of any series of Debt
Securities may, subject to certain limitations, direct the time, method and place of conducting any proceeding for any remedy available to a trustee, or exercising any trust or power conferred upon a trustee, for any series of Debt Securities. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The Company will be required to furnish to the trustees a statement annually as to its compliance with all conditions and covenants under the Indenture and,
if the Company is not in compliance, the Company must specify any defaults. The Company will also be required to notify the trustees as soon as practicable upon becoming aware of any event of default. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">No holder of a Debt Security of any series will have any right to institute any proceeding with respect to the Indenture, or for the appointment of a receiver
or a trustee, or for any other remedy, unless: </P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">the holder has previously given to the trustees written notice of a continuing event of default with respect to
the Debt Securities of the affected series; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">the holders of at least 25% in principal amount of the outstanding Debt Securities of the series affected by an
event of default have made a written request, and the holders have offered reasonable indemnity, to the trustees to institute a proceeding as trustees; and </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">the trustees have failed to institute a proceeding, and have not received from the holders of a majority in
aggregate principal amount of the outstanding Debt Securities of the series affected (or in the case of bankruptcy, insolvency or reorganization, all series outstanding) by an event of default a direction inconsistent with the request, within 60
days after receipt of the holders&#146; notice, request and offer of indemnity. </P></TD></TR></TABLE> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">However, such above-mentioned limitations do not apply
to a suit instituted by the holder of a Debt Security for the enforcement of payment of the principal of or any premium, if any, or interest on such Debt Security on or after the applicable due date specified in such Debt Security. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I>Defeasance </I></B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">When the Company uses the term
&#147;defeasance&#148;, it means discharge from its obligations with respect to any Debt Securities of or within a series under the Indenture. Unless otherwise specified in the applicable Prospectus Supplement, if the Company deposits with a trustee
cash, government securities or a combination thereof sufficient to pay the principal, interest, if any, premium, if any, and any other sums due to the stated maturity date or a redemption date of the Debt Securities of a series, then at the
Company&#146;s option: </P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">the Company will be discharged from the obligations with respect to the Debt Securities of that series; or
</P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">the Company will no longer be under any obligation to comply with certain restrictive covenants under the
Indenture and certain events of default will no longer apply to the Company. </P></TD></TR></TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">22 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left" style="font-size:10pt;font-weight:bold"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">If this happens, the holders of the Debt Securities of the affected series will not be entitled to the
benefits of the Indenture except for registration of transfer and exchange of Debt Securities and the replacement of lost, stolen, destroyed or mutilated Debt Securities. These holders may look only to the deposited fund for payment on their Debt
Securities. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">To exercise the defeasance option, the Company must deliver to the trustees: </P>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">an opinion of counsel in the United States to the effect that the holders of the outstanding Debt Securities of
the affected series will not recognize income, gain or loss for U.S. federal income tax purposes as a result of a defeasance and will be subject to U.S. federal income tax on the same amounts, in the same manner and at the same times as would have
been the case if the defeasance had not occurred; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">an opinion of counsel in Canada or a ruling from the Canada Revenue Agency to the effect that the holders of the
outstanding Debt Securities of the affected series will not recognize income, gain or loss for Canadian federal, provincial or territorial income or other tax purposes as a result of a defeasance and will be subject to Canadian federal, provincial
or territorial income tax and other tax on the same amounts, in the same manner and at the same times as would have been the case had the defeasance not occurred; and </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">a certificate of one of the Company&#146;s officers and an opinion of counsel, each stating that all conditions
precedent provided for relating to defeasance have been complied with. </P></TD></TR></TABLE> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">If the Company is to be discharged from its obligations with
respect to the Debt Securities, and not just from the Company&#146;s covenants, the U.S. opinion must be based upon a ruling from or published by the United States Internal Revenue Service or a change in law to that effect. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">In addition to the delivery of the opinions described above, the following conditions must be met before the Company may exercise its defeasance option: </P>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">no event of default or event that, with the passing of time or the giving of notice, or both, shall constitute an
event of default shall have occurred and be continuing for the Debt Securities of the affected series; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">the Company is not an &#147;insolvent person&#148; within the meaning of applicable bankruptcy and insolvency
legislation; and </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">other customary conditions precedent are satisfied. </P></TD></TR></TABLE>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I>Modification and Waiver </I></B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Modifications and
amendments of the Indenture may be made by the Company and the trustees pursuant to one or more supplemental indentures (each, a &#147;<B>Supplemental Indenture</B>&#148;) with the consent of the holders of at least a majority in aggregate principal
amount of the outstanding Debt Securities of each series affected by the modification. However, without the consent of each holder affected, no such modification may: </P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">change the stated maturity of the principal of, premium, if any, or any instalment of interest, if any, on any
Debt Security; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">reduce the principal, premium, if any, or rate of interest, if any, or change any obligation of the Company to
pay any additional amounts; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">reduce the amount of principal of a debt security payable upon acceleration of its maturity or the amount
provable in bankruptcy; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">change the place or currency of any payment; </P></TD></TR></TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">23 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left" style="font-size:10pt;font-weight:bold"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">

<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">affect the holder&#146;s right to require the Company to repurchase the Debt Securities at the holder&#146;s
option; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">impair the right of the holders to institute a suit to enforce their rights to payment; </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">adversely affect any conversion or exchange right related to a series of Debt Securities; </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">reduce the percentage of Debt Securities required to modify the Indenture or to waive compliance with certain
provisions of the Indenture; or </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">reduce the percentage in principal amount of outstanding Debt Securities necessary to take certain actions.
</P></TD></TR></TABLE> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The holders of at least a majority in principal amount of outstanding Debt Securities of any series may on behalf of the holders of all
Debt Securities of that series waive, insofar as only that series is concerned, past defaults under the Indenture and compliance by the Company with certain restrictive provisions of the Indenture. However, these holders may not waive a default in
any payment of principal, premium, if any, or interest on any Debt Security or compliance with a provision that cannot be modified without the consent of each holder affected. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The Company may modify the Indenture pursuant to a Supplemental Indenture without the consent of any holders to: </P>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">evidence its successor under the Indenture; </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">add covenants of the Company or surrender any right or power of the Company for the benefit of holders;
</P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">add events of default; </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">provide for unregistered securities to become registered securities under the Indenture and make other such
changes to unregistered securities that in each case do not materially and adversely affect the interests of holders of outstanding Debt Securities; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">establish the forms of the Debt Securities; </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">appoint a successor trustee under the Indenture; </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">add provisions to permit or facilitate the defeasance and discharge of the Debt Securities as long as there is no
material adverse effect on the holders; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">cure any ambiguity, correct or supplement any defective or inconsistent provision or make any other provisions in
each case that would not materially and adversely affect the interests of holders of outstanding Debt Securities, if any; or </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">change or eliminate any provisions of the Indenture where such change takes effect when there are no Debt
Securities outstanding which are<B> </B>entitled to the benefit of those provisions under the Indenture. </P></TD></TR></TABLE> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I>Governing Law
</I></B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Unless otherwise provided for in the applicable Prospectus Supplement, the Indenture and the Debt Securities will be governed by and construed in
accordance with the laws of the State of New&nbsp;York. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I>The Trustee </I></B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The trustee under the Indenture or its affiliates may provide banking and other services to the Company in the ordinary course of their&nbsp;business. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">24 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left" style="font-size:10pt;font-weight:bold"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The Indenture will contain certain limitations on the rights of the trustee, as long as it or any of its
affiliates remains the Company&#146;s creditor, to obtain payment of claims in certain cases or to realize on certain property received on any claim as security or otherwise. The trustee and its affiliates will be permitted to engage in other
transactions with the Company. If the trustee or any affiliate acquires any conflicting interest and a default occurs with respect to the Debt Securities, the trustee must eliminate the conflict or&nbsp;resign. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I>Resignation and Removal of Trustee </I></B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">A trustee may
resign or be removed with respect to one or more series of the Debt Securities and a successor trustee may be appointed to act with respect to such series. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I>Consent to Jurisdiction and Service </I></B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">If the Debt
Securities are offered or sold in the United States or to a U.S. person, then, unless otherwise provided for in the applicable Prospectus Supplement for an offering of Debt Securities, under the Indenture, the Company will irrevocably appoint an
authorized agent upon which process may be served in any suit, action or proceeding arising out of or relating to the Offered Debt Securities or the Indenture that may be instituted in any United&nbsp;States federal or New&nbsp;York state court
located in The City of New&nbsp;York, and will submit to such <FONT STYLE="white-space:nowrap">non-exclusive</FONT> jurisdiction. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Units </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">We may issue Units comprised of one or more of the other Securities described in this Prospectus in any combination. Each Unit will be issued so that the
holder of the Unit is also the holder of each of the Securities included in the Unit. Thus, the holder of a Unit will have the rights and obligations of a holder of each included Security. The unit agreement, if any, under which a Unit is issued may
provide that the Securities included in the Unit may not be held or transferred separately, at any time or at any time before a specified date. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The
material terms and provisions of Units offered by any Prospectus Supplement, and the extent to which the general terms and provisions described below may apply thereto, will be described in the applicable Prospectus Supplement filed in respect of
such Units. This description will include, where applicable: </P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">the number of Units offered; </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">the price or prices, if any, at which the Units will be issued; </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">the currency at which the Units will be offered; </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">the Securities comprising the Units; </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">whether the Units will be issued with any other Securities and, if so, the amount and terms of these Securities;
</P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">any minimum or maximum subscription amount; </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">whether the Units and the Securities comprising the Units are to be issued in registered form, &#147;book-entry
only&#148; form, <FONT STYLE="white-space:nowrap">non-certificated</FONT> inventory system form, bearer form or in the form of temporary or permanent global securities and the basis of exchange, transfer and ownership thereof; </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">any material risk factors relating to such Units or the Securities comprising the Units; </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">any other rights, privileges, restrictions and conditions attaching to the Units or the Securities comprising the
Units; and </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">any other material terms or conditions of the Units or the Securities comprising the Units, including whether and
under what circumstances the Securities comprising the Units may be held or transferred separately. </P></TD></TR></TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">25 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left" style="font-size:10pt;font-weight:bold"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The terms and provisions of any Units offered under a Prospectus Supplement may differ from the terms
described above and may not be subject to or contain any or all of the terms described above. </P> <P STYLE="margin-top:24pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B><A NAME="toc850789_17"></A>RISK FACTORS
</B></P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Before making an investment decision to purchase any Securities, investors should carefully consider the information described in this Prospectus and
the documents incorporated or deemed incorporated by reference herein, including the applicable Prospectus Supplement. There are certain risks inherent in an investment in the Securities, including the factors described in the 2024 AIF, in the 2024
Annual MD&amp;A and Interim MD&amp;A and any other risk factors described herein or in a document incorporated or deemed incorporated by reference herein, which investors should carefully consider before investing. Additional risk factors relating
to a specific offering of Securities will be described in the applicable Prospectus Supplement. Some of the factors described herein, in the documents incorporated or deemed incorporated by reference herein, and/or the applicable Prospectus
Supplement are interrelated and, consequently, investors should treat such risk factors as a whole. If any of the adverse effects set out in the risk factors described herein, in the 2024 AIF, in the 2024 Annual MD&amp;A and Interim MD&amp;A, in
another document incorporated or deemed incorporated by reference herein or in the applicable Prospectus Supplement occur, it could have a material adverse effect on the business, financial condition and results of operations of the Company.
Additional risks and uncertainties of which the Company currently is unaware or that are unknown or that it currently deems to be immaterial could have a material adverse effect on the Company&#146;s business, financial condition and results of
operations. The Company cannot assure you that it will successfully address any or all of these risks. There is no assurance that any risk management steps taken will avoid future loss due to the occurrence of the adverse effects set out in the risk
factors herein, in the 2024 AIF, in the 2024 Annual MD&amp;A and Interim MD&amp;A, in the other documents incorporated or deemed incorporated by reference herein or in the applicable Prospectus Supplement or other unforeseen risks. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><U>Risks Related to our Common Shares </U></B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>The price
of our Common Shares historically has been volatile. This volatility may affect the price at which you could sell our Common Shares and the sale of substantial amounts of our Common Shares could adversely affect the price of our Common Shares.
</B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The market price for our Common Shares on the TSX (after giving effect to the Company&#146;s share consolidation on a 10 to 1 basis completed on
February&nbsp;20, 2024) has varied between a high of $12.65 on April 30, 2024 and a low of $3.91 on March 14, 2024 in the twelve-month period ending on February&nbsp;13, 2025, and on Nasdaq (after giving effect to the Company&#146;s share
consolidation on a 10 to 1 basis completed on February&nbsp;20, 2024) has varied between a high of U.S.$9.23 on April 30, 2024 and a low of U.S.$2.89 on March 14, 2024 in the same period. This volatility may affect the price at which you could sell
our Common Shares, and the sale of substantial amounts of our Common Shares could adversely affect the price of our Common Shares. Our share price is likely to continue to be volatile and subject to significant price and volume fluctuations in
response to market and other factors, including the other factors discussed in &#147;<I>Risks Related to our Business</I>&#148; variations in our quarterly operating results from our expectations or those of securities analysts or investors;
downward revisions in securities analysts&#146; estimates; and announcement by us or our competitors of significant acquisitions, strategic partnerships, joint ventures or capital commitments. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>We may not pay dividends in the future. </B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">We have not paid
dividends in the past and do not anticipate paying dividends in the near future. We expect to retain our earnings to finance further growth and, when appropriate, retire debt. Any decision to pay dividends on our Common Shares in the future will be
at the discretion of our board of directors (the &#147;<B>Board</B>&#148;) and will depend on, among other things, our results of operations, current and anticipated cash requirements and surplus, </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">26 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left" style="font-size:10pt;font-weight:bold"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
financial condition, any future contractual restrictions and financing agreement covenants, solvency tests imposed by corporate law and other factors that the Board may deem relevant. As a
result, investors may not receive any return on an investment in our Common Shares unless they are able to sell their shares for a price greater than that which such investors paid for them. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Future sales or issuances of equity securities could decrease the value of our Common Shares, dilute investors&#146; voting power and reduce our earnings
per share. </B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">We may sell additional equity securities in subsequent offerings (including through the sale of securities convertible into equity
securities and may issue equity securities in acquisitions). We cannot predict the size of future issuances of equity securities or the size and terms of future issuances of debt instruments or other securities convertible into equity securities or
the effect, if any, that future issuances and sales of our securities will have on the market price of our Common Shares. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Additional issuances of our
securities may involve the issuance of a significant number of Common Shares at prices less than the current market price for the Common Shares. Issuances of substantial numbers of Common Shares, or the perception that such issuances could occur,
may adversely affect prevailing market prices of our Common Shares. Any transaction involving the issuance of previously authorized but unissued Common Shares, or securities convertible into Common Shares, would result in dilution, possibly
substantial, to security holders. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Sales of substantial amounts of our securities by us or our existing shareholders, or the availability of such
securities for sale, could adversely affect the prevailing market prices for our securities and dilute investors&#146; earnings per share. Exercises of presently outstanding share options or warrants may also result in dilution to security holders.
A decline in the market prices of our securities could impair our ability to raise additional capital through the sale of securities should we desire to do so. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">As of February&nbsp;13, 2025, we had outstanding approximately 54,884,052 Common Shares and securities exercisable for and convertible into approximately
11,315,008 Common Shares (of which approximately 8,064,858 were exercisable as of that date). The sale or the availability for sale of a large number of our Common Shares in the public market could cause the price of our Common Shares to decline.
</P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>The regulated nature of our business may impede or discourage a takeover, which could reduce the market price of our Common Shares. </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">We require and hold various government licenses to operate our business, which would not necessarily continue to apply to an acquiror of our business following
a change of control. These licensing requirements could impede a merger, amalgamation, takeover or other business combination involving us or discourage a potential acquirer from making a tender offer for our Common Shares, which, under certain
circumstances, could reduce the market price of our Common Shares. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>There is no assurance we will continue to meet the listing standards of Nasdaq and
the TSX. </B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">We must meet continuing listing standards to maintain the listing of our Common Shares on Nasdaq and the TSX. If we fail to comply with
listing standards and Nasdaq and/or the TSX delists our Common Shares, we and our shareholders could face significant material adverse consequences, including: </P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">a limited availability of market quotations for our Common Shares; </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">reduced liquidity for our Common Shares; </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">a determination that our Common Shares are &#147;penny stock,&#148; which would require brokers trading in our
Common Shares to adhere to more stringent rules and possibly result in a reduced level of trading activity in the secondary trading market for our Common Shares; </P></TD></TR></TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">27 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left" style="font-size:10pt;font-weight:bold"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">

<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">a limited amount of news about us and analyst coverage of us; and </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">a decreased ability for us to issue additional equity securities or obtain additional equity or debt financing in
the future. </P></TD></TR></TABLE> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">As a public company, Aurora is subject to evolving corporate governance and public disclosure regulations that may from
time to time increase both our compliance costs and the risk of <FONT STYLE="white-space:nowrap">non-compliance,</FONT> which could adversely impact the price of our Common Shares. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><U>Risks Related to Future Offerings </U></B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>There is no
existing trading market for the Warrants, Options, Subscription Receipts, Debt Securities or Units. </B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">There is no existing trading market for the
Warrants, Subscription Receipts, Debt Securities or Units. As a result, there can be no assurance that a liquid market will develop or be maintained for those Securities, or that a purchaser will be able to sell any of those Securities at a
particular time (if at all). We may not list the Warrants, Options, Subscription Receipts, Debt Securities or Units on any Canadian or U.S. securities exchange. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Future Sales May Affect the Market Price of the Company&#146;s Common Shares. </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">In order to finance future operations, we may determine to raise funds through the issuance of additional Common Shares or the issuance of debt instruments or
other securities convertible into Common Shares. We cannot predict the size of future issuances of Common Shares or the issuance of debt instruments or other securities convertible into Common Shares or the dilutive effect, if any, that future
issuances and sales of our securities will have on the market price of our Common Shares. These sales may have an adverse impact on the market price of our Common Shares. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Our management will have substantial discretion concerning the use of proceeds. </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Our management will have substantial discretion concerning the use of proceeds of an offering under any Prospectus Supplement as well as the timing of the
expenditure of the proceeds thereof. As a result, investors will be relying on the judgment of management as to the specific application of the proceeds of any offering of Securities under any Prospectus Supplement. Management may use the net
proceeds of any offering of Securities under any Prospectus Supplement in ways that an investor may not consider desirable. The results and effectiveness of the application of the net proceeds are uncertain. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Negative Cash Flow from Operations </B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The Company had
negative operating cash flows for the fiscal year ended March&nbsp;31, 2024 and the third fiscal quarter ended December&nbsp;31, 2024. Although the Company anticipates it will be able to generate positive cash flow from operating activities in the
future, the Company cannot guarantee it will have positive cash flow from operating activities in any future period. To the extent that the Company has negative operating cash flow in any future period, certain of the proceeds from any offering may
be used to fund such negative cash flow from operating activities. See &#147;<I>Use of Proceeds</I>&#148;. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>The Company is a Canadian company and
shareholder protections differ from shareholder protections in the United States and elsewhere. </B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">We are organized and exist under the laws of British
Columbia, Canada and, accordingly, are governed by the <I>Business Corporations Act</I> (British Columbia) (the &#147;<B>BCBCA</B>&#148;). The BCBCA differs in certain material respects from laws generally applicable to United States corporations
and shareholders, including the provisions relating to interested directors, mergers and similar arrangements, takeovers, shareholders&#146; suits, indemnification of directors and inspection of corporation records. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">28 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left" style="font-size:10pt;font-weight:bold"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>The Company is a foreign private issuer within the meaning of the rules under the Exchange Act, and as
such is exempt from certain provisions applicable to United States domestic public companies. </B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Because we are a &#147;foreign private issuer&#148;
under the Exchange Act, we are exempt from certain provisions of the securities rules and regulations in the United States that are applicable to U.S. domestic issuers, including: </P>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">the requirement to file quarterly reports on Form <FONT STYLE="white-space:nowrap">10-Q</FONT> or current reports
on Form <FONT STYLE="white-space:nowrap">8-K</FONT> with the SEC; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">the requirements relating to the solicitation of proxies, consents or authorizations under the Exchange Act;
</P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">the requirement for insiders to file public reports of their equity ownership and trading activities and
liability for &#147;short swing&#148; profits under Section&nbsp;16 of the Exchange Act; and </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">the selective disclosure rules under Regulation FD. </P></TD></TR></TABLE>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Under MJDS, we are required to file an annual report on Form <FONT STYLE="white-space:nowrap">40-F</FONT> with the SEC at the time our annual information form
is filed in Canada. We do not intend to voluntarily file annual reports on Form <FONT STYLE="white-space:nowrap">10-K</FONT> and quarterly reports on Form <FONT STYLE="white-space:nowrap">10-Q</FONT> in lieu of Form
<FONT STYLE="white-space:nowrap">40-F</FONT> requirements. For so long as we choose to only comply with foreign private issuer requirements, the information we are required to file with or furnish to the SEC may be less extensive and less timely
compared to that required to be filed with the SEC by U.S. domestic issuers. As a result, you may not be afforded the same protections or information which would be made available to you if you were investing in a U.S. domestic issuer. </P>
<P STYLE="margin-top:24pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B><A NAME="toc850789_18"></A>CERTAIN INCOME TAX CONSIDERATIONS </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The applicable Prospectus Supplement will describe certain Canadian federal income tax consequences to investors described therein of acquiring Securities.
</P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The applicable Prospectus Supplement will also describe certain United States federal income tax consequences of the acquisition, ownership and
disposition of Securities by an initial investor who is a &#147;U.S. person&#148; (within the meaning of the United States Internal Revenue Code), if applicable, including, to the extent applicable, any such consequences relating to Securities
payable in a currency other than the United States dollar, issued at an original issue discount for United States federal income tax purposes or other special terms. </P>
<P STYLE="margin-top:24pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B><A NAME="toc850789_19"></A>AGENT FOR SERVICE OF PROCESS </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Miguel Martin, the Chief Executive Officer and a director of the Company, and Simona King, the Chief Financial Officer of the Company, reside outside of
Canada. Each of Miguel Martin and Simona King has appointed the Company, at its head office located at 2207 90B St. SW Edmonton, Alberta, Canada T6X 1V8 as their agent for service of process in Canada. Purchasers are advised that it may not be
possible for investors to enforce judgments obtained in Canada against any such person, even though they have each appointed an agent for service of process. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Investors are advised that it may not be possible for investors to enforce judgments obtained in Canada against any person who resides outside of Canada or a
company that is incorporated, continued or otherwise organized under the laws of a foreign jurisdiction, even if the party has appointed an agent for service of process. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">29 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left" style="font-size:10pt;font-weight:bold"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B><A NAME="toc850789_20"></A>INTERESTS OF EXPERTS </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The following persons or companies are named as having prepared or certified a report, valuation, statement or opinion in this Prospectus, either directly or
in a document incorporated herein by reference, and whose profession or business gives authority to the report, valuation, statement or opinion made by the expert. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">KPMG LLP, Chartered Professional Accountants, is the former auditor of the Company and the auditor of the Annual Financial Statements. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">KPMG LLP has confirmed that they are independent of the Company within the meaning of the relevant rules and related interpretations prescribed by the
relevant professional bodies in Canada and any applicable legislation or regulations and also that they are independent accountants with respect to the Company under all relevant U.S. professional and regulatory standards. </P>
<P STYLE="margin-top:24pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B><A NAME="toc850789_21"></A>LEGAL MATTERS </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Certain legal matters relating to the Securities offered by this Prospectus will be passed upon for us by (i)&nbsp;Stikeman Elliott LLP, Vancouver, B.C., with
respect to matters of Canadian law, and (ii)&nbsp;Paul, Weiss, Rifkind, Wharton&nbsp;&amp; Garrison LLP with respect to matters of United States law. As at the date of this Prospectus, the partners and associates of Stikeman Elliott LLP beneficially
own, directly and indirectly, less than 1% of any class of our issued and outstanding securities or securities of our affiliates or associates. </P>
<P STYLE="margin-top:24pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B><A NAME="toc850789_22"></A>AUDITORS, TRANSFER AGENT AND REGISTRAR </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Ernst&nbsp;&amp; Young LLP, Chartered Professional Accountants was appointed as the new auditor of the Company, effective June&nbsp;25, 2024. Ernst&nbsp;&amp;
Young LLP are the independent accountants of the Company within the meaning of the relevant rules and related interpretations prescribed by the relevant professional bodies in Canada and any applicable legislation or regulations and also are
independent accountants with respect to the Company under all relevant U.S. professional and regulatory standards. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The transfer agent and registrar for
the Common Shares of the Company is Computershare Trust Company of Canada at its principal office in Vancouver, British Columbia and Toronto, Ontario, and the United States <FONT STYLE="white-space:nowrap">co-transfer</FONT> agent for the Common
Shares is Computershare Trust Company, N.A., at its office in Canton, Massachusetts. </P> <P STYLE="margin-top:24pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B><A NAME="toc850789_23"></A>ADDITIONAL INFORMATION
</B></P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">We have or will file with the SEC a registration statement on Form <FONT STYLE="white-space:nowrap">F-10</FONT> under the U.S. Securities Act
relating to the offering of the Securities. The Prospectus, which constitutes part of the Registration Statement, does not contain all of the information set forth in the Registration Statement or the accompanying exhibits and schedules, as certain
items that are not included in the Prospectus are included in the Registration Statement in accordance with the rules and regulations of the SEC. For further information with respect to us and the Securities offered in the Prospectus, we refer you
to the Registration Statement and the accompanying exhibits and schedules. Statements contained in the Prospectus regarding the contents of any contract, agreement or any other document are summaries of the material terms of these contracts,
agreements or other documents. With respect to each of these contracts, agreements or other documents filed as an exhibit to the Registration Statement, reference is made to such exhibit for a more complete description of the matter involved. Such
contracts, agreements, or other documents are or will also be filed by the Company on SEDAR+ at www.sedarplus.ca in accordance with applicable Canadian securities laws. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">We are subject to the informational reporting requirements of the Exchange Act as the Common Shares are registered under Section&nbsp;12(b) of the Exchange
Act. Accordingly, we are required to publicly file reports and other information with the SEC. Under the MJDS, the Company is permitted to prepare such reports and other </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">30 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left" style="font-size:10pt;font-weight:bold"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
information in accordance with Canadian disclosure requirements, which are different from United States disclosure requirements. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">As a foreign private issuer, we are exempt from the rules under the Exchange Act prescribing the furnishing and content of proxy statements in connection with
meetings of its shareholders. In addition, the officers, directors and principal shareholders of the Company are exempt from the reporting and short-swing profit recovery rules contained in Section&nbsp;16 of the Exchange Act. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">We file annual reports on Form <FONT STYLE="white-space:nowrap">40-F</FONT> with the SEC under the MJDS, which annual reports include: </P>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">the annual information form; </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">management&#146;s annual discussion and analysis of financial condition and results of operations;
</P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">consolidated audited financial statements, which are prepared in accordance with IFRS, as issued by the IASB; and
</P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">other information specified by the Form <FONT STYLE="white-space:nowrap">40-F.</FONT> </P></TD></TR></TABLE>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">As a foreign private issuer, we are required to furnish the following types of information to the SEC under cover of Form
<FONT STYLE="white-space:nowrap">6-K:</FONT> </P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">material information that the Company otherwise makes publicly available in reports that the Company files with
securities regulatory authorities in Canada; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">material information that the Company files with, and which is made public by, the TSX and Nasdaq; and
</P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">material information that the Company distributes to its shareholders in Canada. </P></TD></TR></TABLE>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Investors may read and download the documents the Company has filed with the SEC&#146;s Electronic Data Gathering and Retrieval system
(&#147;<B>EDGAR</B>&#148;) website at www.sec.gov. Investors may read and download any public document that the Company has filed with the securities commissions or similar regulatory authorities in Canada at www.sedarplus.ca. </P>
<P STYLE="margin-top:24pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B><A NAME="toc850789_24"></A>DOCUMENTS FILED AS PART OF THE REGISTRATION STATEMENT </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The following documents have been or will be filed with the SEC as part of the Registration Statement of which this Prospectus forms a part: </P>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">(i)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">the documents set out under the heading &#147;<I>Documents Incorporated by Reference</I>&#148;;
</P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">(ii)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">the consents of the Company&#146;s former auditor and legal counsel; </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">(iii)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">the powers of attorney from the directors and certain officers of the Company; </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">(iv)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">the Indenture; and </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">(v)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">the statement of eligibility of Computershare Trust Company, N.A. on Form
<FONT STYLE="white-space:nowrap">T-1.</FONT> </P></TD></TR></TABLE> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">A copy of the form of any warrant indenture or subscription receipt agreement, as
applicable, will be filed by incorporation by reference to documents filed with, or furnished to, the SEC under the Exchange Act. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">31 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left" style="font-size:10pt;font-weight:bold"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B><A NAME="toc850789_25"></A>ENFORCEABILITY OF CIVIL LIABILITIES BY U.S. INVESTORS </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The Company is a corporation existing under the BCBCA. Other than Martin Miguel and Simona King, all of our directors and officers, and all of the experts
named in the Prospectus, are residents of Canada or otherwise reside outside the United States, and all or a substantial portion of their assets, and a majority of our assets, are located outside the United States. We have appointed an agent for
service of process in the United States, but it may be difficult for holders of the Securities who reside in the United States to effect service within the United States upon those directors, officers and experts who are not residents of the United
States. It may also be difficult for holders of the Securities who reside in the United States to realize upon judgments of courts of the United States predicated upon the Company&#146;s civil liability and the civil liability of its directors,
officers and experts under the United States federal securities laws. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">We have been advised by our Canadian legal counsel, Stikeman Elliott LLP, that a
judgment of a United States court predicated solely upon civil liability under United States federal securities laws would probably be enforceable in Canada if the United States court in which the judgment was obtained has a basis for jurisdiction
in the matter that would be recognized by a Canadian court for the same purposes. We have also been advised by Stikeman Elliott LLP, however, that there is substantial doubt whether an action could be brought in Canada in the first instance on the
basis of liability predicated solely upon United States federal securities laws. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">We have or will file with the SEC, concurrently with our Registration
Statement on Form <FONT STYLE="white-space:nowrap">F-10,</FONT> an appointment of agent for service of process on Form <FONT STYLE="white-space:nowrap">F-X.</FONT> Under the Form <FONT STYLE="white-space:nowrap">F-X,</FONT> we will appoint
Corporation Service Company as our agent for service of process in the United States in connection with any investigation or administrative proceeding conducted by the SEC, and any civil suit or action brought against or involving the Company in a
United States court arising out of, related to, or concerning the offering of the Securities under the Prospectus. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">32 </P>

</DIV></Center>

</BODY></HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>2
<FILENAME>g850789g81j29.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 g850789g81j29.jpg
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M<X*3H=$C-%)R=9*BLS-68L$D0V7"X?##)F.#T_'_Q  : 0$  @,!
M         0($!08#_\0 .1$!  $$  (&" 4# P4       $" P01!2$2%#%!
M47$3%31288&1H2(S4\'P0I*Q,M'A%B-B<O'_V@ , P$  A$#$0 _ +4@
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M$@
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M@ */0
M                                        !JVDB[=;,-RLC=E/5+O+
M.5$7W2^+9X4.MHSM4,.%->5C)%KE<Z1')FBM]RC5\2^,TC2;=NN.(GP1NS@H
MTWI.17?&7Q[/ ="Q8LNEEHY:6DE:L+D75;(W6WM5XV_^Y&\HPJYQ8IHY3,[E
MS%SB-NG.FNY&Z:8U'[_ND:UX)H+5B!]T9.G4L2*YD+D_PG<:J[/@1/\ W8=V
M''%AD@FEZLU$B7+5>U4<[G:G&0PRY5K(ZEC*J9&5/^,B/7*3IY3JGM/#IN3N
M]7N>YX1QB+,:Q[<4Q.YGOYLS77K/%,MWH(UA_3[ZQJ_[]/'TDZ6RMBN-OIZN
MG7.*9B/3FYO 5R).T1WG6CGM,SMK?TL.?)\9/,OA4KQ+&B;45T_T_P"%N#9D
MTWYHK_K_ ,I(-*TN>]B+OIGHO-U-*TN>]B+OIGHO-3A?GT>;?\1]EN>2'@ =
M8X-N6B;WTKWN_P [29"&]$WOI7O=_G:3(<WQ3\_Y0['@?LOSD(8TF7IUROKZ
M6-^=-1JL:(B[%?\ &7_;P$RR.U(WN1,U1%4K;*]TLKY'KF]ZJY5Y54]>$VHJ
MKJKGN_=X<>O31;IM1_5^SY !OW*LY@R]/LE\@GUEZG>N]S)RL7C\'"3TBHJ9
MIM0@B_89FL]IH*V>H8Y:M$7>D:J*S-,_"3)AB9T^';9+)GKNIXU55XUU4VF@
MXG%%<4WJ/)U/!)N6YKQ[D=FI^K)@ U#H
M
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MJ:KMZ=UU=OP^  ##;
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MKD1=J9+Q[2ES O6Z9KJCE#UL\5QKU<6Z9YS\&Z  PFQ
M
M             !I.EWWLP=],]%Y#Y,&EWWLP]],]%Y#YTO"_R/G+C>-^U3Y0
M  V+4                      ;CHH]]7_X'_[&G&Y:)T_^JNB!_G0QLS\B
MOR9G#_:;?G"9  <D[T
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MVVQK(ZWP:DDB9.>YRN<J<F:\1E@5JR+M<=&JJ9CS7HQ+%NKI441$^0 #Q9
M
M                             !\2RQPM1TTC(VJJ(BN5$3/D/LP6+\.L
MQ%0,@=4/@DB<KV*FUN>66U.,O;BFJJ(KG4/.[5731,T1N?!EJ^DAKZ*:EJ6Z
M\,K5:Y.8C7!]1486Q9-8JS6=3U#T1BY;-9?<N3I38O\ X/NVU6*<+U\%#54[
MZ^CD>C(\E5R?9=PIT*9S'.**6QSL;3T\,]V5F37N:B[TU>5>';R?^KL+=JNC
M=F/Q4U1RU_GX-3=OV[L1D5;HJHGGN/'N^.WUI*LM=>;?1QVV%)GQRJYS==&Y
M(J<.U4,Y)4I9<-I/5-5>I*=NLUNW-41$R\9"U9BF]U<JODN=2W/BB>L:)X&Y
M'>L^-KQ02(D]0M;3KL=%4+K9I^]PH9%7#[WHZ:)F)B/YVL2CBV/%ZNY$3$U<
MM\IUKX?\MBT?6V:^7NHQ#<TUD:]=Z1>!7\W,U.#_ ,$DSSQ4[->>5D3,\M9[
MD:F?A-:?B%B806Y8?HFRZO:]3M3+>ESVYM3DSXN7,UBCPQ?<4U#:S$53)3T_
M"V-4R=E_I;P-Z5V])C7*/3U3<NST:8Y:[^7=IF6;G5:(M6*9KJJYS/=S[YE*
M!I6ESWL1=],]%YN--"VGIXH6*Y6QM1B*Y<U5$3+:IIVESWL1=],]%YCX?Y]/
MFR^(>RU[\$/  ZQPC<M$WOI7O=_G:3(0WHF]]*][O\[29#F^*?G_ "AV/ _9
M?G(=6Y7"EMM(ZIKIF0PMX7.XUY$3C4[$CV1L5\CFL8FU7.7)$(JN*R8UQPM"
MV=>MU,JHBL7--5ONG)SJNS/H,;&L1=F9JG5,<Y9F9E38IB*(W55.HC^=S,56
MDV@9*K::BJ)F)\9SD9GX-IF,/XVM5XF; CGTU2[8V.;)$<O(B\!E[?9K=04Z
M0TE% QB)DO:(JKTJNU34\?X2I);;/<;="RGJJ=N^.;&FJU[4X=B<:<.9[T]5
MNST(IFG??O\ RQ:^O6:?2S5%6NV-:^DM\!$5FO.,+Y D5KES93-1KI$1J:W)
MFYW"IL6#,4U\UW?9;_'JUK<T8_51JJJ)FJ*B;.#:BH5N8%=N)G<3,=L1/-Z6
M>*6KLTQT9B*NR9CE,^#>P 8+9
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M9\(T^P 8C/
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M
M                                 !$1J9-1$3D0 #!XLP[%B*DA@EG?
M!O3]='-:BY[,LC+T<#:6DAIV*JMB8UB*O"J(F1R@O-RJ:8HF>4/.+5%-<W(C
MG/:9)GGEM !1Z!JFDNWU-QPTK*.)TLD4K958U,U5$147)./A-K!Z6KDVJXKC
MN>5^U%ZW5;GO5RZWUGS2H^[=^0ZWUGS2H^[=^18T&U]<3[GW:+_I^G]3[?\
M**M%-IK8[U+634\L5.R%S-9[5;K.54V)GP\!*H!KLG(G(KZ<QIN,/%C$M>CI
MG8 #'90
M
M
M
M
M
M
M                 *J(BJJY(G&1M-IPT?Q3/C=?D5S'*U5;2S.1<N14;DJ
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M34SX,\DV9Y*8LM'N.>X>)>^8?1<! W8ZQE_E:]>1R?D.QUC+_*UZ\CD_(O\
M@(V\[+OAJ^6:/?+O9KC0QYY:]13/C;XU3(Q)Z35$,51!)#41LEAD:K7L>U'-
M<B\**B\*%%=.&&:7"FDBZ6^W,WNA?J5$$?[#7MS5J<R+FB<V03$M#  ':M5=
M-;+G25U*[5GI9F31KR.:J*GXH>C%!4LK:&GJH?\ #GC;*WH<F:><\W3T&T;2
M.ET>88>_W3K93*OW30B6Q@ (0+NM\2/H<+VVPT[U:ZY2K+-DO#''DJ(O2Y6K
M]DJ@3?NN*ETND6@@5>TAMK,DYW22*J^;Q$(!:   #)VC#]XO.?6BTU]<B+DJ
MTU.^1$Z51"9]S9HNH<2MGQ'B*!*B@IY=YIJ9_N)7HB*YSDXVIFB9<"KGGP;;
M5T\$5- R&GB9%"Q-5K(VHUK4Y$1. (VH._1KC1C-=V%KQJ\U*]5\61KMRME?
M:YMYN=%54<W[%1$Z-WB5$/1XZ-YM%OO=!)17>B@K*61,G13,1R=.W@7G3:#;
MSD!)&G;1]'@+%;(J!7NM-<Q9J777-69+DZ-5X\MFWD5.,C<)  !>G0-B1^)M
M&5JJ:AZOJZ9%HYW+M571[$5>=6ZJ^$D K_N/*E[\+X@IE7M(ZQDB=+F9+Z"%
M@ J$9;I/X';Y^]!_>82:1END_@=OG[T']Y@(4C  6#MVJV5UWK64=JHZBLJG
MHJMA@C5[U1.'8FTZA,NY/^%&3^'S>DP#1.QUC+_*UZ\CD_(=CK&7^5KUY')^
M1?\  1MYZW#!>)[="Z:NP[=Z>%J9NDDHY$:G2N62& /2DJ?NK\)4%FOEKO-L
M@CI^N22-J&1MU6K(S577RY51VW]W/C!$H&  2%Z] ]W?>M%.'ZB5VM+%"M,_
M/A_1N5B?TM1?"44+C;E&1S]%KFKP1U\S4Z,F+_N$2F, !   !6C=@8ASDLF'
M8G^Y1U=.W/I8S_Y/&67*$Z8L0^R;2/?+@Q^O3I.L$"\6]Q]HU4Z<L_"$PTP
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MT3H;I61/3)S)GM7I1RH=4+!D,.]W[9WU%Z:&//N&5\$T<L3M61CD<U>147-
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M,'"B+R*Y<E5.1&\>8$U@ *A73=C]S,+_ %U1YF%BRNF['[F87^NJ/,P$*P@
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MHDUU75SU43)$1$[9>+C"-MO  0
M
8                            #__9

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>3
<FILENAME>g937513g49a27.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 g937513g49a27.jpg
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MHK&ST=-3@L'#TB,D,U9BDN(U0V/"A.'P@__$ !L! 0$  @,!
M   ! @4#! 8'_\0 .A$!  $# 0,(" 8" 04       $" P01%2$Q!1)!4F%Q
MD;$3,S11<J'!T084(C*!X5/P%B-"8I+Q_]H # ,!  (1 Q$ /P"U(
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M5%V'L.O53-,Z2[=-45Q%5/"0 $9
M
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M.UJRERCD5=]R>Y=]7A0UG*N+I_UZ?Y^[=<@YVL?EJ_X^S;  :1Z8
M
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M >9>U
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MHT54]<^1?7/=QJ90'7OY=5ZF*(C2F.B';Q<"C'JFY,S57/3( #J.^
M
M                        :Y?L9VBR5BTE7)*^H1$5S(F:VKGO9FQE?\?=
MV%U^5_@AW^3\:C(N337PB&KY6S:\.U%5OC,Z;TE^J78N*L\4GYCU2[%Q5GBD
M_,A0&WV38[?%Y[;V5V>":_5+L7%6>*3\QZI=BXJSQ2?F0H!LFQV^)M[*[/!-
M?JEV+BK/%)^8]4NQ<59XI/S(4 V38[?$V]E=G@FOU2[%Q5GBD_,_':3+$C55
M&UBKQ=23;]9"H&R;';XFWLKL\&1Q#<EN]ZJZ]6=3ZL_-&YYY(B9)]2(8X V5
M-,4Q%,<(:>NN:ZIJJXR$DX&QW0VFQQ6^Y13HL*NU'QM1R.155=NW8N:D; XK
M^/1D4\RO@Y\7+N8E?I+?'@FOU2[%Q5GBD_,>J78N*L\4GYD* Z6R;';XMCM[
M*[/!-?JEV+BK/%)^8]4NQ<59XI/S(4 V38[?$V]E=G@FOU2[%Q5GBD_,>J78
MN*L\4GYD* ;)L=OB;>RNSP37ZI=BXJSQ2?F$TE6%51%Z[3E6+_[(4 V38[?$
MV]E=GA_:S-#5P5U)%54DB2P2MUF/3A0^YJNB[N*H?C2>>XVH\[>HBW<JHCHE
MZ_'N3=M4W)Z8B0 '&Y@
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MUMH8W7\W<V1F=3YQ]T< D?U*JSOG3^+4>I56=\Z?Q:C:&-U_,V1F=3YQ]T<
MD?U*JSOG3^+4>I56=\Z?Q:C:&-U_,V1F=3YQ]T< D?U*JSOG3^+4_4T55>>V
MYP9?)J-H8W7\S9&9U/G'W;=HN[BJ'XTGGN-J,?AZU166STU! Y7MA1<WKL5R
MJJJJ^%3('F+]<5W:JHX3,O;8MN;5BBBKC$1'R  <3G
M
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M.1%:J*B[45 8.0
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M;EO2J>;$Z=S<6;T541SYCG=._I>T '$YP
M
M Q6);'3X@MO655)+&S721'1JF>:9\:<IE094531,54\885T4W*9HJC6)1_ZE
MMK^&UOA9_2>;2?:4H<'6R&F5[X*.1(U5VU<E:J9KT_>?;%&.JIMQEM.'Z.22
MM:]8G2.9FJ.38NJWAYU\![<+X=NDMLN,>*:IT[*YJ9P.?KK&OOL]Y%WMB;-B
M&UBN];YMZ_5PWQ'3+13:QKO/Q\6C?,:3,<(_V4*@S^(L+UUFD<_5ZYH57M*J
M+MF*G+EO*8%$55R1,U-_1<IN1SJ9UAY2Y:KM5<RN-)?A-5JPO%>, VB@N#YH
MM1$J$6-4145=943:B\#C2L%X+GKZR"HN[.M:'6S:R7M7SKOZJ(NW+E\!MN,[
M;B6GNWHM8JJ22!C&M2EC]PB)M34WG(J[>/P&KS;]-RNFU17$3&_7M]S><FXU
M5FW7?NVYJB=VG3IQF='\^I;:_AM;X6?TF\6ZD904%-20JY8X(VQ-5V^J(F29
M^ U3!&-%OM2Z@K:1T%>QJN<K$747+?SSVM7D-S-1E5W]>9?G@]!@V\7F^EQH
MTU0'I&[M+G\=OF--;-DTC=VES^.WS&FMGJ,;U-'='D\1F>T7/BGSD)ZT:=Q-
MLYI/Q'$"D]:-.XFV<TGXCC7\L>ICO^DMK^'O::OA^L-0Q<Q+MI0H;?5;:9G4
MVZJ[RIEK+X=XE1K4:U&M1$:B9(B;R$=:3[15PUM+B&V-59*;5ZKJIFK=5<VN
MRXN!>@R]BQ_9[A3,6LG;15*)V[)<]7/D=O9&NOT57K-NJW&L1&D]DMQBW:,?
M)NT7ITFJ=8F>F.CP9JZ76T-;445=<J2%[F*R1CIFM<B*G$J[-BD?^E'!W^8T
M\IB_(]MYM6#;M<IZZ>]HR69<W(R=F6>67"BGB]+."._SO*&?TG-8IIM4_IJJ
MB9X[G!E557ZOUT451'#6KH/2C@[_ #(GE,7Y#THX._S(GE,7Y#TLX([_ #O*
M&?TCTLX([_.\H9_2<WI9Z]?@ZOH(_P 5O_V/2C@[_,B>4Q?D9ZS:/;31UM)<
M*:LJYNI.;-'F]JM=PHNQ-J'AMV ,-7&)TE!<:FHC:NJYT<S%R7B]:;]04L=#
M0T])!GU*"-L;<US7)$R3,ZF3E51'-HN3/OUC1W\/!HJGG7+5,1T3$ZON #6-
MV
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M7+(RP!UZZZJYYU4ZR[5NW3;IBBB-(@ !BS
M
M               &*N^';5=Y6RW&BCFD:F2/S5JY<6:*F9C_ $BX<[V,\:_^
MHV4'+3?NTQI35,1WN"K%L5SSJJ(F>Z&MMP/AQKD5+8S--NV1Z_Q-BBC9#$R.
M)C61L1&M:U,D1$X$0_H&-=VNO]\S/>RMV+=KU=,1W1H  P<H
M
M
M
M
M
M
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MY[CHJ<ZL4]TUW^>3>>X+#%@ *R&'.Z"V?.HO/0Z,G.;#G=!;/G47GH=&0D@
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M;F))2O<N:N@SR5O[JJG0Y$X"J!O^@6[.L^E?#\C79,J)^M'I[Y)$5B?6K5Z
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M<W6B6I;-*G K(^W<B\Z-RZ2TNZ6L?HQHKKY6-UIK=(RL9QY(NJ[[+G+T 4I
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MW+FKE7-57C/Y#(,Q@UR,Q=8WNWFUT"KXQIAS9=&=N?==(.':.-JN62NA5V7
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M:T,U0YL*_P#B;VK/LM0N7IHQ!Z6M&E\KF/U:A\/6T&6_KR=HBIS9J[H*&!8
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MXEM,;$S<^KA:B<JO0Z+%%-!%D??=*=BB1NM%33)62KP(V/MDSYW(U.DO6$D
M 163=D^S,*?)U/WQE<2QV[)]F84^3J?OC*XAE   -SP5HSQ1C.WS5V'Z!D])
M%)U%TCYF1IKY(JHFLJ9[%3PFP>H'C_O53^61?U$U[DCVLZSZ3E_#B)K":J'X
MNT4XOPG:'72\VQL="QR,?)',R345=B9HU55$SV9\QHQT?NMOI;K;:J@N$+9Z
M2IC=%+&[><U4R4H;I1P758%Q;56JHUGT_P#BTLRI_BQ*JY+SIO+RHH6):D
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MY&2JY=D,F\V3D3@7DV\!=%%S3--J'-8MWN9M(GIBL7I=NLVM=;=&G47/7;/
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M.^%\\=%^F #5)6C_  9;,"V%;39G5#X%E=.Y]0]'/<]41%5<D1-YJ)L3@-D
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6[&23,U5<U<TSR8BY9IP*@ $Q  #_V0$!

end
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
